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ABSTRACT 
Multilocus Sequence-Typing (MLST) is a phylogenetic technique based on the 
detection of differences in multiple conserved housekeeping genes. Together with 
powerful evaluation software, MLST provides an extensive classification scheme for 
highly diverse species. However, despite the increasing use of MLST as a trusted 
epidemiological tool, the population structure of UPEC has been poorly studied using 
this technique, as most of the previous studies conducted have been limited either by 
bias towards certain characteristics, such as antimicrobial resistance and serogroup, or 
included a limited number of strains. Such studies can give a false impression of the 
population structure due to overrepresentation of certain Sequence types (STs). 
 
In this thesis, MLST was applied to 300 E. coli isolates collected from in the North 
West of England between June 2007 and June 2009. Firstly, the prevalence, diversity, 
epidemiological relationships and phylogenetic origins of the identified STs were 
determined. Secondly, possible associations of key UPEC STs with other genotypic and 
phenotypic profiles were assessed. Thirdly, as ST131 was recently reported as one of 
the most successful UPEC clones, an extensive examination of isolates of this clone 
was carried out involving identification of multiple drug resistant subclones and 
attempts were made to recognise putative predictor markers for identification of the 
ST131 clone. 
 
MLST analysis of the studied population revealed a consistent profile of STs that 
occurred repeatedly in the collection. It consisted primarily of ST73 (16%) followed by 
ST131 (13.3%), ST69 (9%), ST95 (6.3%), ST10 (4.3%), ST127 (3.6%), ST14 (2.6%) 
and ST405 (1.6%) some of the STs (ST127 and ST80) in the panel have never been 
reported as remarkable uropathogens. 
 
The broad range of virulence factor (VF) genes screened here allowed the recognition 
of VF patterns significantly associated with different STs. Most notably, ST127, which, 
based on phylogenetic analysis, appears to be a newly evolved clone, gave the highest 
virulence score. This virulent genotype may permit survival of ST127 isolates in the 
population long enough for them to gain antibiotic resistance. In contrast, multidrug 
resistant isolates of the ST131 clone were defined by a low virulence score and 
distinctive VF profiles. 
 
Metabolic reactions have been conventionally used for the classification of bacteria into 
families and species. Interestingly, in the assessment of the metabolic activity of 
different STs, members of the ST131 clone showed a high metabolic capacity 
compared to those of other STs, which may compensate for the low virulence capacity 
and explain the virulence reported for members of this ST. In contrast, ST127 showed 
the lowest metabolic capacity, even though it held the highest VF-score among the 
commonly detected STs.  
 
Multivariate logistic regression analysis demonstrated that ST131 is best described by 
its fluoroquinolone resistance and possession of PAI, the ibeA gene and expression of 
DR antigen-specific adhesins, whereas the O25b-CTX-M-15 ST131 sub-clone was 
only differentiated from the rest of the ST131 clone members by the production of 
Extended spectrum Beta-lactamase (ESBL) enzymes. 
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1. Introduction 
Since it was discovered in 1885, Escherichia coli has been subjected to comprehensive 
studies and become one of the best understood and characterized organisms (Kuhnert, 
Boerlin & Frey 2000; Weintraub 2007). 
Despite the vast knowledge accumulated throughout the last decades, E. coli is still one 
of the major causes of infection in humans. In addition to urinary tract infection (UTI), 
where it is responsible for most of the reported cases and gastrointestinal disease, E. 
coli has been associated with a number of other diseases including pneumonia and 
meningitis (Kaper, Nataro & Mobley 2004; Kuhnert et al. 2000). 
Emergence of pathogenic E. coli strains has frequently been reported worldwide. 
Sporadic outbreaks caused by E. coli O157:H7 are increasingly being reported 
worldwide (Duffell et al. 2003) and in the United States it causes 73,000 enteric related 
illnesses with 2,168 hospitalizations and 61 deaths annually (Rangel et al. 2005).  
Recently, a new class of Extended Spectrum Beta-Lactamase producing strain (called 
CTX-M producing E. coli) has emerged and spread globally and is most often seen in 
urinary tract infections (Lavigne et al. 2007; Mugnaioli et al. 2006; Woodford et al. 
2007).  
Certain multidrug-resistant, uropathogenic lineages of E. coli have been associated with 
outbreaks such as the one reported between 1987-1988 in south London where E. coli 
O15:K52:H1 caused community acquired cystitis, pyelonephritis and septicaemia 
(Manges et al. 2001).  
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1.1. Escherichia coli  
Escherichia coli is  a very diverse species of bacteria that forms a major part of the 
normal intestinal flora of humans and other mammals. Because of its wide distribution 
in the environment E. coli is able to colonise the intestines shortly after birth following 
the ingestion of contaminated food or water and is known to have a principle role in 
maintaining healthy guts (Kaper et al. 2004; Weintraub 2007).  
1.2. Growth characteristics 
E. coli is gram negative facultative anaerobic, motile bacteria, a taxonomically well 
defined member of the family Enterobacteriaceae.  Its capability to grow in 
temperatures ranging from 7°C to 50°C and tolerate acidic condition down to pH 4.4 is 
reflected in its ability to survive various environmental conditions and it can be 
detected contaminating different surfaces from hands and clothes to soil and 
underground water (Kaper et al. 2004; Kramer, Schwebke & Kampf 2006; Kuhnert et 
al. 2000). It can be recovered easily from clinical specimens using simple culture media 
incubated at 37
o
C either in the presence or absence of oxygen (Garrity 2005; Weintraub 
2007).  
1.3. Pathotypes of Escherichia coli 
Strains constituting the species E. coli are of a broad variety ranging between non-
pathogenic commensals that commonly inhabit the gastrointestinal tract of humans and 
other mammals and major pathogenic strains that may cause serious diseases. 
According to its capability of causing disease, pathogenic E. coli are broadly classified 
into two major categories, enteric E. coli (EC) that mainly cause infections limited to 
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the mucous lining of the intestines and extra intestinal pathogens (ExPEC), which have 
the capability to spread from the intestine and to cause infections in other parts of the 
body (Kuhnert et al. 2000; Marrs, Zhang & Foxman 2005; Xie et al. 2006).  
On the basis of their pathogenic features the enteric pathogenic E. coli are further 
differentiated into  six pathotypes: enteropathogenic E. coli (EPEC); enterohemorrhagic 
E. coli (EHEC); enterotoxigenic E. coli (ETEC); enteroinvassive E. coli (EIEC); 
enteroaggregative E. coli (EAEC); and diffusely adherent E. coli (DAEC) (Kaper et al. 
2004; Weintraub 2007). 
1.3.1. Extra intestinal pathogenic Escherichia coli 
Compared to enteric E. coli, ExPEC has not yet been well categorized. According to 
the type of disease they cause, the ExPEC are differentiated into: Uropathogenic E. coli 
(UPEC); Sepsis-associated E. coli (SEPEC); and Neonatal meningitis associated E .coli 
(NMEC) (Johnson et al. 2003a; Johnson & Russo 2005; Kuhnert et al. 2000). 
 However, E. coli is known to cause infections in other anatomical sites. It has been 
recently suggested that the use of an inclusive term, such as ExPEC, rather than the 
restrictive terms such as UPEC , SEPEC and NMEC, would be useful to reflect their 
broad infectious abilities (Johnson et al. 2003a; Johnson & Russo 2002). 
1.4. Escherichia coli as an uropathogen 
E. coli is the commonest pathogen to cause UTI, accounting for as much as 90% of all 
UTIs seen among non-hospitalized patients and up to 50% of all nosocomial UTI 
(Srinivasan, Foxman & Marrs 2003; Tartof et al. 2005). Due to anatomical differences 
(i.e. the shorter female urethra), UTIs are more common among women than men with 
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almost all women experiencing at least one UTI in their lifetime (Moore, Day & Albers 
2002; Tartof et al. 2005). UPEC are responsible for 85-95% of uncomplicated cystitis 
in premenopausal women, the estimated number of cases being 130-175 million/year 
worldwide. In addition, UPEC cause 90% of uncomplicated pyelonephritis (5.4 million 
cases/year worldwide) (Russo & Johnson 2003). 
1.4.1. Clinical aspects and pathogenesis 
UPEC are associated with asymptomatic bacteriuria and uncomplicated cystitis as well 
as severe pyelonephritis.  Infection usually occurs following the movement of UPEC 
from the intestinal tract and, in some cases, the vagina where it persists as a component 
of the normal flora, to the periurethral area (Kuhnert et al. 2000; Xie et al. 2006). These 
movements occur as a result of a complex combination of host behaviours, host 
susceptibility and certain abilities possessed by UPEC that have yet to be fully 
understood (Xie et al. 2006).  From the periurethral area the bacteria ascend the urethra 
and colonize the bladder resulting in cystitis. Some strains may be able to invade the 
lining epithelial cells and multiply intracellularly, forming bacterial inclusions that may 
play an important role in recurrent UTIs (Schilling & Hultgren 2002). However from 
the bladder UPEC may spread to the kidneys and cause pyelonephritis and other serious 
complications may occur when the bacteria invade the blood stream resulting in 
systemic infection (Kaper et al. 2004).  
Clinically, a total count of >10
5
 CFU/ml of UPEC in midstream urine is considered as 
indicative of bacteriuria, however, in women a count of less than 10
5
 CFU/ml appear to 
be associated with UTIs (Lloyd, Rasko & Mobley 2007). The clinical features vary 
considerably and depend in part on the age and the gender of the patient and other 
underlying clinical conditions. Disease ranges from painful urination in uncomplicated 
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urethritis or cystitis to severe systemic illness associated with abdominal or back pain, 
fever, sepsis and decreased kidney function in some cases of pyelonephritis (Naber et 
al. 2001).  
Generally the ability of UPEC to move from the intestinal tract, colonize and cause 
infection in the urinary tract has resulted from a cumulative action of several specific 
virulence factors. The virulence factors include determinants that aid resistance to host 
defences, mediate adhesion, increase iron acquisition or paralyse ureteric peristalsis 
(Johnson 1991). Table 1.1 shows different types of virulence factors associated with 
different types of UTIs.  
Simultaneous expression of multiple virulence factors appears to be more common 
among UPEC than faecal isolates and it is more common among UPEC isolated from 
upper UTI than isolates from lower UTI, suggesting synergistic activity of the virulence 
factors to overcome host defence and establish an infection (Johnson 1991; Yamamoto 
2007).  
Moreover, in a comparative genomic hybridization analysis of a set of UPEC and 
faecal / commensal E. coli isolates against a pyelonephritogenic E. coli strain (CFT073) 
using microarray, Lloyd and his colleagues were able to delineate 13 genomic islands 
of which 10 were previously unrecognized islands. The authors also identified 131 
genes exclusively found in UPEC isolates, many of which are of hypothetical function 
and may play important role in pathogenesis of UTI (Lloyd et al. 2007).  
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Table 1.1 Summary of extra intestinal virulence factors and their association with UPEC 
Factor activity Epidemiology Remarks 
 
          P fimbriae  
 
 
 
 
 
         X adhesins 
                 Dr. family 
 
 
              
                
                 S fimbriae 
 
 
 
 
 
                  F1C 
 
 
 
        Type 1 fimbriae 
 
Adhesion 
 
 
 
 
 
 
Adhesion 
 
 
 
 
Adhesion 
 
 
 
 
 
Adhesion 
 
 
 
Adhesion 
 
70%, 36%, 24% and 19% of isolates from 
pyelonephritis, cystitis, asymptomatic bacteriuria 
and faeces of healthy individuals, respectively. 
 
 
 
 
Up to 50%, 26%, 6% and 18% associated with 
isolates isolated from cystitis, pyelonephritis, 
asymptomatic bacteriuria and faecal isolates 
respectively. 
 
Mainly associated with meningitis and 
bacteraemia  
 
 
 
 
- 
 
 
 
Present in almost all E. coli isolates. 
 
Prevalence of P fimbriae among 
isolates from bacteraemia arising 
from UTI is as high as 71%, 
suggesting strong correlation of P 
fimbriae with the ability of UPEC 
to cause severe infections. 
 
 
 
 
 
 
Binding sites for S fimbriae are 
found on the epithelial cells of the 
proximal and distal tubules, 
collecting ducts and glomerulae 
and in the renal interstitium. 
 
Binding site found on some renal 
tissue. Its role in facilitating UTI 
still unknown. 
 
Binding sites are found on several 
cells including buccal, intestinal, 
vaginal epithelial cells suggesting 
a role in the colonization of 
mouth, gut and vagina. 
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Summarized from: (Guyer et al. 2002; Johnson 1991; Kaper et al. 2004; Mills, Meysick & O'Brien 2000)
Continued.  
Factor activity Epidemiology remarks 
 Siderophores 
       Aerobactin  
 
Iron acquisition 
 
73%, 49%, 58%, 41% and 38% of isolates from 
pyelonephritis, cystitis, bacteraemia, asymptomatic 
bacteriuria and faecal isolates, respectively. 
 
Proposed association with E. coli 
causing serious and complicated 
UTI, as it promotes bacterial growth 
in conditions limited in iron 
concentration. 
Toxins  
     Haemolysin (HlyA) 
 
 
 
  
   Cytotoxic necrotizing factor 1    
   (CNF1) 
    
 
   Secreted autotransporter toxin (Sat) 
 
Lysis of 
erythrocytes and 
leukocytes 
 
 
Inhibit phagocytic 
activity 
 
 
Vacuolating 
cytotoxin 
 
Present in 49%, 40%, 20% and 12% of isolates from 
pyelonephritis, cystitis, asymptomatic bacteriuria and 
faecal isolates. 
 
 
Frequently associated with UTI isolates and 
significantly related to prostatitis. 
 
 
More frequently associated with pyelonephritis 
causing isolates. 
 
Mainly associated with invasive UTI. 
It plays a complex role from aid in 
iron acquisition to disruption of 
phagocyte function and direct 
toxicity to host cells. 
Capsular polysaccharide  
        K antigen 
      
 
       
        
        O antigen 
 
Antiphagocytic 
 
 
 
 
Serum resistance 
 
Certain types of K antigen commonly detected 
among isolates from pts UTI in comparison to faecal 
isolates. K1 & K5 were detected in 63% of isolates 
from women with pyelonephritis. 
 
Certain types of O antigen exhibit 
anticomplementary activity are associated with E. 
coli isolated from UTIs, (such as O1, O2, O4, O6, 
O16, O18, O22, O25 and O75). 
  
 
 
Together K & O antigens serve as an 
important tool to differentiate UPEC 
from other E. coli strains. 
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1.5. Antimicrobial resistance in UPEC 
As one of the most frequently isolated pathogens in clinical practice, UPEC are 
considered to be a major reservoir for genes encoding antimicrobial resistance. Several 
factors may contribute to the development and spread of antibiotic resistance including 
volume of antibiotic use, poor hygienic conditions, use of antibiotics in animal feeds 
and overcrowded living conditions together with bacterial virulent characteristics (Erb 
et al. 2007; Lau et al. 2008b; Moreno et al. 2009). In addition to pathogenic E. coli, 
antibiotic resistance may involve commensal E. coli in the bowel, which may become a 
major reservoir of resistant strains (Erb et al. 2007). 
Results from the Sentry antimicrobial surveillance programme, which is a longitudinal 
surveillance program designed to track global antimicrobial resistance trends, show  
remarkable variations in antibiotic resistance involving most of the known antibiotic 
groups with high resistance rates reported from South America and Asia and the lowest 
in Europe and North America (Fluit et al. 2000; Gordon & Jones 2003). 
1.5.1. Beta-lactam antibiotics 
These are the most widely used antibiotics in clinical medicine (Bush & Macielag 
2010). In the treatment of UTI, amoxicillin with or without clavulanic acid and the first 
generation cephalosporins have been used in the treatment of uncomplicated UTIs, 
whereas third generation cephalosporins are recommended for treatment of complicated 
upper UTI (Anonymous 2006). 
Resistance to beta-lactam antibiotics is mostly associated with bacterial production of 
different beta-lactamase enzymes that break the beta-lactam ring and inactivate the 
antibiotics (Bush & Macielag 2010). 
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1.5.1.1. Beta-lactamases 
TEM1 and TEM2 are the most common plasmid-mediated beta-lactamases in Gram-
negative bacteria, including E. coli. In addition to a less common enzyme termed SHV, 
all are able to hydrolyze penicillins and narrow spectrum cephalosporins, such as 
cephalothin but they are not effective against higher generation cephalosporins such as 
cefotaxime, ceftazidime, ceftriaxone, or cefepime. However, their action can be 
overcome with beta-lactamase inhibitors like clavulanic acid (Canton & Coque 2006). 
1.5.1.2. Extended Spectrum Beta-lactamases 
Shortly after the introduction of cefotaxime early in 1980s, new derivatives of the 
common TEM-1, -2 and SHV-1 enzymes, named SHV2 and TEM3, were detected with 
transferable resistance to the oxyimino-cephalosporins (eg, cefotaxime, ceftazidime, 
and ceftriaxone). They were named extended spectrum beta-lactamases (ESBLs) in 
1989 by Philippon and colleagues (Philippon, Labia & Jacoby 1989). At the same time, 
a new family of ESBLs was detected and named CTX-M. These were characterized by 
higher levels of resistance to cefotaxime than to ceftazidime and the first description 
was in an isolate from Munich (Canton & Coque 2006). 
Although TEM and SHV ESBLs were dominant among ESBLs during the 1990s, 
occasional nosocomial outbreaks, mostly of CTX-M-2-producing Enterobacteriaceae, 
were reported (Pitout 2009). This situation changed during the 2000s with the 
worldwide emergence of CTX-M-15 producing E. coli as an important cause of 
community-onset UTIs (Canton & Coque 2006; Coque et al. 2008; Ellington et al. 
2006; Lavigne et al. 2007; Pitout 2009; Woodford et al. 2007). According to the 
www.lahey.org database accessed  on  January 2011,  137 different CTX-M enzymes 
Chapter 1                                                                             Introduction 
26 
 
have been identified (www.lahey.org/studies/other.asp#table1) and can be clustered 
into five different groups (CTX-M-1, -2, -8, -9 and -25) (Canton & Coque 2006).  
 
 
CTX-M-15 beta-lactamase belongs to the CTX-M-1 group and is characterized by an 
increased catalytic activity against ceftazidime, and bacteria producing these enzymes 
often test resistant to this agent. It has often been associated with carriage of other beta-
lactamases such as TEM-1 and OXA-1 as well as the aminoglycoside-modifying 
enzyme AAC(6‟)-Ib-cr  that has an additional ability to acetylate fluoroquinolones 
offering resistance to norfloxacin and ciprofloxacin (Peirano & Pitout 2010). 
1.5.2. Fluoroquinolone 
Quinolones are family of synthetic antibacterial agents with broad spectrum activity. 
They bind DNA gyrase and topoisomerase IV when they are in a complex with DNA 
and inhibit chromosome re-ligation after enzyme-mediated cleavage (Walker 1999). 
Quinolones have long been used in the treatment of UTIs with the first developed 
quinolone (nalidixic acid) in 1962, which had marked antibacterial activity against 
gram-negative bacteria making it suitable for the treatment of UTI. This was followed 
by introduction of the fluoroquinolones with broad spectrum activity and better 
systemic distribution allowing use in upper and complicated UTIs (Ball 2000). 
Ciprofloxacin is the fluoroquinolone currently recommended for the treatment of upper 
and complicated UTI (Anonymous 2006). Due to the increased resistance against most 
commonly used antibiotics, fluoroquinolones have been used with increasing frequency 
in both complicated and uncomplicated UTI leading to a rapid increase in 
fluoroquinolone resistance (Jacoby 2005). 
Chapter 1                                                                             Introduction 
27 
 
Resistance to fluoroquinolones typically arises as a result of a series of mutations in the 
target enzymes (DNA gyrase and topoisomerase IV) and of changes in drug entry and 
efflux. Mutations are selected first in the more susceptible target genes coding DNA 
gyrase and topoisomerase IV, gyrA resulting in resistance to nalidixic acid, whereas 
additional mutations in the next most susceptible target parC augment resistance 
further, to involve fluoroquinolones. Resistance to quinolones can also be mediated by 
plasmids that produce the Qnr protein, which protects the quinolone targets from 
inhibition (Hooper 2001).The resistance to fluoroquinolones in E. coli has increased 
significantly over the last decade. In the annual reports of the European Antimicrobial 
Resistance Surveillance Network (EARS-Net), 28 of 29 countries in Europe reported a 
significant increase in fluoroquinolone resistance between 2001–2007 and 8 of 28 for 
the period 2006- 2009 with the majority reporting resistance around 20% (with a range 
between 7% and 43%). In the UK, resistant isolates of E. coli increased from 7–18% 
between 2001 and 2009(Anonymous 2007; Anonymous 2009). 
1.5.3. Trimethoprim 
Trimethoprim is a bacteriostatic antibiotic that has been widely used alone or in 
combination with sulphonamides (SXT) in the treatment and prophylaxis of UTI 
(Huovinen et al. 1986). Trimethoprim acts by interfering with the action of bacterial 
dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid leading to the 
inhibition of DNA replication and resistance in E. coli is mainly mediated by plasmid 
mediated gene (dfr) encoded modified dihydrofolate reductases whose configuration is 
not susceptible to trimethoprim (Skold 2001).  
Although resistance to trimethoprim alone or as a combination with sulphonamides has 
increased during recent decades (Steinke et al. 2001), it is still recommended for 
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treatment of uncomplicated UTI(Anonymous 2006). However, in 2001, Manges et al. 
described a clonal group of SXT resistant E. coli, named clonal group A (CGA), which 
was found among women with acute uncomplicated UTI in one university community 
(Manges et al. 2001). Since then CGA isolates have been recovered from several 
populations across the United States (Johnson et al. 2002; Manges, Dietrich & Riley 
2004; Manges et al. 2001) and has also been described in other parts of the world 
(Johnson et al. 2009; Johnson et al. 2005c; Manges et al. 2008) suggesting clonal 
dispersion leading to a remarkable increase in SXT resistance (Johnson et al. 2002).  
1.5.4. Aminoglycosides 
Aminoglycosides are a group of broad spectrum bactericidal drugs, which includes 
many drugs such as gentamicin, amikacin, streptomycin, tobramycin, kanamicin and 
neomycin. They share chemical, antimicrobial, pharmacologic and toxicity 
characteristics and because of their poor pharmacokinetics and considerable toxicity 
their use been limited to serious infections (Mingeot-Leclercq, Glupczynski & Tulkens 
1999). 
Aminoglycosides act by inhibiting protein synthesis in bacteria through binding to the 
ribosomes. In gram negative enteric bacteria, resistance to aminoglycosides is mainly 
mediated by plasmid encoded aminoglycoside modifying enzymes (Mingeot-Leclercq 
et al. 1999). To date, over 85 aminoglycoside modifying enzymes have been identified, 
however only few such as AAC(3)-I, AAC(3)-II, AAC(3)-III, AAC(3)-IV, AAC(6‟)-I 
and ANT(2‟‟) appear to cause the majority of aminoglycoside resistance among E. coli 
isolates (Ho et al. 2010) 
Chapter 1                                                                             Introduction 
29 
 
Although aminoglycosides are not recommended for the treatment of UTI in 
UK(Anonymous 2006), aminoglycoside resistant E. coli have previously been reported 
(Johnson et al. 1995; Woodford et al. 2007), Recent studies have suggested food 
producing animals are an important reservoir for the aminoglycoside-resistance gene 
found in human isolates (Chaslus-Dancla et al. 1991; Johnson et al. 1994). 
1.5.5. Overview of antimicrobial drug resistance in UPEC 
During recent decades, antimicrobial resistance has significantly increased among 
UPEC (Erb et al. 2007; Moreno et al. 2006; Yu et al. 2007) and unexpected trends of 
antimicrobial resistance among E. coli have been reported globally. In the UK, concern 
was raised over the emergence of community acquired gentamicin resistant UPEC 
(Woodford et al. 2007), as well as the increase in ciprofloxacin resistance in E. coli 
isolated from blood (Livermore et al. 2003) and the global spread of CTX-M ESBL 
producing strains (Canton & Coque 2006; Ellington et al. 2006; Lavigne et al. 2007; 
Woodford et al. 2007). In 2001, Manges and colleagues, reported community spread of 
one clonal group of UPEC responsible for up to 50% of E. coli isolates resistant to co-
trimoxazole derived from women with acute cystitis in California, Michigan and 
Minnesota, USA (Manges et al. 2001). 
Several biological mechanisms may contribute to development and spread of these 
distinctive resistance patterns in UPEC. Although mutations responsible for antibiotic 
resistance are in some cases a result of positive selection pressure (Martinez & Baquero 
2000), the main mechanism for the development of antibiotic resistance is horizontal 
gene transfer, which has been considered an important route for transmission of 
virulence factors and antimicrobial resistance in E. coli (Blahna et al. 2006).  
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The conjugative plasmids responsible for the spread of antibiotic resistance usually 
contain an integron structure consisting of an int-1-gene encoding the integrase that 
catalyzes the integration and excision of the gene cassettes encoding antibiotic 
resistance (Hall & Collis 1998). For trimethoprim resistance, where horizontal 
dissemination is so far considered to be the main route of spread, at least 30 different 
dfr genes are known to be responsible for trimethoprim resistance. These genes are 
mostly located on plasmids and reside within integrons (Blahna et al. 2006). 
The role of plasmids in dissemination of antibiotic resistance has long been established 
and involves almost every class of clinically important antibiotics. The recent spread of 
ESBL producing strains in the community has been strongly associated with plasmid 
mediated CTX-M enzymes particularly CTX-M 15 (Nicolas-Chanoine et al. 2008). 
Similarly, the rise in fluoroquinolone resistance has increasingly been associated with 
plasmid mediated aac (6)-lb-cr and qnr genes (Coque et al. 2008; Sabtcheva et al. 
2009), which suggests horizontal transfer of these resistance encoding plasmids 
(Nicolas-Chanoine et al. 2008) and the fact that these different resistance genes co-exist 
on same plasmid, together with other antibiotic resistance genes, facilitates their 
dissemination through co-selection processes. However, the fact that many of these 
geographically dispersed strains share considerable genomic and phenotypic 
characteristics, supports an alternative explanation, that is of clonal expansion (Nicolas-
Chanoine et al. 2008). 
However, the extent that each mechanism contributes to the observed rise in antibiotic 
resistance is not always clear. Under conditions where horizontal gene transfer was 
sufficient to drive the dissemination of antibiotic resistance with clonal expansion 
amplifying the genes within individual hosts, regionally independent gene distributions 
were expected. Conversely, in cases where horizontal gene transfer is rare, clonal 
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expansion accounts for most of the increase in the resistance level and region-
dependent gene distributions are to be expected (Blahna et al. 2006). 
 The role of mutators (section 1.6.2.1.2) in causing the high prevalence of antimicrobial 
resistance among UPEC is still under debate. However, a strong correlation between 
antimicrobial resistance and high frequency mutators is often reported, suggesting that 
it could be a result of the selection pressure exerted by commonly used antibiotics 
(Baquero et al. 2005; Denamur et al. 2002; Ellington et al. 2006; Miller, O'Neill & 
Chopra 2004). In addition, the increasing use of fluoroquinolones, which are known to 
be a mutagenic drugs, as an alternative therapy for UTIs could explain the high 
prevalence of hyper mutable ESBL producing strains (Baquero et al. 2005).  
Furthermore, the ability to form biofilms and to develop intracellular bacterial 
communities within murine bladder urothelium allows UPEC to establish reservoirs 
protected from the immune system and antibiotic treatment and serve as a persistent 
source of bacteria. This may contribute to the emergence of antibiotic resistant UPEC 
strains (Parsek & Singh 2003; Rosen et al. 2007)         
Recently, management of UTIs has become increasingly challenging as a result of 
emerging resistance to most first-line antimicrobial agents, necessitating revised 
empirical treatment approaches (Cagnacci et al. 2008). 
Understanding the rules governing the interplay among all these discrete factors 
involved in the development, transfer and spread of antibiotic resistance could help 
explain the emergence and dissemination of successful strains and increase an 
understanding the evolution and population structure of UPEC may eventually facilitate 
development of better management strategies.  
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1.6. Epidemiology of UPEC 
The epidemiology of UTIs caused by UPEC has always been difficult to assess as UTI 
in general is not a reportable disease in many countries (Foxman et al. 2002; Stamm 
2001). However, recent community spread of certain lineages of UPEC with abnormal 
characteristics, such as resistance to antibiotics or high level of virulence, provide 
evidence of sporadic epidemics or outbreaks, which otherwise would have remained 
unrecognised (Johnson et al. 2009; Leflon-Guibout et al. 2004; Manges et al. 2001; 
Woodford et al. 2007). In addition, with a lack of ongoing surveillance, conventional 
epidemiology fails to appreciate fully the specificity of UPEC and the fact that its 
pathogenicity is distinct from other E. coli. In contrast, molecular epidemiological tools 
provide a closer look at microbial traits explaining virulence behaviour and host 
predilections of the pathogen and offer insights into the origins and spread of bacterial 
diseases (Johnson & Russo 2005). 
1.6.1. Molecular epidemiology of UPEC 
The completion of the genome sequence of E. coli K-12 created a great opportunity to 
determine the precise functions of all encoded genes. This provided data for complete 
genome comparisons, to identify genes coding for unique properties in related 
pathogens, as well as giving an insight into the evolutionary relations of different 
pathogens (Blattner et al. 1997). However, the available genetic data on pathogenic E. 
coli indicates that up to 10-20% of the genomic information found in highly pathogenic 
E. coli is not present in E. coli K-12. Most of the pathogen specific DNA appears to 
encode various virulence factors responsible for the pathogenicity of E. coli  (Kuhnert 
et al. 2000). 
Chapter 1                                                                             Introduction 
33 
 
1.6.2. Evolution of UPEC 
Based on phenotypic studies carried out on a defined standard reference set of natural 
isolates from a variety of hosts and geographical locations (the ECOR collection), the 
natural populations of E. coli appear to exist as a collection of lineages with limited 
exchange of chromosomal genes (Ochman & Selander 1984; Selander & Levin 1980).  
On the other hand, the rapid development of molecular techniques such as polymerase 
chain reaction (PCR), DNA sequencing and molecular typing has had a great impact on 
the study of bacterial evolution and, thus, genetic studies of UPEC show evidence of a 
much more diverse population structure (Foxman 2007). 
1.6.2.1. Sources of genetic variation 
Generally, three basic mechanisms can generate genetic variation leading to bacterial 
diversity: mutation; hypermutation; genetic recombination. The impact of each 
mechanism on the evolution and the diversity of UPEC will be considered below. 
1.6.2.1.1. Mutation 
Referring to any inheritable change in genetic material, mutations are basically caused 
by DNA replication errors and include substitutions and insertion or deletion of 
nucleotides. In some cases this is promoted by the activity of different transposable 
elements.  
1.6.2.1.1.1. Substitutions 
 
Substitutions or point mutations can be synonymous (changes in DNA sequence do not 
affect the translated amino acid) or non-synonymous (changes in DNA sequence result 
in altered amino acid sequence). Such mutations occur randomly but continuously in 
most bacteria during DNA replication.  Most synonymous substitutions are free from 
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natural selection and therefore provide a good measuring index for time of divergence 
between two species. On the other hand, non-synonymous substitutions are mostly 
deleterious in nature due to positive selection. Detection of both types may therefore 
provide information about the degree of selection exerted on a defined gene (Kimura 
1983). 
1.6.2.1.1.2. Insertions and deletions 
 
Insertions and deletions is another type of mutation, which could be the result of errors 
in DNA replication in which a few bases are inserted or deleted, such as seen with 
slipped-strand mispairing (Levinson & Gutman 1987). Insertion or deletion of large 
blocks of DNA is usually caused by DNA crossover or DNA transposition. Generally if 
it occurs in a coding region, it causes frame shift mutations, which almost always result 
in altered amino acid sequence (Snyder & Champness 2007a). 
1.6.2.1.1.3. Inversions 
 
Inversion mutations are usually caused by homologous recombination between inverted 
repeats in the same DNA fragment in which a DNA sequence is flipped over and lies in 
the reverse orientation. Inversion mutations often cause no phenotypic alteration and 
rarely occur in the evolution of E. coli (Mahan & Roth 1991). 
1.6.2.1.2. Hypermutation  
Hypermutators, which are strains that show a higher mutation rate than wild type 
organism due to deficient mismatch repair systems, are able to exchange genetic 
material at a higher rate than the wild type organism, which eventually increases the 
rate of genetic variation (LeClerc et al. 1996; van Belkum et al. 2001). Hypermutators 
have been detected among different bacterial populations including Neisseria 
meningitidis, Salmonella enterica and E. coli. Although their evolutionary value is 
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limited, UPEC generally express a high frequency of mutators (Denamur et al. 2002; 
Hall & Henderson-Begg 2006; van Belkum et al. 2001). Furthermore, they could be 
associated with the development of chronic UTI through the development of persistent 
intracellular reservoirs (Labat et al. 2005). 
1.6.2.1.3. Homologous recombination 
This occurs more often and refers to the genetic exchange between homologous 
sequences of closely related organisms and affects the variation in existing genes rather 
than introducing new genetic information into the genome. The fact that almost all 
organisms have some kind of homologous recombination mechanism indicates its 
important role in bacterial survival allowing rapid adaptation to the environment 
(Snyder & Champness 2007b). 
1.6.2.1.4. Lateral gene transfer 
Similar to homologous recombination, lateral gene transfer involves acquisition of new 
genetic material, but unlike homologous recombination it involves different 
strains/species and results in introduction of new genetic information into the lineage 
and, hence, is often referred to as non-homologous recombination (Doolittle 1999). 
Recent studies on genetic evolution of enteric bacteria reveals an integral role of lateral 
gene transfer in the diversification and speciation of enteric organisms (Lawrence & 
Ochman 1998; Ochman, Lawrence & Groisman 2000). Although the level of 
recombination and its effect on population structure in E. coli are still a matter of 
debate, several reports strongly suggest that horizontal transfer has a great impact on 
the evolution and the diversity of UPEC through acquisition of new genetic material 
either by conjugation or transduction (Guttman & Dykhuizen 1994; Oelschlaeger, 
Dobrindt & Hacker 2002; van Belkum et al. 2001). 
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Comparative studies on genetic structure of E. coli and other enteric pathogens were 
able to identify reliable indicators of lateral gene transfer, which include atypical GC 
content, mosaic alleles and inconsistency between gene trees (Lawrence & Ochman 
1998). 
1.6.2.1.5. Pathogenicity islands (PAIs)  
These were first described in E. coli, but have recently been found in the genomes of 
various pathogens of humans, animals and plants (Schmidt & Hensel 2004). 
Pathogenicity islands, which are unstable regions of chromosomal DNA 10-200 
kilobases (kb) in size that encode determinants responsible for extra intestinal 
pathogenicity, were frequently detected in UPEC isolates but are absent from the 
genomes of non-pathogenic E. coli. The instability of these pathogenic sequences is 
related to its acquisition of mobility genes (e.g. integrases and insertion sequences) and 
the association with tRNA genes, which have been suggested to act as integration sites 
for foreign DNA. 
The G+C content of pathogenicity islands frequently differs from the rest of the 
genome, suggesting that they have been acquired from other related bacterial species by 
horizontal gene transfer (Lloyd et al. 2007). In their study of the genetic variation of the 
P-associated pilus gene (pap) in different UPEC, Plos et al (1989) provided evidence 
supporting the horizontal gene transfer hypothesis for pap genes among UPEC (Plos et 
al. 1989) and similar findings were reported by others (Bingen et al. 1998; Hacker & 
Kaper 2000).  
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1.6.3. Population genetics  
Population genetics of bacteria is the study of genetic variation of bacterial populations 
and is used to explain the evolutionary basis of genetic variation between and within 
bacterial species (Trevors 1998). 
Earlier studies suggested that E. coli form a clonal population structure (Achtman et al. 
1983; Achtman & Pluschke 1986; Ochman & Selander 1984).  
In typical clonal populations, clonality arises solely from vertical transmission of 
genetic information through binary fission whereby new lineages emerge by the 
accumulation of mutations over successive generations. Consequently, the distribution 
of chromosomal polymorphisms will be non-random, or in linkage disequilibrium 
(Spratt & Maiden 1999). 
However, bacterial make attempts to conserve genomic integrity and possess a number 
of mechanisms that, in addition to DNA-damage repair, promote genetic diversity 
through homologous exchange of sequences between members of the same clone or 
otherwise different clones (Aguilera et al. 2007). The frequency of such 
recombinational events in bacterial populations, which can vary from very low (clonal 
populations) as seen with Enterococcus faecium, to very high (non-clonal populations) 
such as Helicobacter pylori, determine the population structure. Differences in the ratio 
of genetic change caused by recombination in relation to that caused by mutation leads 
to a spectrum of bacterial population structures, with most diversification in the 
bacterial population involving recombination. However, recombination often will not 
prevent the emergence of clonal lineages within the population (Spratt & Maiden 1999; 
Turner et al. 2007). 
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1.6.4. Population structure of UPEC 
The strong association of certain serotypes with UTIs (Johnson et al. 1997; Kuhnert et 
al. 2000) and with certain subgroups of E. coli such as UPEC clonal group A strains, 
which share similar O antigen groups (O11, O17, O73 & O77) (Kuhnert et al. 2000; 
Lloyd et al. 2007; Prats et al. 2000; Tartof et al. 2005) initially lead to the suggestion 
that E. coli populations are in general clonal in nature. The successful application of 
techniques such as multilocus enzyme electrophoresis (MLEE), which indexes the 
allelic variation in multiple chromosomal genes, generated large databases that allowed 
statistical analysis of bacterial populations with enough data to strongly support the 
suggestion that populations exhibit strong linkage disequilibrium (non-random 
association of alleles) and revealed the rarity of recombinational exchanges between 
bacterial lineages (Feil et al. 2001; Smith et al. 1993). 
Conversely, analysis of closely related E. coli clones reveals frequent involvement of 
recombination in the diversification of E. coli (Guttman 1997; Guttman & Dykhuizen 
1994). 
Phylogenetic analysis of MLEE profiles of the E.coli Reference collection (ECOR) 
strains define four major phylogenetic groups (A, B1, B2, D) and ungrouped strains 
(UG) (LeCointre et al. 1998). Most ExPEC are derived from group B2 and to a lesser 
extent from group D, while the other pathogenic E. coli are consistently distributed in 
all classes with the commensal strains belong to group A (Clermont, Bonacorsi & 
Bingen 2000). Results from molecular studies of the recognised extra-intestinal 
virulence factors are compatible with this classification, where B2 group strains are 
highly pathogenic with numerous virulence determinants responsible for extra intestinal 
infections and strains of phylogenetic group D seem to have fewer virulence 
determinants than B2 group strains, whereas strains of the group A and B1, are most 
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often devoid of extra intestinal virulence determinants (Figure 1.1) (Johnson & Russo 
2005). Recent efforts have been applied to further sub-typing of UPEC based on 
acquisition of specific pathogenicity islands, which could provide an ideal diagnostic 
tool for UTI caused by UPEC (Kanamaru et al. 2006a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.7. Methods used for typing pathogenic E. coli  
The ability to carry out epidemiological investigations to determine the population 
structure and the epidemiological distribution of pathogens is important to increase our 
understanding of the evolutionary processes of such pathogens, and subsequently 
improve public health.   
Usually, the closeness of strains is a reflection of the phenotypic and genotypic 
variation seen either in bacterial behaviour toward the environment or the chromosomal 
Figure 1.1 Phylogenetic distribution of Extra intestinal virulence associated 
genes in E. coli adapted  from  (Johnson & Russo 2005) (papA, P fimbriae; kpsMT, 
group II capsule synthesis; sfa/foc, S and F1C fimbriae; iutA, aerobactin; traT, serum 
resistance; fimH, type I fimbriae) 
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DNA of the examined strains. Therefore, the ability of a typing technique to identify 
related strains depends greatly on the rate at which these variations occur in the tested 
parameter (Tenover, Arbeit & Goering 1997).  
Several successful approaches have been introduced for typing and classification of E. 
coli. These range from novel methods to modification of existing ones to enable more 
precise, sensitive, cheap and most of all rapid methods for the identification and 
differentiation of UPEC strains. 
 
Based on the target parameter, typing methods can be divided into two categories            
                    1. Phenotyping methods          2. Genotyping methods 
 
Phenotyping methods are those that characterize the products of gene expression in 
order to identify and further classify strains into different subgroups such as biotyping, 
phage typing, antibiotyping, serotyping, polyacrylamide gel electrophoresis and 
multilocus enzyme electrophoresis. All of which differ in their characteristics such as 
sensitivity, precision and availability, but most of them have limited discriminatory 
power (van Belkum et al. 2001). 
Genotypic methods are those that are based on direct analysis of the genetic structure of 
examined strains. The nature of the genetic screen will vary depending on whether it is 
for the detection of certain genes or plasmids or screening for pathogenicity islands or a 
certain clonal/phylogenetic group. Several typing methods are commonly used for E. 
coli  including , pulsed field gel electrophoresis (PFGE), restriction fragment length 
polymorphism analysis (RFLP), ribotyping, random amplification of polymorphic 
DNA (RAPD), enterobacterial repetitive intergenic consensus sequence PCR (ERIC) 
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and multilocus sequence typing (MLST) (Johnson & Russo 2005; Olive & Bean 1999; 
Power 1996). 
Most of these methods differ in their characteristics such as typeability, discriminatory 
power, reproducibility, cost and time consumption (Johnson & Russo 2005; van 
Belkum et al. 2001) (Soll, Pujol & Lockhart 2007)  
 
Moreover, using these techniques to examine the relation between strains depends 
greatly on the rate at which changes occurs in the examined parameter. Phenotyping 
methods such as biotyping and antibiotyping tend to change at a rapid pace according 
to the changes in the growth environment, which makes them mostly suitable to detect 
recent changes among closely related strains, providing sufficient information for 
primary epidemiological investigation (Hopkins & Hilton 2000). 
 
1.7.1. Phenotyping methods 
1.7.1.1. Biotyping 
Generally biotyping, like most phenotypic methods, is considered to be an unreliable 
epidemiological tool because of its modest reproducibility and poor discriminatory 
power. However, advancement in automated biotyping methods provide more reliable 
tools that rely on a variety of novel substrates and precise interpretation techniques that 
increase the reproducibility and discriminatory power (Tenover et al. 1997).  
The reliability of biotyping as an epidemiological tool depends greatly on the pathogen 
in question, as bacteria vary in their biochemical reactions, some bacterial species 
lacking biochemical diversity, whereas others, such as E. coli, have considerable 
biochemical variability (Godbout-DeLasalle & Higgins 1986). Despite this, biotyping 
methods designed for identification of strains of the family Enterobacteriaceae have 
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been shown to be dependable and a useful method in characterization of E. coli 
(Brauner et al. 1987; Leclercq et al. 2001). 
Moreover, automation of biochemical fingerprinting methods, based on numerical 
analysis of biochemical reaction kinetics to differentiate bacterial strains, has been 
proven to be highly discriminatory and reproducible when fermenting bacteria are 
tested and the resulting classifications were comparable to that of PFGE (Kuhn 1985; 
Kuhn et al. 1995). 
1.7.1.2. Antibiogram typing  
Similar to biotyping, antimicrobial susceptibility patterns are of poor discriminatory 
power and of low reproducibility because of the selective pressure exerted by frequent 
exposure to antibiotics, especially in healthcare facilities. In addition, the fact that many 
antimicrobial resistance genes are associated with mobile genetic elements significantly 
decreases the reliability of antibiotyping methods as an epidemiological tool (Tenover 
et al. 1997). 
However, detection of unusual antimicrobial susceptibility patterns often indicates 
spread of certain strains and, thus, can be used in combination with other typing 
methods to provide an initial screening tool (Manges et al. 2001; Phillips et al. 1988).  
1.7.1.3. Serotyping  
Serotyping remains an important epidemiological tool to describe lineages and 
population composition. It is based on antibodies directed against 173 O antigens, 80 K 
antigens and 56 H antigens creating up to 100,000 or more possible combinations 
(Orskov & Orskov 1992). Several studies showed a strong association of different 
serotypes with different pathotypes. Certain serotypes are commonly associated with 
UTIs (Johnson et al. 1997; Kuhnert et al. 2000) and with certain subgroups of E. coli 
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such as UPEC clonal group A strains, which share similar O antigen groups (O11, O17, 
O73 & O77) (Kuhnert et al. 2000; Lloyd et al. 2007; Prats et al. 2000; Tartof et al. 
2005).  
However, the high diversity of E. coli requires strains to be tested against a large 
number of antisera, which reduces the practicality of using this method and increases 
the cost further limiting its use. 
1.7.1.4. Multilocus enzyme electrophoresis (MLEE) 
Until the application of DNA sequencing became more routinely available, multilocus 
enzyme electrophoresis had a great role in describing the phylogenetic structure of E. 
coli and other organisms. It uses the electrophoretic mobility of enzyme variants to 
detect polymorphism in housekeeping genes. Variations in electrophoretic mobility are 
the result of DNA variations at sites leading to amino acid changes (Selander et al. 
1986). Regardless of its contribution to global epidemiological studies, multilocus 
enzyme electrophoresis has limitations regarding standardization and comparability 
with data from other laboratories (Selander et al. 1986; Urwin & Maiden 2003). 
1.7.2. Genotyping 
1.7.2.1. Restriction based methods 
1.7.2.1.1. Plasmid analysis 
Plasmids are self replicating, extrachromosomal circles of DNA that encode a wide 
variety of genes, including those mediating antimicrobial resistance, virulence and 
metabolism of hydrocarbons (Snyder & Champness 2007c). 
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Upon cell division, copies of plasmid are transferred to daughter cells and subsequently 
cells of the same clone carry the same plasmids. The number and the size of plasmid in 
each cell provide a comparable profile that can be used to differentiate strains. Despite 
the natural ability of plasmids to transfer horizontally, which can interfere resolution of 
a strain‟s true relationship, and its low discrimination power, plasmid profiling still 
provides a reliable initial epidemiological screening tool (Foley, Lynne & Nayak 2009). 
In addition to antibiotic resistance, other features may be plasmid coded such as 
serotype or phage susceptibility and, thus, different typing systems may not be totally 
independent of one another. Plasmid profiles are most useful when combined with 
other methods of screening or typing (Mayer 1988). 
Following the first report of using agarose gel electrophoresis for plasmid profile 
characterization using E. coli K-12 to standardize the method (Meyers et al, 1976), a 
number of widely used procedures for plasmid isolation and profiling have been 
described, including those by (Birnboim & Doly 1979; Kado & Liu 1981; Samrook & 
Russell 2001). 
Most of these methods rely on alkaline denaturation of chromosomal DNA while 
supercoiled plasmid DNA remains intact and separation of the nucleic acid is carried 
out on the basis of physical differences between circular plasmid and linear 
chromosomal fragments in the purification process (Cloninger et al. 2008). 
One of the problems with these methods is in the coexistence of three conformations 
(linear and supercoiled) of the same plasmid, which may affect the migration properties 
of plasmids during gel electrophoresis (Olsen et al. 1993). 
To overcome this drawback and improve discrimination between strains, restriction 
endonucleases, such as HindIII, can be used to generate more distinctive profiles (Foley 
et al. 2009). 
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From the literature, it can be seen that plasmid profiling has been used for a wide range 
of pathogens such as E. coli (Domingue et al. 2003);(Bebora et al. 1994; Jan, Meshram 
& Kulkarni 2009), Shigella (Dutta et al. 2002) and Salmonella (Mohan et al. 1995; 
Threlfall et al. 1990). 
1.7.2.1.2. Pulsed field gel electrophoresis (PFGE) 
PFGE is often referred to as the gold standard of molecular typing methods, as it is 
characterized by a high discriminatory power that is superior to other typing methods 
(Olive & Bean 1999).  
PFGE directly detects variation in the genetic sequence of chromosome by scanning the 
entire genome. The bacterial genome is digested by specific restriction enzymes 
followed by electrophoretic separation using a current with variable polarity. The 
resulting electrophoretic patterns are strain specific (Olive & Bean 1999; Tenover et al. 
1995). 
A few limitations have been associated with PFGE including standardization and time 
consumption (Olive & Bean 1999; van Belkum et al. 2001). In an attempt to improve 
its reproducibility Tenover et al. (1995) suggested interpretation criteria for the analysis 
of restriction patterns.  
From the literature, PFGE appears to have been used in epidemiological studies of a 
broad range of microorganism (Fukigai et al. 2007; Germon et al. 2005) including E. 
coli, especially O157:H7, where an association between PFGE profile and isolate 
source were proposed (Bender et al. 1997; Parveen et al. 2001). 
1.7.2.2. Polymerase chain reaction based methods 
Since its development in the mid 80s by Mullis and his colleagues (Saiki et al. 1985), 
numerous PCR based methods have been introduced for epidemiological purposes, 
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including restriction fragment length polymorphism PCR (RFLP-PCR), ribotyping 
PCR, arbitrary primed PCR (AP-PCR/RAPD) and enterobacterial repetitive intergenic 
consensus sequence PCR (ERIC-PCR) (Power 1996). 
However, development of quantitative real time PCR provided a great tool for 
epidemiological research and routine diagnosis. Recently, Birkett et al. (2007) 
developed a new multiplex real time taqMan PCR assay for rapid detection and 
genotyping of CTX-M ESBL producing enteric bacteria, which could be useful for 
local epidemiological investigations (Birkett et al. 2007). 
1.7.2.2.1. Random amplification of polymorphic DNA (RAPD) 
Different terms have been used to describe these methods including arbitrary primer – 
PCR or random amplification of polymorphic DNA or multiple arbitrary amplification 
profiling (MAAP). In these techniques, short primers of non specific sequence (around 
10 bases) are used to initiate random amplification of the targeted DNA. The number 
and the location of these priming sites vary for different strains based on the bacterial 
genome sequence and the resulting electrophoresed DNA profile is strain specific 
(Olive & Bean 1999; Power 1996). 
A number of studies have successfully use RAPD assays in typing E. coli (Ensor et al. 
2006; Vidovic, Germida & Korber 2007). Furthermore, in a study by Garcia-Martinez 
et al. (1996), characterizing a collection of 74 UPEC isolates obtained from three 
hospitals located in geographically distant towns in Spain and some reference 
strains.RAPD method showed a high discriminatory power and was able to cluster most 
of the tested isolates in to two major groups.  
The principle advantage of RAPD is the lack of a requirement for prior knowledge of 
the target DNA sequence, but several limitation have been associated with it including 
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limited reproducibility and difficulty comparing profiles with others from different 
laboratories (Power 1996). 
1.7.2.2.2. Enterobacterial repetitive intergenic consensus (ERIC-PCR) 
Several highly conserved repeated sequence sets were identified in E. coli, including 
repetitive extragenic palindromic (REP) and enterobacterial repetitive intergenic 
consensus (ERIC) sequences (Hulton, Higgins & Sharp 1991). 
The ERIC-PCR method uses these specific intergenic repeated sequences found in the 
family Enterobacteriaceae as primer sites to amplify the regions between them. The 
number and location of these sequences varies from strain to strain and the 
electrophoretically resolved amplified fragment will form a distinct DNA fingerprint 
(Power 1996). 
In a comparison study of prevalence of colonization with UPEC, carried out by 
Johnson et al. (1998), ERIC-PCR appeared as discriminative as commonly used typing 
methods but was less time consuming. In another study, Manges et al. (2001) 
successfully used ERIC-PCR to screen a collection of UPEC for clonal group A strains. 
Using a similar technique with another set of specific repeated sequences (BOX A1R), 
Johnson et al. (1997) were able to distinguish strains of the J96-like clonal group 
among O4:H5 UPEC, allowing rapid identification of members of this clone, which is 
responsible for significant infections in human.  
Lack of reproducibility was commonly reported, which could be explained by the low 
stringency annealing conditions used (Chulain, Morris & Cormican 2006; Hopkins & 
Hilton 2000). However, an automated format was developed using separation of 
fluorescently labelled fragments with a DNA sequencer to enhance consistency and 
allow creation of a portable database to enable intra-laboratories comparison (Olive & 
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Bean 1999). More recently, the DiversiLab System, which is a rapid reproducible 
automated fingerprinting system using repetitive based sequence PCR (rep-PCR) was 
successfully used as an epidemiological tool to investigate different microorganisms 
including UPEC (Kilic et al. 2010; Lau et al. 2010; Ratkai et al. 2010)  
1.7.2.2.3. Restriction fragment length polymorphisms RFLP and PCR-RFLP 
In these approaches, the DNA sequence is subjected to restriction by specific 
endonuclease enzyme resulting in strain specific patterns of DNA fragments of 
different size and number (Foley et al. 2009). RFLP has widely been used in typing 
food borne pathogens such as Salmonella (Jordan et al. 2009; Paiva et al.), 
Campylobacter species, (Ayling et al. 1996) and E. coli (Arthur et al. 1990). 
As a variation of the original RFLP, PCR-RFLP involves amplification of specific 
sequences in the bacteria and digestion of the PCR amplicons with specific 
endonucleases to generate strain specific banding patterns (Foley et al. 2009). Studies 
using PCR-RFLP cover a wide range of application from population structure 
determination (Shima et al. 2006) to detection of various characteristics such as 
antibiotic resistance (Jones et al. 2008). 
1.7.2.2.4. Ribotyping 
Ribotyping relies on differences in the location and number of ribosomal RNA (rRNA) 
gene sequences present in the bacterial genome. In a similar way to RFLP, ribotyping 
involves restriction of bacterial DNA with specific endonucleases and the separation of 
the DNA fragments by gel electrophoresis followed by Southern blotting and probing 
with rRNA specific probes (Bouchet, Huot & Goldstein 2008). 
Despite the low discriminatory power of ribotyping compared to other typing methods 
such as PFGE (Clermont et al. 2001; Hahm et al. 2003), examination of the literature 
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shows that ribotyping has been successfully used to evaluate the relatedness and 
clinical importance pathogens such as E. coli (Parveen et al. 1999; Tarkka, Ahman & 
Siitonen 1994), Salmonella enterica (Olsen et al. 1992) and Vibrio cholerae O1 
(Popovic et al. 1993). 
1.7.2.3. DNA Sequence based methods 
1.7.2.3.1. Single nucleotide polymorphism (SNP) analysis 
The increased number of fully sequenced bacterial genomes has facilitated 
identification of single nucleotide polymorphisms (SNPs), which provides a reliable 
epidemiological tool with high discriminatory power. As bacterial species evolve, 
changes take place as a result of point mutations or horizontal transfer of genetic 
information, resulting in strains divergence. SNP analysis takes advantage of these 
changes at multiple loci to differentiate isolates.  
Several methods have been used to detect polymorphisms at defined SNP locations 
including sequencing of the region, mass spectrometry, which detects mass differences 
in the target sequence due to difference in the mass of various nucleotides, real-time 
PCR using hybridization probes where the variation in nucleotides affect the efficiency 
of probe binding and other methods including microarray, RFLP and flow cytometery 
(Foley et al. 2009).  
SNP analysis has been used successfully in characterization and differentiation of 
several pathogens including Bacillus anthracis (Pearson et al. 2004), Mycobacterium 
tuberculosis (Filliol et al. 2006), Yersinia pestis (Achtman et al. 2004), Campylobacter 
jejuni (Best et al. 2004) and Salmonella species including Salmonella Typhi (Ben-Darif 
et al.; Octavia & Lan 2007). 
Chapter 1                                                                             Introduction 
50 
 
Identification of informative SNPs, specific for six major clonal complexes within 
discriminatory alleles of an MLST database, was used for rapid identification of C. 
jejuni (Best et al. 2004) and SNP analysis was used for development of an automated 
phylogenetic grouping technique for reconstruction of the relationships between 30 E. 
coli reference strains (Hommais et al. 2005). 
Zhang and colleagues recognized 906 SNPs in 523 chromosomal genes for use in 
genotyping E. coli O157:H7 using comparative genome sequencing microarray 
techniques (Zhang et al. 2006).  
1.7.2.3.2. Multilocus sequence typing 
Most of the currently used genotyping methods rely on detection of genetic differences 
between tested populations with no consideration given to the frequency of genetic 
variation, which may accumulate rapidly. These methods are useful in the investigation 
of local or sporadic outbreaks.  
However for long term or global epidemiological studies, methods that differentiate 
isolates based on genes that exhibit slowly accumulated genetic variation are required 
(Enright & Spratt 1999; Urwin & Maiden 2003). As mentioned above, MLEE, which 
has long been used in population genetic studies, differentiates isolates by the relative 
electrophoretic mobility of gene products. However, even though the profiles generated 
group strains in a similar manner to other techniques, the profiles are difficult to 
compare between laboratories (Maiden et al. 1998; Selander et al. 1986). Based on 
MLEE principles and overcoming this limitation, MLST benefited from the advances 
made in DNA sequencing and has become an important method for typing of 
epidemiologically important pathogenic strains (Enright & Spratt 1999; Lau et al. 
2008a; Spratt 1999; Tartof et al. 2005). 
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1.7.2.3.3. Methodology 
MLST directly detects the genetic variation of specific genes (housekeeping genes) that 
are present at different loci by sequencing of the genes. The housekeeping genes are 
characterized by not being subjected to any unusual selective forces, such as exposure 
to antimicrobial agents and exhibit neutral genomic variation that accumulates slowly. 
Genetic variation of selected housekeeping genes is identified by nucleotide sequencing 
of 450-500 bp fragments of (usually) seven housekeeping genes. The length of the 
DNA fragment is selected to enable accurate sequencing of the genome fragment with 
single pair of primers and to provide a sufficient discriminatory power to allow 
differentiation of alleles within the population. In addition, the number of house 
keeping genes used affects the resolution power of the selected scheme (Figure 1.2). 
For each gene, different sequences are given different allele numbers and the allele 
numbers of the seven housekeeping genes provides an allelic profile, which is assigned 
a sequence type (ST) that defines the genotype of each isolate (Figure 1.3). 
The inter-isolate relationship can be defined by the closeness of the assigned ST, where 
closely related isolates have similar STs or slightly different ST and unrelated isolates 
have markedly different STs.  
The resulting allelic profile is transferable and can be analysed and compared via an 
international epidemiological database using the internet (Enright & Spratt 1999; Spratt 
1999; Urwin & Maiden 2003).  
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Figure 1. 2 Escherichia coli CFT073 complete genome showing the position of the 
seven house keeping genes used in the Achtman MLST protocol. Adapted from 
(http://www.ncbi.nlm.nih.gov) 
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Figure1.3 Snapshots of the Achtman MLST database website illustrating the data 
submission page and ST assigning page 
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1.7.2.3.4. The E. coli MLST schemes 
The success of an MLST protocol as a typing method greatly depends on the selection 
of the examined genes. In addition to being characterized by slow genomic variation 
the examined genes should reflect the epidemiological purpose of the assay and the 
selected genes should show no genetic relatedness (Adiri, Gophna & Ron 2003; Nemoy 
et al. 2005; Tartof et al. 2005). Therefore different MLST schemes were developed to 
suit different groups of E. coli using different housekeeping genes.(Adiri et al. 2003; 
Beutin et al. 2005; Noller et al. 2003). 
In their comparison study Tartof and his colleagues (2005) evaluated a standardized 
MLST protocol (accessible through the MAX-PLANCK institute) for the typing of 
UPEC isolates and compare it with PFGE and ERIC2 assays. The study reveals that the 
MLST used scheme provides high discriminatory power as ERIC2, furthermore it was 
able to distinguish human clonal group A strains from other (species/nonhuman) 
sourced clonal group A strains but it failed to supersede PFGE assay in the 
differentiation of UPEC clonal group A. However, a study by Nemoy et al.  (2005) 
revealed that the MLST could offer a better discriminatory power than PFGE if the 
scheme used is supported by additional genes such as antimicrobial resistance genes 
(Nemoy et al. 2005)  
Three distinct MLST schemes associated with discriminative databases are available 
through three centres. Institut Pasteur‟s MLST scheme (www.pasteur.fr/mlst); M. 
Achtman‟s MLST scheme (www.mlst.ucc.ie) supported by University Collage Cork, 
Ireland and T. Whittam‟s MLST scheme (www.shigatox.net) supported by the 
Shigatoxin E. coli Centre based at National food safety and Toxicology Centre, 
Michigan State University, USA., as shown in Table 1.2. Between these sites, a total of 
Chapter 1                                                                             Introduction 
55 
 
18 housekeeping genes are targeted for strain discrimination. Based on citations, 
Achtman‟s scheme is the most widely used MLST scheme for typing E. coli isolates. 
 
 
 
Table 1.2 Housekeeping genes supported by internet assessable discriminatory 
databases 
Genes Gene product Pasteur’s Achtman’s Whittam’s 
adk Adenylate kinase  ✓  
fumC Fumarate hydratase  ✓  
gyrB DNA gyrase  ✓  
icd 
Isocitrate/isopropylmalate 
dehydrogenase 
icdA  ✓ icdA  
mdh Malate dehydrogenase ✓ ✓ ✓ 
purA 
Adenylosuccinate 
dehydrogenase 
 ✓  
recA ATP/GTP binding motif  ✓  
aspC Aspartate aminotransferase   ✓ 
clpX 
ATP-dependent Clp 
protease 
  ✓ 
fadD Cyl-CoA synthetase   ✓ 
lysP Lysine-specific permease   ✓ 
uidA Beta-D-glucuronidase ✓ ✓ ✓ 
dinB DNA polymerase IV ✓   
papB 
Pap operon regulatory 
protein 
✓   
polB DNA polymerase II ✓   
putP proline:sodium symporter  ✓   
trpA 
tryptophan synthase, alpha 
subunit  
✓   
trpB 
tryptophan synthase, beta 
subunit  
✓   
 Collected from: http://www.Shigatoxin.net, http://mlst.ucc.ie and http://www.psteur.fr 
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1.7.2.3.5. Applications of MLST 
Due to its high discriminatory power and the portability of the results, in addition to its 
contribution in the studies of evolution and population biology of organisms, MLST 
has been widely applied to study a variety of problems including the emergence of 
antibiotic resistant clones of pathogenic organisms (Nemoy et al. 2005; Reinert et al. 
2005). MLST even shows potential to be used directly on clinical material, which may 
make MLST as essential a tool for routine clinical diagnosis as it is in epidemiological 
research (Diggle, Bell & Clarke 2003; Spratt 1999). 
1.7.3. Phylogenetic analysis 
With the rapid accumulation of genomic sequence data, phylogenetic analyses have 
evolved from being descriptive and speculative analysis of evolutionary relationships to 
a more mathematics based science, as a result of advances in mathematical models of 
sequence evolution and statistical evolutionary tools (Whelan, Lio & Goldman 2001).  
For phylogenetic analysis of aligned sequences, all evolution analysis methods describe 
sequence evolution using phylogenetic trees. Methods used to construct phylogenetic 
trees fall into two categories: distance methods; and discrete methods.  
1.7.3.1. Distance methods 
These involve the calculation of matrices of evolutionary distances between taxa on a 
pairwise basis. The evolutionary distance used for this purpose is usually an estimation 
of the number of nucleotide substitutions per site (Nei 1996).  
There are several distance methods for construction of phylogenetic trees, the most 
commonly used ones being the unweighted pair group method with arithmetic means 
(UPGMA) and neighbour joining (NJ) methods. 
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UPGMA is the simplest method of tree construction and was originally developed to 
construct taxonomic phenograms, which are trees that reflect the phenotypic 
similarities between taxa. It uses a sequential clustering algorithm that starts by 
grouping two taxa with the most similarity and then progressively adding less similar 
taxa to the groups.  It is generally not considered a good algorithm for construction of 
phylogenetic trees, as it assumes that the evolution rates of different lineages are 
approximately equal. Although this is not the case in bacterial population biology, 
UPGMA may prove useful as a quick guide to identifying similar isolates (Morrison 
1996). 
NJ is based on the minimum-evolution criterion to re-construct a phylogenetic tree 
from evolutionary distance data i.e. the topology that gives the least total branch length 
is preferred at each step of the algorithm. Unlike UPGMA constructed trees, NJ does 
not assume that all lineages evolve at the same rate and it is largely recommended to 
analyze populations where lineage evolution rate varies. However, as the NJ algorithm 
seeks to represent the data in the form of an additive tree, NJ may not find the true tree 
topology with least total branch length. Even though it is sub-optimal in this sense, the 
reliability of the NJ tree obtained can be extensively tested using bootstrap analysis, 
which usually finds a tree that is quite close to the optimal tree (Saitou & Nei 1987).  
1.7.3.2. Discrete (character-based) methods 
Discrete methods consider each nucleotide site directly, rather than on pairwise 
distances, using optimality criteria to choose among the set of all possible trees. The 
optimality criteria give each tree a score that is based on the comparison of the tree to 
other possible trees according to used criteria (Nei 1996). 
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The commonly used distance methods are the maximum parsimony (MP) and the 
maximum likelihood (ML) methods (Whelan et al. 2001). 
ML is one of the standard tools of statistics. In phylogenetic analysis, it evaluates the 
probability that the chosen evolutionary model will have generated the observed 
sequences. The preferred trees are those that yield the highest likelihood over the whole 
tree. It involves two steps: building mathematical models taking in account all possible 
nucleotide substitution configurations; and then finding the tree that is most likely to 
have produced the observed data. Because it analyzes each nucleotide position of the 
multiple alignment, maximum likelihood is CPU consuming and, thus, extremely slow 
(Felsenstein 1981). 
The MP method attempts to determine a phylogenetic tree that requires the smallest 
number of evolutionary changes to explain the variation in a given set of data. In 
construction of MP trees, only informative or substitution sites are considered and the 
sum of the minimum possible substitutions over all sites is called the tree length. The 
tree with the minimum length is selected as the tree of maximum parsimony (Whelan et 
al. 2001). 
1.8. Aims of the project 
The spread of highly virulent strains of UPEC such as E. coli CGA and the emergence 
of unique antimicrobial resistance profiles among the UPEC population, provide 
evidence of epidemic clonal dissemination. To determine the epidemiological 
significance of these pathogens, a full understanding of the population biology is 
required.  
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The overall aims of this thesis were to study the population biology of UPEC in the 
North West of England with a view to understanding the most significant lineages 
causing UTI and to inform development of rapid assays to allow identification of 
members of these lineages. To achieve these overall aims, the following objectives 
were set: 
 
 Generate a collection (n≥300) of UPEC isolates that meet a selection criterion 
of identifying E. coli  causing UTI used by the UK Health Protection Agency 
(Anonymous 2004).  
 Identify successful clones and clonal complexes within the strain collection 
using multilocus sequence typing (MLST). 
 Assess the phylogeny and the microevolution of clones and clonal complexes 
that constitute the UPEC population and examine their phylogenetic 
relationships with other E. coli pathotypes using different molecular 
phylogenetic analysis methods and online MLST database resources. 
 To further examine isolates of identified clones and clonal complexes using 
phenotypic and genotypic methods and measure the possible association of key 
UPEC clones with different pheno- and genotypic profiles. 
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2. Materials and Methods  
2.1. Uropathogenic E. coli strain selection  
A total of 300 isolates of UPEC were collected and, in order to minimize the possibility 
of collecting non-UPEC, the selection was limited to urine isolates that showed pure 
culture with a significant total count, accompanied with significant pyuria according to 
the national standard method (BSOP 41) Health Protection Agency (Anonymous 2004). 
Urine samples were plated onto CLED agar plates (Oxoid, Ltd, UK), which were 
incubated at 37
ο
C for 18 hrs in a normal atmosphere. 
Of the 300 non-replicated isolates collected, 150 were recovered in June 2007 in the 
Manchester area (100 isolates) and Preston area (50 isolates), another 150 isolates being 
collected within the same period of 2009 and with the same geographic representation. 
2.2. Isolate collection 
The collection was carried in two settings, one in the microbiology laboratory at the 
Central Manchester and Manchester Children‟s University Hospital (MRI), which 
served both the MRI and the surrounding general practitioners in Manchester, and the 
other in the microbiology laboratory at the Preston Royal Hospital.  
To maximize the chances of collecting E. coli, all lactose fermenting strains were 
further examined using chromogenic media CPS3 (Biomérieux), as per manufacturer‟s 
directions, on which E. coli are identified based on the ability to produce β –
glucuronidase.  
 
Chapter 2                                                         Materials and Methods 
61 
 
2.3. Identification and antibiotic susceptibility  
The Vitek 2 compact automated system (Biomérieux) was used for the identification 
and the antibiotic susceptibility testing of the collected isolates.  By using the Vitek 2 
ID-GNB card (Biomérieux), identification of Gram negative bacilli occurs through 
testing the organism‟s metabolic activity in 41 fluorescent biochemical tests including 
18 enzymatic tests, 18 fermentation tests, two decarboxylase tests and three other 
miscellaneous tests. 
Antibiotic susceptibility testing is based on kinetic analysis of the bacterial growth in 
the presence of selected antibiotics (20 antibiotics representing all antibiotic families) 
and the antibiotic susceptibility profile is then analysed in order to predict the 
underlying resistance mechanisms present in each isolate. 
The antibiotic panel (Vitek 2 AST-054) was selected, as it covers the commonly used 
antibiotics for UTI and it is one of the standard antibiotic panels used in the UK. It 
consists of the following antibiotics: Ampicillin, Amoxicillin/Clavulanic acid, 
Piperacillin, Piperacillin/Tazobactam, Cefalotin, Cefuroxime, Cefuroxime axeil, 
Cefoxitin, Cefotaxime, Ceftazidime, Cefepime, Aztreonam, Meropenem, Ertapenem, 
Trimethoprim, Tobramycin, Amikacin, Gentamicin, Nalidixic acid, Ciprofloxacin and 
Nitrofurantoin.   
Isolates that were previously identified as E. coli using CPS3 chromogenic media were 
cultured on Nutrient agar (Oxoid) and incubated for 18-24 hrs at 37ºC. The 
identification and antimicrobial susceptibility testing was performed following the 
manufacturer‟s instructions, and the resulting biochemical activity and antibiotic 
susceptibility data were recorded in spreadsheets for subsequent analysis. 
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The fully identified UPEC strains were stored using the microbank system (ProLab 
Diagnostics, UK) in duplicate (-20ºC and -70ºC). 
2.4. DNA extraction  
Prior to DNA extraction, strains were cultured on Columbia agar and MacConkey agar 
plates (Oxoid) at 37
o
C for 18 hrs and pure single colonies from Columbia agar plates 
were used for extraction. Genomic DNA extraction was carried out using PrepMan 
Ultra sample preparation reagent (Applied Biosystems, USA) following the 
manufacturer‟s instructions. Extracted DNA was stored in a freezer at -20ºC, ready to 
be used for PCR. 
2.5. Multilocus sequence typing of UPEC  
The previously collected DNA extracts from the 300 UPEC isolates were genotyped 
using the MLST scheme developed by Achtman and colleagues (Wirth et al. 2006).  
2.5.1. Selection of the targeted loci  
The success of MLST protocol as a typing method greatly depends on the selection of 
the examined genes. From the few schemes available that are supported by an 
international database, Achtman‟s scheme (http://mlst.ucc.ie/mlst/dbs/Ecoli/) provides a 
high discriminatory power, capable of clustering populations in to different clonal 
groups and is one of the more widely used schemes. 
Seven genes were selected according to the Achtman scheme, adk: adenylate kinase; 
fumC: Fumarate hydratase; gyrB: DNA gyrase; icd: Isocitrate/isopropylmalate 
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dehydrogenase; mdh: Malate dehyrogenase; purA: adenylosuccinate; recA: ATP/GTP 
binding motif. 
2.5.2. PCR amplification of the targeted genes  
Internal fragments of the seven house-keeping genes, which ranged between 583bp to 
932bp, were amplified using pairs of primers listed in Table 2.1. 
The amplification reactions were carried out in 50 μl volumes containing 5 μl of each 
primer (10pmol/μl), 5μl of PCR buffer (x10) (Qiagen, Sussex, UK), 10 μl of 1mM 
deoxynucleoside triphosphates (dNTPs) (Roche, GmbH, Germany) and 0.25 units of 
Taq DNA polymerase (Qiagen) and 1 μl of chromosomal DNA. 
Amplification conditions were: 2 min at 94 ºC, followed by 35 cycles of 1 min at 94 ºC, 
1 min at annealing temperature (as listed in Table 2.1), 1 min at 72 ºC followed by 5 
min at 72 ºC and finally the reactions were held at 4 ºC. Amplification was carried out 
using an Eppendorf thermal cycler (Mastercycler; Helena Biosciences, Gateshead, UK). 
 
Table ‎2.1 PCR primers for the seven selected house keeping genes used in MLST 
Gene Primer‎Sequence‎(5’‎– 3’) 
Annealing 
temp. (℃) 
Size of  
product  (bp) 
adk 
F'-ATTCTGCTTGGCGCTCCGGG 
R –CCGTCAACTTTCGCGTATTT 
60 583 
fumC 
F -TCACAGGTCGCCAGCGCTTC 
R –GTACGCAGCGAAAAAGATTC 
63 806 
gyrB 
F –TCGGCGACACGGATGACGGC                                            
R-ATCAGGCCTTCACGCGCATC 
60 911 
icd 
F -ATGGAAAGTAAAGTAGTTGTTCCGGCACA 
R –GGACGCAGCAGGATCTGTT 
53 878 
mdh 
F –ATGAAAGTCGCAGTCCTCGGCGCTGCTGGCGG            
R -TTAACGAACTCCTGCCCCAGAGCGATATCTTTCTT 
53 932 
purA 
F -CGCGCTGATGAAAGAGATGA 
R –CATACGGTAAGCCACGCAGA 
67 816 
recA 
F -CGCATTCGCTTTACCCTGACC 
R –TCGTCGAAATCTACGGACCGGA 
60 780 
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2.5.3. Detection of the PCR product  
The presence and the purity of the PCR product was confirmed electrophoretically by 
mixing 5μl of each PCR product with 5μl of loading buffer [70% (w/v) sterile injectable 
water (Phoenix Pharmaceuticals, Gloucester, UK), 29.5% (w/v) Glycerol (Sigma) and 
0.5% (w/v) Bromophenol Blue (Bio-Rad, Hertfordshire, UK)] and passing the PCR 
product mixture through 2% (w/v) of agarose (Promega Corporation, Madison, USA) in 
Tris-borate-EDTA (TBE) (Sigma Dorset, UK) incorporating 15μl of SYBR safe gel 
stain (Invitrogen, Paisley, UK) at 132 V for 20 min followed by visualization of the 
bands under UV transillumination (Gel Doc 1000, Bio-Rad Laboratories). 
2.5.4. Post PCR purification  
The Whatman vacuum filtration system (Whatman, UK) was used to clean the PCR 
product of unwanted components in the reaction mixture. As recommended by the 
manufacturer, each sample was treated with 80 μl of binding buffer (4M Guanidine-
HCL, 0.75 M Potassium Acetate, pH 406) before being passed through the DNA 
binding plate under vacuum (-15 and -20 inches Hg), followed by washing the captured 
DNA with 400 μl of washing buffer (mixture of 40% (v/v) 100mM Tris, 20 mM EDTA, 
0.4M NaCl. pH 7.5 and 60% (v/v) ethanol). DNA was then recovered by adding 50μl of 
elution buffer (10mM Tris, 0.1 mM EDTA, pH 7.5). The purified DNA product was 
stored at -20 ºC. 
2.5.4.1. Sequencing of amplified DNA fragments  
SEQ Dye terminator cycle sequencing (DTCS) Quick start kits (Beckman Coulter Inc.) 
were used for sequencing of the target DNA fragments. As recommended by the 
manufacturer, the sequencing reactions were carried out in 10 μl volumes, each reaction 
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containing 2μl of DTCS Quick start master mix (Genome LabTM DTCS- Quick Start 
Kit, Beckman Coulter), 1μl of genetix buffer (half CEQTM Genetix, UK), 0.5μl of 
primer (10 pmol/μl), as shown in Table 2.2, 0.5μl of purified DNA template and DNA 
free water to adjust the volume to 10μl. 
The sequencing reaction conditions were 40 consecutive cycles of 96 ºC for 20 seconds, 
50 ºC for 20 seconds and 60 ºC for 4 minutes, finally held at 4 ºC and were carried out 
using an Eppendorf thermal cycler (Mastercycler; Helena Biosciences). 
 
Table ‎2.2 Sequencing primers for analysis of the target gene fragments in MLST 
Gene Primer Sequence  
adk 
F 5‟- GCAATGCGTATCATTCTGCT-3‟                                                                             
R 5‟- CAGATCAGCGCGAACTTCAG-3‟ 
fumC 
F 5‟- CCACCTCACTGATTCATGCG-3‟                                                                            
R 5‟- CGGTGCACAGGTAATGACTG-3‟ 
gyrB 
F 5‟- CGGGTCACTGTAAAGAAATTATCG-3‟                                                                              
R 5‟- GTCCATGTAGGCGTTCAGGG-3‟ 
icd 
F 5‟- TACATTGAAGGTGATGGAATCG-3‟                                                                         
R 5‟- GTCTTTAAACGCTCCTTCGG-3‟ 
mdh 
F 5‟- TCTGAGCCATATCCCTACTG-3‟                                                                              
R 5‟- CGATAGATTTACGCTCTTCCA-3‟ 
purA 
F 5‟- CTGCTGTCTGAAGCATGTCC-3‟                                                                             
R 5‟- CAGTTTAGTCAGGCAGAAGC-3‟ 
recA 
F 5‟- AGCGTGAAGGTAAAACCTGTG-3‟                                                                             
R 5‟- ACCTTTGTAGCTGTACCACG-3‟ 
2.5.5. Post sequencing purification  
To remove unincorporated primers and master mix residues, the ethanol plate 
precipitation method was used, as recommended by the manufacturer of the sequencing 
kit (Beckman Coulter). Freshly prepared stop solution/glycogen mixture was prepared 
as follows. For each sequencing reaction: 1μl of 3M sodium Acetate (pH 5.2) (Sigma), 
1μl of 100mM Na2-EDTA (pH 8.0) (Sigma) and 0.5 μl of 20 mg/ml of glycogen 
(Genetix). 2.5 µl of stop solution and 30 µl of ice cold 95% (v/v) Ethanol/H2O (kept at -
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20ºC) were added to each sequencing reaction and plates were sealed with an 
aluminium foil lid (Beckman Coulter). The mixture was mixed by inverting the plate 
15-20 times vigorously and immediately centrifuged at 14,000 rpm at 4 ºC for 30 
minutes using a Beckman Coulter Allegro
TM
 21R centrifuge (Beckman Coulter Inc.). 
After centrifugation, the alcohol was removed by spinning the plate, after inverting it on 
folded paper towels, at 300 rpm for 2 seconds. The pellets, which formed at the bottom 
of the wells, were then rinsed twice with 100 μl of ice cold 75% (v/v) Ethanol/H2O. 
After each rinse, the plate was immediately centrifuged at 14,000 rpm for 5 minutes at 4 
ºC. After centrifugation the supernatant was carefully removed by gently inverting the 
plate and as mentioned above the excess alcohol was removed by spinning the inverted 
plate at 300 rpm for 2 seconds.  
Finally, the plate was vacuum dried for 20 minutes, and the pellets were suspended in 
50 μl of the Sample Loading Solution (supplied with the kit) and each sample was 
overlaid with one drop of mineral oil (supplied with the kit). The plate was then kept at 
-20 ºC ready for sequence analysis. 
2.5.6. Sequence determination and analysis  
The sequences of the reaction products were then determined using a capillary 
electrophoresis sequencer (CEQ 8000 BECKMAN COULTER). Assembly and analysis 
of each target gene fragment was performed using Sequencher
TM 
v.4.0 software (Gene 
Codes Corporation). The sequence fragments were trimmed to a uniform length that 
corresponded with the region used to identify the target, by reference to allele sequences 
recovered from the Achtman MLST protocol published on the 
http://mlst.ucc.ie/mlst/dbs/Ecoli website.  
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2.5.7. Allele and sequence type assignment  
The sequences of target genes fragments were then assigned distinct allele numbers by 
submitting them to the MLST E. coli data base website 
(http://mlst.ucc.ie/mlst/dbs/Ecoli).  
Finally, a Sequence Type (ST) and its associated Sequence Type Complex were 
assigned for each isolate by comparing its allelic profile with that available in the 
MLST database. In the case of new alleles being identified, a unique allele number and, 
subsequently, a new ST was issued by the curator of the database, following 
examination of the DNA sequence trace files for the respective isolate. 
2.6. Phylogenetic analysis  
2.6.1. Characteristics of housekeeping genes 
The statistical tools implemented in the START v2 program (Jolley et al. 2001) were 
used to describe the molecular characteristics of housekeeping genes. The total number 
of polymorphic sites and the ratio (dS/dN) of synonymous substitutions to non-
synonymous substitutions per nucleotide for all target gene fragments were estimated. 
The dN/dS ratio is used to assess the degree of selective pressure operating on target 
genes. An excess of non-synonymous (dN) over synonymous (dS) substitutions is 
indication of positive selection indicating that non-synonymous changes are being fixed 
faster than they occur by mutation. A dN/dS <1 indicates negative selection in which 
non-synonymous changes are usually deleterious and therefore selected out of the 
population.  
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2.6.1.1. Index of association 
The extent of linkage equilibrium or clonality among the defined population was 
estimated by calculating the standardized index of association (ISA) values (Haubold & 
Hudson 2000) as implemented in the START v2 program. Within a monophyletic 
population an IA significantly different than Zero in 1000 randomized trials would 
suggest linkage disequilibrium indicating that the population has a clonal structure, 
while IA values not significantly different than Zero indicate linkage equilibrium and the 
population is considered to be freely recombining. 
2.6.1.2. Simpson’s index of diversity 
The Simpson‟s Index of Diversity (Simpson 1949) was used to determine the level of 
diversity within each house keeping gene in the studied population compared to ExPEC 
and other E. coli populations reported in the database. The following equation was used 
to measure the level of diversity 
 
 
      
       
      
 
 
 
Where N represents the total number of different STs in the population and n is the total 
number of STs that have the same allele type. 
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2.6.2. eBURST 
The Based Upon Related Sequence Types (BURST) clustering algorithm was originally 
designed by Dr. Ed Feil and his colleagues in Imperial College London and upgraded in 
2004 when it was entitled eBURST. eBURST is available freely online 
(http://eburst.mlst.net/). The algorithm attempts to cluster STs into clonal complexes 
(CC) based on the number of shared gene loci and further predict a founder for each CC 
based on the abundance of STs that are linked to a particular ST by a single allelic 
difference. The algorithm draws conclusions about the relatedness of individual STs, 
describing the ST as single locus variant (SLV), double locus variant (DLV) or triple 
locus variant (TLV) in relation to the founder ST and to each other. Additionally, 
eBURST was able to estimate the relative age of a CC by how many SLVs it has and 
the presence of related subgroups (Feil et al. 2004). 
2.6.3. UPGMA (unweighted pair group method with arithmetic mean) 
cluster analysis 
As it uses the assumption of an equal evolutionary rate of change in all lineages, this 
method is not considered a good algorithm for construction of Phylogenetic trees. 
However, for MLST, in which the target genes were carefully selected to exhibit slow 
and steady mutation rates, UPGMA can provide a quick guide to identify similarity 
between STs. Using the START package, UPGMA was performed on allelic profiles of 
the dataset rather than the nucleotide sequences, which provides additional credibility to 
the phylogenetic inference obtained. 
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2.6.4. Neighbour-Joining (NJ) cluster method 
The NJ construction tool available in MEGA 4.11.1 software (www.megasoftware.net) 
was used to draw phylogenetic trees for concatenated sequences of the seven loci and 
for sequences of each locus alone using the Jukes-Cantor based algorithm and 
bootstrapping using 1000 data sets for each analysis. 
2.6.5. Clonalframe 
Clonalframe is a computer package used for the inference of bacterial microevolution 
using multilocus sequence data and was developed in 2007 by Didelot and Falush and is 
available freely from http://bacteria.stats.ox.ac.uk/ (Didelot & Falush 2007). It is based 
on a coalescent approach assuming that all isolates in a dataset had equal chances of 
reproduction in a constant sized population. As it takes into account both point mutation 
and homologous recombination, the method provides information on potential 
recombination sites and, therefore, calculates genealogies after ignoring these 
recombination events. A consensus tree based on the posterior probabilities of 
genealogies is generated, showing clonal relationships among the strains and attempting 
to suggest ancestral STs not found amongst the study population. 
Ten Clonalframe runs were computed on unique STs from the dataset, each with 
100,000 iterations after 10,000 burn-in iterations. 50% consensus trees and network 
representations of the analysis were generated using the graphical user interface of the 
program. 
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2.6.6. Neighbour-net 
Neighbour-net is a distance-based method that constructs phylogenetic networks using 
nucleotide sequence data. The neighbour-net algorithm is an extension of the neighbor-
joining algorithm in which an agglomerative process of pairing nodes is followed by 
collection of weighted splits that are converted into a split network rather than 
phylogenetic tree. This has the advantage of resolving conflicting signals generated by 
evolutionary processes, such as lateral transfer of genes and recombination within a 
population (Bryant & Moulton 2004).  
Concatenated sequences of the seven loci for all STs in the dataset were analyzed to 
generate a phylogenetic network using the Neighbour-net algorithm implemented in 
SplitsTree 4.11 (www.splitstree.org) (Huson & Bryant 2006). 
2.6.7. Tests for recombination 
In addition to index of association, which measures the clonality of a population by 
determining the contribution of recombination in shaping the population structure, 
nucleotide sequences of STs in dataset were analysed for evidence of recombination by 
several methods, each with its own specifications. 
2.6.7.1. Maximum Chi-squared test 
This is a method in which the sequences are examined in pairs for clusters of 
substitutions indicating a putative recombination event and to test whether the putative 
recombination sites are significant. Random trials are run where equal length sequences 
with the same number of polymorphic sites were created. The significance level was 
determined as the proportion of trial pairs with greater max X
2
 values than were 
observed for strain data (Smith 1992). 
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All seven loci of the 100 unique STs in the dataset were tested for recombination using 
the max X
2
 test included in the START v2 package. 1000 random pair comparison trials 
between allele sequences of each locus were run and putative recombination sites with p 
values <0.05 were considered significant. 
2.6.7.2. Split decomposition 
An initial search for recombination was conducted using the split decomposition 
algorithm, which is a parsimony method that represents conflicting phylogenetic signals 
in the data as parallel networks. Using the SplitsTree program v. 4.11, evidence for 
recombination in the concatenated dataset for each ST and for each house keeping gene 
was examined by split decomposition analysis with default settings (uncorrected P 
method) and 1000 bootstrap replicates. 
2.6.7.3. Pairwise homoplasy index test  
Based on the compatibilities between informative sites in a nucleotide sequence 
alignment, the pairwise homoplasy index test for recombination is able to distinguish 
recombination from frequent mutations. Using the pairwise homoplasy index test 
implemented by the SplitsTree program v.4.11, alleles of each house keeping gene were 
tested for recombination in addition to possible recombination within clonal complexes. 
2.7. Triplex PCR for Phylogenetic grouping 
This was performed based on methods described by Clermont and colleagues. A triplex 
PCR reaction was conducted to determine the phylogenetic group of each isolate in the 
data set (Clermont et al. 2000). Fragments of a combination of three DNA markers 
(chuA, yjaA and DNA fragment tspE4C2) were amplified using pairs of primers as 
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listed in Table 2.3. The amplification reactions were carried out in 50 μl volumes 
containing 25 μl of BioMix™ Red (Bioline USA Inc.), 1 μl of each primer (10pmol/μl) 
and 2 μl of 100 ng/μl chromosomal DNA. 
 
 
Table ‎2.3 Primers used in Triplex PCR to detect phylogenetic groups 
Gene Primer‎Sequence‎(5’‎– 3’) 
Size of  product      
(bp) 
chuA 
F-GACGAACCAACGGTCAGGAT                                       
R-TGCCGCCAGTACCAAAGACA 
279 
yjaA 
F-TGAAGTGTCAGGAGACGCTG                                       
R-ATGGAGAATGCGTTCCTCAAC 
211 
tspE4C2 
F-GAGTAATGTCGGGGCATTCA                                       
R-CGCGCCAACAAAGTATTACG 
152 
 
 
 
Amplification was carried out using the following conditions: 4min at 94 ºC; followed 
by 30 cycles of 5 sec at 94 ºC, 10 sec at 59 ºC, 10 sec at 72 ºC; followed by 5 min at 72 
ºC and finally the reactions were held at 4 ºC.  
The PCR products were analyzed electrophoretically by passing  the PCR product 
through 1.5 % (w/v) agarose (Promega) in Tris-borate-EDTA (TBE) (Sigma) 
incorporating 15μl of SYBRsafeTM gel stain (Invitrogen) at 132 V for 20 min and 
visualisation under UV transillumination (Ge Doc 1000, Bio-Rad Laboratories) 
Interpretation: 
Band patterns on agarose gels were then analyzed to determine the phylogenetic group 
according to the dichotomous decision tree proposed by Clermont (Clermont et al. 
2000), (Figures 2.1 & 2.2). 
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Figure ‎2.2 Dichotomous decision tree proposed by Clermont et al (2000) 
 
2.8. Pulse-field gel electrophoresis (PFGE) 
The genetic relatedness of 32 representative isolates of the common UPEC sequence 
types ST69 (n=10 isolates), ST73 (9) and ST131 (13), taken from different phylogenetic 
groups, was determined by XbaI PFGE analysis performed according to the PulseNet 
standardized PFGE protocol (Ribot et al. 2006). Generated profiles were compared 
digitally using BioNumerics v.3.5 (Applied Maths). A dendrogram was generated from 
Figure ‎2.1 Triplex PCR profiles for each phylogenetic group 
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the Cluster analysis of Dice similarity indices based on UPGMA. Isolates were 
considered to belong to the same PFGE group if their Dice similarity index was ≥85%. 
2.9. Virulence factor screening 
The entire culture collection was screened for the presence of twenty-nine ExPEC 
associated VF genes encompassing five categories (adhesins, toxins, siderophores, 
capsule and “miscellaneous”). The adhesin genes investigated included fimH (mannose 
specific adhesin of type I fimbriae), P fimbriae elements (papAH, papC, papEF and 
papG alleles I, II, III, sfaS (S fimbrial adhesin), focG (the putative F1C fimbrial 
adhesin), sfa/focDE (central region of sfaS and focG operons), afa/draBC (Dr antigen-
specific adhesin operons), bmaE (Blood group M-specific adhesion), nfaE (non-fimbrial 
adhesin), gaf D (glucosamine specific G fimbriae). Toxin genes screened were cnf1 
(cytotoxic necrotizing factor), cdtB (cytolethal distending toxin) and hlyA (α-
haemolysin). The siderophore genes studied were fyuA (yersiniabactin) and iutA 
(aerobactin). Capsule synthesis associated genes screened were kpsMT groups (II and 
III) in addition to specifically targeting K1 and K5 genes of group II capsules. The 
miscellaneous VF genes were cvaC (colicin V; multifunctional serum resistance-
associated plasmids), traT (serum resistance associated), ibeA (invasion of brain 
endothelium), and PAI, a coding region of unknown significant of a sequenced PAI 
from archetypal ExPEC strain CFT073 was used as a generic marker for uropathogenic 
PAIs..   
VF profiles of the 300 isolates were determined using primers listed in Table 2.4 and an 
established multiplex PCR–based assay (Johnson & Stell 2000). 
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            Table ‎2.4 Primers used in Triplex PCR to detect different VFs 
Gene Primer sequence*  (5’-3’) 
Size of product 
(pb) 
papAH 
F-ATGGCAGTGGTGTCTTTTGGTG                                                
R-CGTCCCACCATACGTGCTCTTC 
720 
papC 
F-GTGGCAGTATGAGTAATGACCGTTA                                       
R-ATATCCTTTCTGCAGGGATGCAATA 
200 
papEF 
F-GCAACAGCAACGCTGGTTGCATCAT                                   
R-AGAGAGAGCCACTCTTATACGGACA 
336 
papG I, II,III 
papG II, III   
papG I 
F-CTGTAATTACGGAAGTGATTTCTG                                       
R-ACTATCCGGCTCCGGATAAACCAT                                     
R-TCCAGAAATAGCTCATGTAACCCG 
1070                    
1190 
allele I 
F-TCGTGCTCAGGTCCGGAATTT                                              
R-TGGCATCCCCCAACATTATCG 
461 
allele II 
F-GGGATGAGCGGGCCTTTGAT                                                
R-CGGGCCCCCAAGTAACTCG 
190 
Allele III 
F-GGCCTGCAATGGATTTACCTGG                                             
R-CCACCAAATGACCATGCCAGAC 
258 
Sfa/focDE 
F-CTCCGGAGAACTGGGTGCATCTTAC                                  
R-CGGAGGAGTAATTACAAACCTGGCA 
410 
sfaS 
F-GTGGATACGACGATTACTGTG                                                 
R-CCGCCAGCATTCCCTGTATTC 
240 
focG 
F-CAGCACAGGCAGTGGATACGA                                           
R-GAATGTCGCCTGCCCATTGCT 
360 
Afa/draBC 
F-GGCAGAGGGCCGGCAACAGGC                                           
R- CCCGTAACGCGCCAGCATCTC 
559 
bmaE 
F-ATGGCGCTAACTTGCCATGCTG                                          
R-AGGGGGACATATAGCCCCCTTC 
507 
gafD 
F-TGTTGGACCGTCTCAGGGCTC                                             
R-CTCCCGGAACTCGCTGTTACT 
952 
nfaE 
F-GCTTACTGATTCTGGGATGGA                                             
R-CGGTGGCCGAGTCATATGCCA 
559 
fimH 
F-TGCAGAACGGATAAGCCGTGG                                           
R-GCAGTCACCTGCCCTCCGGTA 
508 
hlyA 
F-AACAAGGATAAGCACTGTTCTGGCT                                  
R-ACCATATAAGCGGTCATTCCCGTCA 
1177 
cnfI 
F-AAGATGGAGTTTCCTATGCAGGAG                                    
R-CATTCAGAGTCCTGCCCTCATTATT 
498 
cdtB 
F-AAATCACCAAGAATCATCCAGTTA                                    
R-AAATCTCCTGCAATCATCCAGTTTA 
430 
fyuA 
F-TGATTAACCCCGCGACGGGAA                                            
R-CGCAGTAGGCACGATGTTGTA 
880 
iutA 
F-GGCTGGACATCATGGGAACTGG                                         
R-CGTCGGGAACGGGTAGAATCG 
300 
kpsMT-II 
F-GCGCATTTGCTGATACTGTTG                                              
R-CATCCAGACGATAAGCATGAGCA 
272 
kpsMT-III 
F-TCCTCTTGCTACTATTCCCCCT                                            
R-AGGCGTATCCATCCCTCCTAAC 
392 
kpsMT K1 
F-TAGCAAACGTTCTATTGGTGC                                             
R-CATCCAGACGATAAGCATGAGCA 
153 
kpsMT K2 
F-CAGTATCAGCAATCGTTCTGTA                                           
R-CATCCAGACGATAAGCATGAGCA 
159 
rfc 
F-ATCCATCAGGAGGGGACTGGA                                                           
R-AACCATACCAACCAATGCGAG 
788 
ibeA 
F-AGGCAGGTGTGCGCCGCGTAC                                             
R-TGGTGCTCCGGCAAACCATGC 
170 
cvaC 
F-CACACACAAACGGGAGCTGTT                                             
R-CTTCCCGCAGCATAGTTCCAT 
680 
traT 
F-GGTGTGGTGCGATGAGCACAG                                              
R-CACGGTTCAGCCATCCCTGAG 
290 
PAI 
F-GGACATCCTGTTACAGCGCGCA                                          
R-TCGCCACCAATCACAGCCGAAC 
930 
             *(Johnson & Stell 2000) 
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2.10. Identification of isolates from the CTX-M-15 producing O25b 
ST131 clone 
2.10.1. Screening for extended spectrum beta-lactamase enzyme type 
ST131 isolates with ESBL phenotypes were screened for blaCTX-M alleles by PCR with 
universal primers MA1 and MA2 (Table 2.5). The amplification reactions were carried 
out in 50 μl volumes containing 5 μl of each primer (20pmol/μl), 5μl of PCR buffer 
(x10) (Qiagen), 10 μl of 1mM deoxynucleoside triphosphates (dNTPs) (Roche), 0.25 
units of Taq DNA polymerase (Qiagen) and 2 μl of 100 ng/μl chromosomal DNA.  
Amplification conditions were: Initial denaturation for 2 min at 94 ºC; followed by 35 
cycles of 30 sec. at 94 ºC, 30 sec. at 55 ºC, 45 sec. at 72 ºC; followed by final elongation 
for 5 min at 72 ºC; and finally the reactions were held at 4 ºC and the resulting 
amplicons (size 554 bp) were defined by comparison to a standard 100bp DNA ladder 
(Invitrogen). 
Determination of different blaCTX-M group was carried out using specific primers for 
each of the 5 groups (Table 2.5) following the amplification reaction conditions 
described above. 
2.10.2. Detection of CTX-M-15 O25b ST131 clone 
ST131 isolates identified as being positive for group 1 CTX-M were investigated for 
inclusion of the CTX-M-15 producing O25b clone. This was carried out by PCR using 
specific primers listed in Table 2.5. The amplification reactions were carried out in 50 
μl volumes containing 25 μl of BioMix™ Red (Bioline USA Inc.), 1 μl of each primer 
(20pmol/μl) and 2 μl of 100 ng/μl chromosomal DNA. 
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Table ‎2.5 Primers used to screen for different CTX-M alleles and for the CTX-M-15 
producing O25b clone 
Target 
Description 
Primer  Primer‎Sequence‎(5’‎– 3’) 
Size of 
product   
(bp) 
*Reference 
Universal 
CTX-M 
MA  
F-SCSATGTGCAGYACCAGTAA           
R-CCGCRATATGRTTGGTGGTG 
554 1 
CTX-M-G1 blaCTX-M-1 
F-AAAAATCACTGCGCCAGTTC            
R-AGCTTATTCATCGCCACGTT 
415 2 
CTX-M-G2 blaCTX-M-2 
F-CGACGCTACCCCTGCTATT            
R-CCAGCGTCAGATTTTTCAGG 
552 2 
CTX-M-G8 blaCTX-M-8 
F-GCACGATGACATTCGGG                
R-AACCCACGATGTGGGTAGC 
666 2 
CTX-M-G9 blaCTX-M-9 
F-CAAAGAGAGTGCAACGGATG       
R-ATTGGAAAGCGTTCATCACC 
205 2 
CTX-M-G25 blaCTX-M-25 
F-GCACGATGACATTCGGG                
R-AACCCACGATGTGGGTAGC 
327 2 
CTX-M-15 blaCTX-M-15 
F-ATAAAACCGGCAGCGGTG 
R-GAATTTTGACGATCGGGG 
500 3 
O25b 
rfb.1bis 
rfbO25b.r 
F-ATACCGACGACGCCGATCTG      
R-TGCTATTCATTATGCGCAGC 
300 3 
*1 (Saladin et al. 2002) ; 2 (Woodford, Fagan & Ellington 2006); 3 (Blanco et al. 2009); Abbreviations: 
S: G or C, Y: C or T, R: A or G  
 
 
 
Amplification conditions were: Initial denaturation for 5 min at 94 ºC; followed by 30 
cycles of 30 sec. at 94 ºC, 30 sec. at 55 ºC, 90 sec. at 72 ºC; followed by final elongation 
for 7 min at 72 ºC and finally the reactions were held at 4 ºC (Blanco et al. 2009). The 
produced amplicons (300 and 483bp) were identified using a 100bp DNA Ladder 
(Invitrogen) as a marker. 
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2.10.3. Detection of mechanisms of quinolone resistance in ST131 isolates 
All quinolone resistant ST131 isolates were screened for the presence of different 
resistance mechanisms using published methods. 
Mutations in QRDRs of gyrA and parC were detected as described by Yue and 
colleagues (Yue et al. 2008). The amplification reactions were carried out in 50 μl 
volumes containing 5 μl of each primer (10pmol/μl) (Table 2.6), 5μl of PCR buffer 
(x10) (Qiagen), 10 μl of 1mM deoxynucleoside triphosphates (dNTPs) (Roche) and 
0.25 units of Taq DNA polymerase (Qiagen) and 1 μl of chromosomal DNA. The 
resulting amplicons were purified using a Whatman vacuum filtration system 
(Whatman) and were sequenced using a Dye terminator cycle sequencing (DTCS) 
Quick start kit (Beckman Coulter), as described in Section 2.5.4. The final assembly and 
analysis of each target gene fragment was carried out using Sequencher
TM
 v.4.0 
software (Gene Codes Corporation) and comparison with relevant native sequences for 
the gyrA (X06373) and parC genes (M58408) in the genebankTM database. 
PCR-based Restriction Fragment Length Polymorphism (PCR-RFLP) assay was used to 
identify the aac (6’)-lb-cr variants. PCR reactions were performed to amplify all aac 
(6’)-lb sequences using primers and PCR condition described previously (Jones et al. 
2008). The amplified DNA was purified as mentioned above (Section 2.5.4) and the 
cleaned amplicons were digested with NdeI and FokI restriction enzymes (Sigma) as 
described previously (Jones et al. 2008). 
Screening for the three known qnr genes was carried out using multiplex PCR (Cattoir 
et al. 2007) and three strains were used as positive controls, two of which (qnrA and 
qnrB) were kindly provided by Dr. Neil Woodford (ARMRL, HPA, UK) and the qnrS 
positive strain was obtained from the National Collection of Type Cultures (NCTC) 
(HPA, UK). The expected product sizes for qnrA, qnrB and qnrS were 580, 264 and 428 
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bp, respectively (Figure 2.3). Amplification products were sized using a 100bp DNA 
Ladder (Invitrogen). 
Table ‎2.6 Primers used in PCR reactions to detect different quinolone resistance 
mechanisms 
Gene Primer‎sequence‎‎(5’- 3’) 
Size of product 
(pb) 
*Reference 
gyrA 
F-  GGATAGCGGTTAGATGAGC                     
R- CGTTCACCAGCAGGTTAGG 
521 1 
parC 
F-  AATGAGCGATATGGCAGAGC                                                         
R- TTGGCAGACGGGCAGGTAG 
376 1 
qnrA 
F-  AGAGGATTTCTCACGCCAGG                                    
R- TGCCAGGCACAGATCTTGAC 
580 2 
qnrB 
F-  GGMATHGAAATTCGCCACTG                                     
R- TTTGCYGYYCGCCAGTCGAA 
264 2 
qnrS 
F-  GCAAGTTCATTGAACAGGGT                                       
R- TCTAAACCGTCGAGTTCGGCG 
428 2 
aac(6’)-lb 
F-  ATGACTGAGCATGACCTTGC                            
R- TTAGGCATCACTGCGTGTTC 
519 3 
*1 (Yue et al. 2008); 2 (Cattoir et al. 2007); 3 (Jones et al. 2008). Abbreviations: M: A or C, Y: C or T, 
H: A or C or T.  
 
 
Figure ‎2.3 Three Positive qnrA, qnrB and qnrS controls subjected to electrophoresis in 
1.5% agarose gels with a 100bp DNA marker (Invitrogen) 
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2.11. Statistical analysis  
Statistical analysis was performed using SPSS software version 16.0 (SPSS Inc.) and 
the add-in Excel statistical tool software XLSTAT–Pro (Addinsoft Digital River GmbH. 
Germany).  
Associations between different parameters were analysed by using Fisher‟s Exact or 
Mann-Whitney U test and the threshold for statistical significance was a P value of ≤ 
0.05 and, where appropriate, more stringent criteria for statistical significance were 
used.  
Aggregate scores for metabolic activities, resistance to different antimicrobial drugs and 
carriage of virulence factors were calculated for each isolate as the sum of all 
parameters for which the isolates tested positive divided by the total number of the 
tested parameters. Correlation analysis between biochemical scores, antimicrobial 
resistance scores and virulence scores were analysed using Pearson‟s correlation 
coefficients. Correlation analysis was also used to describe the association of different 
STs to the aggregate scores calculated for metabolic activities, resistance to different 
antimicrobial drugs and carriage of virulence factors and the significance criterion was a 
P value of ≤ 0.05. 
Correspondence analysis was used to represent the interrelationships of the UPEC 
isolates according to their STs and on the basis of their phylogenetic groups and to 
describe the distribution of urovirulence traits among different phylogenetic types. 
To assess the best combination of variables to identify ST131 and the CTX-M-15 
producing O25b clone, a stepwise logistic multivariate regression analysis was applied 
with 95% confidence intervals (CIs). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
                                                         Results                                                
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3. Results 
Full data relating to the genotypic and phenotypic analyses of the isolates studied here 
are given in Appendices I to VI. 
3.1. UPEC strains  
A total of 300 E. coli isolates (200 from Manchester and 100 from Preston in the 
Northwest of England) were typed using MLST. 
3.2. Allelic variation 
Allelic characterisation of isolates in the study population was carried out using START 
v2. For the seven housekeeping gene fragments amplified and sequenced in the present 
study, a total of 195 different alleles were detected. These consisted of 187 (96%), that 
had been described previously and eight (4%) novel alleles. The number of alleles for 
each targeted gene ranged from 22 (icd and mdh) to 33 (fumC and gyrB) with an 
average of 28 per locus (Table 3.1). 
  
 
Table ‎3.1 Allelic characterisation of UPEC housekeeping genes 
Gene 
Size of sequenced 
fragment (bp) 
No. of 
alleles 
No. of polymorphic sites 
(%) 
dN/dS 
adk 536 26 44 (8.2) 0.0056 
fumC 469 33 76 (16.2) 0.0143 
gyrB 460 33 33 (7.1) 0.0168 
icd 518 22 37 (7.1) 0.0087 
mdh 452 22 26 (5.7) 0.0126 
purA 478 31 34 (7.1) 0.0154 
recA 510 28 26 (5.0) 0.0000 
mean 489 28 39 (8.0) 0.0105 
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The degree of sequence diversity within the housekeeping genes was relatively high 
with the proportion of polymorphic sites ranging from 5.0% (recA) to 16.2% (fumC) 
with an average of 8.0%. The ratio of non-synonymous to synonymous dN/dS   changes 
for each gene locus were calculated using START v2, and all observed ratios were less 
than 1, indicative of negative or stabilising selection, with gyrB noted to have the 
highest dN/dS  ratio (0.0168) whilst recA had the lowest ratio (0.000; Table 3.1). 
To confirm that the population was not under focal positive selection leading to a 
flourish of allelic diversity, the allelic structure seen in the collected population was 
compared with that of STs reported in the international MLST database. Despite the 
relatively low Simpson‟s Index of Diversity (SID) detected for most enteric E. coli (EC) 
related target gene alleles, when compared to ExPEC all of the housekeeping gene 
fragments in the current dataset demonstrated diversity consistent with that of the entire 
ExPEC collection (Table 3.2). 
 
Table ‎3.2 Diversity of NW-UPEC STs compared to that of ExPEC and EC in the 
international MLST database.  
Gene 
NW-UPEC 
(100) 
International database 
ExPEC (293) EC (525) 
  No. of Alleles SID No. of Alleles SID No. of Alleles SID 
adk 26 0.89 53 0.90 102 0.84 
fumC 33 0.94 68 0.96 117 0.89 
gyrB 33 0.93 64 0.94 101 0.93 
icd 22 0.90 49 0.93 103 0.93 
mdh 22 0.89 40 0.92 78 0.92 
purA 31 0.91 49 0.91 87 0.84 
recA 28 0.94 43 0.93 70 0.86 
SID: Simpson‟s index of diversity 
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3.3. Allele specificity 
The majority of the alleles identified in the present study were found in both ExPEC and 
EC databases (Figure 3.1). The incidence of each allele of the seven housekeeping gene 
fragments differed little between our collection (195 alleles) and the ExPEC database 
(366 alleles) with only three alleles (fumC39, mdh8, mdh17) showing significant 
differences in their frequency of incidence. On the other hand when compared with the 
658 alleles in the EC database, 49 alleles were significantly associated with either the 
NW-UPEC collection or the EC database (Table 3.3). 
3.4. Sequence types and clonal complexes 
From 300 UPEC isolates tested, a total of 100 sequence types (STs) and 17 clonal 
complexes (CCs) were identified, CCs accounted for 54.7% of the tested population 
(Figure 3.2). All of the 17 CCs reported here were previously described and available in 
the international MLST database (http://mlst.ucc.ie). A total of 74 STs in the dataset 
were not able to be assigned to a CC. Forty-four STs were novel, of which 8 contained 
new alleles, the remainder were novel combinations of previously characterised alleles 
(Table 3.4). 
Figure 3.3 shows the frequency of repeatedly detected STs among collections from 
Manchester and Preston, where 9 STs were consistently detected in both collections. 
Although the number of isolates was too small to allow examination of statistical 
significance, some notable changes occurred between 2007 and 2009 with increases in 
the proportion of ST73 in Preston and ST131 in Manchester, but a decrease in ST69 in 
Manchester. 
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Figure ‎3.1 Proportional Venn-diagrams showing the number of alleles shared 
between the three screened populations (NW-UPEC, ExPEC and EC databases) 
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         Table ‎3.3 NW-UPEC allelic specificity compared to that reported for database ExPEC and EC isolates. 
           
         Significant differences were identified using Fisher‟s exact test. Highlights indicate significant (P≤0.05) differences in the incidence of alleles in the different populations. 
 
No. (%)  of Sequence type 
adk fumC gyrB icd mdh purA recA 
Allele NW UPEC ExPEC NW UPEC ExPEC NW UPEC ExPEC NW UPEC ExPEC NW UPEC ExPEC NW UPEC ExPEC NW UPEC ExPEC 
8 0 (0.0) 1 (0.3) 1 (1.0) 2 (0.7) 0 (0.0) 2 (0.7) 4 (4.0) 21 (7.2) 3 (3.0) 27 (9.2) 15 (15.2) 61 (20.8) 0 (0.0) 0 (0.0) 
17 0 (0.0) 1 (0.3) 0 (0.0) 0 (0.0) 3 (3.0) 6 (2.0) 0 (0.0) 0 (0.0) 28 (28.3) 53 (18.1 0 (0.0) 0 (0.0) 2 (2.0) 10 (3.4) 
39 0 (0.0) 1 (0.3) 4 (4.0) 2 (0.7) 1 (1.0) 1 (0.3) 0 (0.0) 1 (0.3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
 
Allele NW UPEC EC NW UPEC EC NW UPEC EC NW UPEC EC NW UPEC EC NW UPEC EC NW UPEC EC 
2 0 (0.0) 0 (0.0) 0 (0.0) 4 (0.8) 1 (1.0) 12 (2.)3 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (1.0) 22 (4.2) 9 (9.1) 114 (21.7) 
4 2 (2.0) 13 (2.5) 13 (0.0) 114 (21.7) 10 (10.1) 89 (17.0) 0 (0.0) 2 (0.4) 5 (5.1) 6 (1.1) 0 (0.0) 3 (0.6) 6 (6.1) 30 (5.7) 
5 0 (0.0) 1 (0.2) 0 (0.0) 1 (0.2) 3 (3.0) 44 (8.4) 0 (0.0) 0 (0.0) 11 (11.1) 33 (6.3) 13 (13.1) 25 (4.8) 0 (0.0) 0 (0.0) 
6 24 (24.2) 165 (31.4) 4 (4.0) 26 (5.0) 0 (0.0) 0 (0.0) 6 (6.1) 9 (1.7) 0 (0.0) 2 (0.4) 0 (0.0) 0 (0.0) 8 (8.1) 88 (16.8) 
7 0 (0.0) 3 (0.6) 1 (1.0) 28 (5.3) 0 (0.0) 17 (3.2) 0 (0.0) 2 (0.4) 3 (3.0) 40 (7.6) 6 (6.1) 51 (9.7) 11 (11.1) 109 (20.8) 
8 0 (0.0) 8 (1.5) 1 (1.0) 4 (0.8) 0 (0.0) 3 (0.6) 4 (4.0) 63 (12.0) 3 (3.0) 74 (14.1) 15 (15.2) 178 (33.9) 0 (0.0) 1 (0.2) 
9 0 (0.0) 18 (3.4) 0 (0.0) 1 (0.2) 16 (16.2) 8 (1.5) 0 (0.0) 5 (1.0) 6 (6.1) 67 (12.8) 0 (0.0) 4 (0.8) 5 (5.1) 3 (0.6) 
10 3 (3.0) 46 (8.8) 0 (0.0) 0 (0.0) 8 (8.1) 12 (2.3) 4 (4.0) 22 (4.2) 0 (0.0) 5 (1.0) 3 (3.0) 5 (1.0) 10 (10.1) 5 (1.0) 
11 0 (0.0) 0 (0.0) 4 (4.0) 70 (13.3) 0 (0.0) 1 (0.2) 0 (0.0) 2 (0.4) 6 (0.0) 51 (0.0) 20 (20.2) 19 (3.6) 0 (0.0) 5 (1.0) 
13 17 (17.2) 25 (4.8) 5 (5.1) 5 (1.0) 0 (0.0) 16 (3.0) 24 (24.2) 27 (5.1) 0 (0.0) 0 (0.0) 2 (2.0) 14 (2.7) 0 (0.0) 2 (0.4) 
14 5 (5.1) 0 (0.0) 7 (7.1) 2 (0.4) 1 (1.0) 13 (2.5) 9 (9.1) 5 (1.0) 0 (0.0) 0 (0.0) 1 (1.0) 11 (2.1) 1 (1.0) 24 (4.6) 
15 0 (0.0) 7 (1.3) 0 (0.0) 3 (0.6) 0 (0.0) 23 (4.4) 0 (0.0) 5 (1.0) 0 (0.0) 4 (0.8) 0 (0.0) 2 (0.4) 0 (0.0) 4 (0.8) 
16 0 (0.0) 11 (2.1) 0 (0.0) 1 (0.2) 0 (0.0) 2 (0.4) 4 (4.0) 56 (10.7) 6 (6.1) 4 (0.8) 1 (1.0) 17 (3.2) 1 (1.0) 6 (1.1) 
17 0 (0.0) 1 (0.2) 0 (0.0) 1 (0.2) 3 (3.0) 5 (1.0) 0 (0.0) 5 (1.0) 28 (28.3) 32 (6.1) 0 (0.0) 1 (0.2) 2 (2.0) 7 (1.3) 
18 1 (1.0) 7 (1.3) 0 (0.0) 2 (0.4) 0 (0.0) 4 (0.8) 2 (2.0) 43 (8.2) 2 (2.0) 6 (1.1) 2 (2.0) 20 (3.8) 0 (0.0) 1 (0.2) 
19 0 (0.0) 7 (1.3) 3 (3.0) 7 (1.3) 16 (0.0) 31 (0.0) 0 (0.0) 2 (0.4) 0 (0.0) 0 (0.0) 1 (1.0) 0 (0.0) 2 (2.0) 12 (2.3) 
21 4 (4.0) 5 (1.0) 0 (0.0) 6 (1.1) 0 (0.0) 1 (0.0) 0 (0.0) 4 (0.8) 0 (0.0) 4 (0.8) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
24 0 (0.0) 1 (0.2) 14 (14.1) 16 (3.0) 1 (1.0) 0 (0.0) 0 (0.0) 6 (1.1) 1 (1.0) 35 (6.7) 0 (0.0) 0 (0.0) 1 (1.0) 1 (0.2) 
25 0 (0.0) 0 (0.0) 0 (0.0) 5 (1.0) 1 (1.0) 1 (0.2) 7 (7.1) 8 (1.5) 0 (0.0) 1 (0.2) 3 (3.0) 4 (0.8) 12 (12.1) 15 (2.9) 
27 1 (1.0) 0 (0.0) 0 (0.0) 10 (1.9) 3 (0.0) 0 (0.0) 0 (0.0) 5 (1.0) 0 (0.0) 0 (0.0) 1 (1.0) 1 (0.2) 0 (0.0) 0 (0.0) 
28 1 (1.0) 0 (0.0) 0 (0.0) 2 (0.4) 1 (0.0) 1 (0.0) 0 (0.0) 4 (0.8) 1 (1.0) 2 (0.4) 4 (4.0) 1 (0.2) 2 (2.0) 0 (0.0) 
30 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.4) 2 (0.0) 0 (0.0) 0 (0.0) 1 (0.2) 2 (0.0) 4 (0.8) 0 (0.0) 1 (0.2) 1 (0.0) 1 (0.2) 
34 2 (2.0) 5 (1.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.2) 0 (0.0) 4 (0.8) 4 (0.0) 0 (0.0) 
36 7 (7.1) 3 (0.6) 2 (2.0) 3 (0.6) 0 (0.0) 0 (0.0) 6 (6.1) 8 (1.5) 3 (0.0) 3 (0.6) 0 (0.0) 1 (0.2) 0 (0.0) 5 (1.0) 
37 8 (8.1) 8 (1.5) 4 (4.0) 1 (0.2) 0 (0.0) 0 (0.0) 8 (8.1) 12 (2.3) 0 (0.0) 3 (0.6) 1 (1.0) 4 (0.8) 0 (0.0) 2 (0.4) 
38 2 (2.0) 0 (0.0) 9 (0.0) 12 (0.0) 0 (0.0) 1 (0.2) 0 (0.0) 1 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.0) 4 (0.8) 
39 0 (0.0) 0 (0.0) 4 (0.0) 4 (0.0) 1 (0.0) 6 (1.1) 0 (0.0) 1 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.0) 0 (0.0) 0 (0.0) 
40 5 (5.1) 2 (0.4) 2 (0.0) 3 (0.0) 0 (0.0) 1 (0.2) 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.0) 1 (0.0) 9 (0.0) 0 (0.0) 0 (0.0) 
56 0 (0.0) 29 (5.5) 0 (0.0) 1 (0.0) 0 (0.0) 2 (0.4) 0 (0.0) 2 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 4 (0.0) 0 (0.0) 9 (1.7) 
68 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 3 (0.6) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.0) 5 (0.0) 1 (0.0) 0 (0.0) 0 (0.0) 
69 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.0) 0 (0.0) 5 (1.0) 0 (0.0) 0 (0.0) 2 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.2) 
73 0 (0.0) 1 (0.2) 0 (0.0) 1 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.4) 4 (4.0) 2 (0.4) 
74 0 (0.0) 1 (0.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.0) 2 (2.0) 0 (0.0) 
99 0 (0.0) 1 (0.2) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.2) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (2.0) 0 (0.0) 
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Figure ‎3.2 The frequency of clonal complexes among the 300 UPEC isolates 
 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎3.3 Frequency of different STs detected in both Manchester and Preston   
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      Table ‎3.4 Frequency of detected sequence types and their allelic profiles 
ST CC 
Profile 
Frequency 
% of 
Database adk fumC gyrB icd mdh purA recA 
73 ST-73 36 24 9 13 17 11 25 50 16.67 
131 - 53 40 47 13 36 28 29 37 12.33 
69 ST-69 21 35 27 6 5 5 4 27 9 
95 ST-95 37 38 19 37 17 11 26 19 6.33 
10 ST-10 10 11 4 8 8 8 2 13 4.33 
127 - 13 14 19 36 23 11 10 11 3.67 
14 ST-14 14 14 10 14 17 7 10 8 2.67 
88 ST-23 6 4 12 1 20 12 7 6 2 
372 - 88 103 19 36 23 44 26 5 1.67 
405 ST-405 35 37 29 25 4 5 73 5 1.67 
141 - 13 52 10 14 17 25 17 4 1.33 
420 - 13 38 84 13 17 68 34 4 1.33 
58 ST-155 6 4 4 16 24 8 14 3 1 
62 - 28 33 25 29 7 11 24 3 1 
393 ST-31 18 106 17 6 5 5 4 3 1 
404 ST-14 14 14 10 14 17 7 74 3 1 
843 - 40 24 19 14 23 1 10 3 1 
12 ST-12 13 13 9 13 16 10 9 2 0.67 
38 ST-38 4 26 2 25 5 5 19 2 0.67 
59 ST-59 27 32 24 29 26 19 22 2 0.67 
80 ST-568 13 24 19 14 23 1 10 2 0.67 
93 ST-168 6 11 4 10 7 8 6 2 0.67 
104 ST-73 13 24 9 13 17 11 25 2 0.67 
106 ST-69 21 35 27 6 5 8 4 2 0.67 
117 - 20 45 41 43 5 32 2 2 0.67 
362 - 62 100 17 31 5 5 4 2 0.67 
410 ST-23 6 4 12 1 20 18 7 2 0.67 
550 ST-14 14 14 10 14 17 92 10 2 0.67 
638 ST-73 76 24 9 13 17 11 25 2 0.67 
808 - 36 38 19 37 17 11 26 2 0.67 
48 ST-10 6 11 4 8 8 8 2 1 0.33 
92 - 40 14 19 36 23 11 10 1 0.33 
136 - 38 39 30 13 17 11 28 1 0.33 
167 ST-10 10 11 4 8 8 13 2 1 0.33 
210 - 6 8 4 1 9 48 7 1 0.33 
224 - 6 4 33 16 11 8 6 1 0.33 
295 - 6 4 12 1 9 2 7 1 0.33 
297 - 6 65 32 26 9 8 2 1 0.33 
345 - 6 4 14 1 20 62 7 1 0.33 
399 ST-399 6 4 1 95 69 8 20 1 0.33 
448 ST-448 6 6 5 16 11 8 7 1 0.33 
491 - 13 39 19 36 30 14 82 1 0.33 
493 ST-12 40 13 9 13 16 10 9 1 0.33 
538 ST-538 13 40 19 13 36 28 30 1 0.33 
568 - 13 24 19 14 17 1 10 1 0.33 
636 - 13 108 10 97 18 68 93 1 0.33 
648 - 92 4 87 96 70 58 2 1 0.33 
681 - 38 39 30 13 17 25 28 1 0.33 
706 - 88 24 49 36 17 11 91 1 0.33 
779 - 37 38 19 37 17 11 2 1 0.33 
780 - 37 38 19 37 17 11 25 1 0.33 
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    Table 3.4. Continued… 
ST CC 
Profile 
Frequency 
% of 
Database adk fumC gyrB icd mdh purA recA 
781 - 76 39 50 16 16 37 25 1 0.33 
782 - 21 35 27 6 5 5 99 1 0.33 
783 - 6 4 33 10 20 12 7 1 0.33 
784 - 13 167 19 13 36 28 10 1 0.33 
786 - 36 24 9 13 17 27 25 1 0.33 
787 - 141 37 29 25 4 5 73 1 0.33 
804 - 6 24 9 13 17 11 25 1 0.33 
805 - 6 19 52 18 9 13 6 1 0.33 
806 - 14 4 12 1 20 12 7 1 0.33 
807 - 37 14 10 14 17 7 74 1 0.33 
809 - 36 96 121 13 17 11 10 1 0.33 
842 - 76 24 9 13 16 11 25 1 0.33 
844 - 20 45 41 43 5 8 2 1 0.33 
845 - 13 38 9 37 18 76 16 1 0.33 
999 - 13 166 47 13 23 28 122 1 0.33 
1000 - 37 24 9 172 17 11 25 1 0.33 
1001 - 6 23 4 18 7 7 6 1 0.33 
1002 - 35 37 4 25 4 5 73 1 0.33 
1003 - 34 36 39 87 67 131 4 1 0.33 
1004 - 6 19 3 171 11 8 6 1 0.33 
1005 - 36 24 9 13 17 113 25 1 0.33 
1058 - 37 38 19 37 17 11 34 1 0.33 
1059 - 6 6 5 136 11 130 6 1 0.33 
1303 - 10 7 4 8 12 35 2 1 0.33 
1524 - 6 19 64 26 11 8 6 1 0.33 
1525 - 6 4 1 13 69 8 20 1 0.33 
1526 - 13 52 41 14 17 25 17 1 0.33 
1527 - 40 13 9 13 16 126 9 1 0.33 
1528 - 6 6 4 1 9 8 6 1 0.33 
1529 - 40 1 84 13 17 68 34 1 0.33 
1530 - 13 24 19 36 23 11 34 1 0.33 
1531 - 37 38 19 37 17 5 26 1 0.33 
1532 - 6 6 5 10 11 8 7 1 0.33 
1533 - 13 13 9 13 16 76 9 1 0.33 
1534 - 36 24 9 13 30 11 25 1 0.33 
1535 - 52 116 55 10 35 40 38 1 0.33 
1536 - 126 160 131 6 9 5 99 1 0.33 
1537 - 1 4 12 1 20 12 7 1 0.33 
1538 - 6 220 3 26 28 7 10 1 0.33 
1539 - 34 36 28 25 5 16 4 1 0.33 
1540 - 14 14 10 14 20 7 10 1 0.33 
1541 - 37 38 19 37 17 68 26 1 0.33 
1542 - 6 4 60 1 31 18 7 1 0.33 
1543 - 4 26 17 25 5 5 19 1 0.33 
1544 - 100 37 29 25 4 5 73 1 0.33 
1545 - 21 35 67 6 5 5 44 1 0.33 
1546 - 13 108 10 97 17 68 93 1 0.33 
1547 - 36 24 9 13 4 11 25 1 0.33 
1548 - 13 13 9 13 20 10 9 1 0.33 
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3.5. Phylogenetic analysis 
3.5.1. eBURST analysis of STs 
Using the eBURST v3 (http://eburst.mlst.net) clustering algorithm, 17 CCs 
encompassing 59 STs represented 259 UPEC isolates. The remaining 41 isolates 
appeared as singletons, which do not fall into any eBURST CC (Table 3.5). For clarity 
it should be mentioned that eBURST CC have a nomenclature that is not related to the 
conventional MLST naming schemes. Clonal Complexes were identified according to 
the number of single locus variants (SLVs) and double locus variants (DLVs) shared 
between isolates, where only STs that share six or more loci are designated to a defined 
CC. The largest CC (CC1) accounted for 20% (60) of the tested population and was 
dominated by a single ST (ST 73). ST73 was identified by eBURST as the founder of 
the CC1 group with the greatest number of SLVs and DLVs and with a bootstrap value 
of 96%. Additionally, there were eight other major groups comprising of more than 2 
STs for which eBURST was able to identify founders with a reasonable level of 
confidence indicated by bootstrap values ranging between 98% and 29%. 
Figure 3.4 illustrates eBURST clonal lineages showing in addition to SLVs, numerous 
inter-clonal and intra-clonal DLVs suggesting that frequent recombinational events 
occur within the defined population. CC1 shows the highest DLVs, some of which, for 
example ST1000, exist outside of the CC. Similarly CC5 reveals numerous DLVs with 
many outsider STs (ST295, ST345, ST783 and ST1542). 
According to eBURST default definitions, each ST that has at least two descendent 
SLVs beside the SLV that is its progenitor, will be assigned as a subgroup founder 
(represented by a yellow dot in Figures 3.3, 3.4 and 3.5). In the dataset presented there 
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are three CCs with a subgroup founder (ST638 for CC1, ST404 for CC4 and ST493 for 
CC3). 
As many of the successful STs, such as ST131 and ST 127, failed to be assigned to a 
well defined clonal lineage, even when less stringent conditions were applied (i.e. 
sharing identical alleles at four of seven loci), the clonality of NW-UPEC dataset was 
examined in an eBURST comparison analysis with the international MLST database to 
explore the possibility of a common ancestor not present in current dataset. Firstly, with 
ExPEC associated STs, both ST131 and ST127 were assigned as founders of distinct 
CCs with six and five STs, respectively associated with numerous SLVs and DLVs with 
bootstrap values of 97% and 94% but none of which stretched to involve other CCs 
(Figure 3.5). Secondly when expanding the comparison to involve the whole E. coli 
database, in addition to the re-enforcement of the existing clonal lineage the layout of 
clonal lineages dramatically changed as CC7, with its founder ST10 became the 
predominant CC in the whole E. coli snapshot with the most SLVs and DLVs and 
subgroup founders. CC131 and CC127 remained with inclusive SLVs and DLVs 
(Figure 3.6). 
3.5.2. Phylogenetic Trees 
The phylogenetic relationship between STs was presented by generating a UPGMA 
dendrogram using graphical tools integrated within the START v2.0 software. Figure 
3.7 shows an unrooted UPGMA dendrogram resolving the 100 allelic profiles of the 
seven genes into 2 large clusters (GI & GII) at 0.9 linkage distance. This distance 
represented the number of loci that were identical between two allelic profiles, which 
ranged from zero (100% similarity) to 1 (dissimilar). These results correlated well with 
those obtained using eBURST. 
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Table ‎3.5 The 17 clonal complexes obtained from eBURST analysis of the UPEC 
population, showing the frequency of each sequence type and their corresponding SLVs 
and DLVs, the predicted founder of each group is highlighted and the level of 
confidence in assignation of the founding genotype is indicated by the bootstrap value. 
 
 
  
CC 1:  No. Isolates = 60  |  No. STs = 9  |  Predicted Founder = 73 
ST FREQ SLV DLV TLV 
ST Bootstrap 
Group Subgrp 
73 50 7 1 0 96% 97% 
638 2 4 4 0 25% 14% 
104 2 3 5 0 1% 0% 
804 1 3 5 0 3% 0% 
1534 1 2 6 0 0% 0% 
1547 1 2 6 0 0% 0% 
1005 1 2 5 1 0% 0% 
786 1 2 5 1 0% 0% 
842 1 1 5 2 0% 0% 
       
CC 2:  No. Isolates = 26  |  No. STs = 7  |  Predicted Founder = 95 
ST FREQ SLV DLV TLV 
ST Bootstrap 
Group Subgrp 
95 19 6 0 0 98% 95% 
779 1 3 3 0 4% 1% 
1058 1 3 3 0 5% 1% 
780 1 3 3 0 10% 1% 
1531 1 2 4 0 0% 0% 
1541 1 2 4 0 0% 0% 
808 2 1 5 0 0% 0% 
       
CC 3:  No. Isolates = 6  |  No. STs = 5  |  Predicted Founder = 12 
ST FREQ SLV DLV TLV 
ST Bootstrap 
Group Subgrp 
12 2 3 1 0 63% 17% 
493 1 2 2 0 17% 0% 
1533 1 1 3 0 0% 0% 
1527 1 1 2 1 0% 0% 
1548 1 1 2 1 0% 0% 
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CC 4:  No. Isolates = 15  |  No. STs = 5  |  Predicted Founder = 14 
ST FREQ SLV DLV TLV 
ST Bootstrap 
Group Subgrp 
14 8 3 1 0 61% 16% 
404 3 2 2 0 17% 0% 
550 2 1 2 1 0% 0% 
1540 1 1 2 1 0% 0% 
807 1 1 1 2 0% 0% 
       
CC 5:  No. Isolates = 10  |  No. STs = 4  |  Predicted Founder = 88 
ST FREQ SLV DLV TLV 
ST Bootstrap 
Group Subgrp 
88 6 3 0 0 61% 16% 
1537 1 2 1 0 5% 0% 
806 1 2 1 0 8% 0% 
410 2 1 2 0 0% 0% 
       
CC 6:  No. Isolates = 8  |  No. STs = 4  |  Predicted Founder = 405 
ST FREQ SLV DLV TLV 
ST Bootstrap 
Group Subgrp 
405 5 3 0 0 63% 13% 
787 1 2 1 0 4% 0% 
1544 1 2 1 0 10% 0% 
1002 1 1 2 0 0% 0% 
       
CC 7:  No. Isolates = 15  |  No. STs = 3  |  Predicted Founder = 10 
ST FREQ SLV DLV TLV 
ST Bootstrap 
Group Subgrp 
10 13 2 0 0 29% 0% 
48 1 1 1 0 0% 0% 
167 1 1 1 0 0% 0% 
       
CC 8:  No. Isolates = 6  |  No. STs = 3  |  Predicted Founder = 80 
ST FREQ SLV DLV TLV 
ST Bootstrap 
Group Subgrp 
80 2 2 0 0 30% 0% 
843 3 1 1 0 0% 0% 
568 1 1 1 0 0% 0% 
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CC 9:  No. Isolates = 30  |  No. STs = 3  |  Predicted Founder = 69 
ST FREQ SLV DLV TLV 
ST Bootstrap 
Group Subgrp 
69 27 2 0 0 31% 0% 
106 2 1 1 0 0% 0% 
782 1 1 1 0 0% 0% 
       
CC 10:  No. Isolates = 12  |  No. STs = 2  |  Predicted Founder = None 
ST FREQ SLV DLV TLV ST Bootstrap 
127 11 1 0 0 - 
92 1 1 0 0 - 
       
CC 11:  No. Isolates = 2  |  No. STs = 2  |  Predicted Founder = None 
ST FREQ SLV DLV TLV ST Bootstrap 
1532 1 1 0 0 - 
448 1 1 0 0 - 
       
CC 12:  No. Isolates = 5  |  No. STs = 2  |  Predicted Founder = None 
ST FREQ SLV DLV TLV ST Bootstrap 
141 4 1 0 0 - 
1526 1 1 0 0 - 
       
CC 13:  No. Isolates = 3  |  No. STs = 2  |  Predicted Founder = None 
ST FREQ SLV DLV TLV ST Bootstrap 
117 2 1 0 0 - 
844 1 1 0 0 - 
       
CC 14:  No. Isolates = 2  |  No. STs = 2  |  Predicted Founder = None 
ST FREQ SLV DLV TLV ST Bootstrap 
1525 1 1 0 0 - 
399 1 1 0 0 - 
       
CC 15:  No. Isolates = 3  |  No. STs = 2  |  Predicted Founder = None 
ST FREQ SLV DLV TLV ST Bootstrap 
38 2 1 0 0 - 
1543 1 1 0 0 - 
       
CC 16:  No. Isolates = 2  |  No. STs = 2  |  Predicted Founder = None 
ST FREQ SLV DLV TLV ST Bootstrap 
636 1 1 0 0 - 
1546 1 1 0 0 - 
       
CC 17:  No. Isolates = 2  |  No. STs = 2  |  Predicted Founder = None 
ST FREQ SLV DLV TLV ST Bootstrap 
136 1 1 0 0 - 
681 1 1 0 0 - 
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Figure ‎3.4 eBURST diagram of NW-UPEC showing clusters of related STs (CC) and individual singleton STs of the 300 UPEC. Seventeen 
CCs are identified, each ST is represented by a circle, the size of the circle indicates the frequency of each ST. Predicted founders are 
positioned centrally in each cluster and shown in blue and SLVs and DLVs shown in pink and blue, respectively 
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Figure ‎3.5 eBURST snapshot of NW-UPEC projected over ExPEC related STs, showing clusters of related STs (CC) and individual singleton 
STs of the NW-UPEC in pink, ExPEC from the database in black and shared STs in green. Predicted founders are positioned centrally in each 
cluster and shown in blue, subgroup founders are shown in yellow. 
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Figure ‎3.6 eBURST snapshot E. coli population illustrating the structure of common uropathogenic CCs and their related STs and showing 
clusters of related STs (CCs) and individual singleton STs of the NW-UPEC in pink and other E. coli from the database in black. Predicted 
founders are positioned centrally in each cluster and shown in blue, subgroup founders are shown in yellow 
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The nucleotide sequences of the seven gene fragments of unique STs were concatenated 
in the order adk, fumC, gyrB, icd, mdh, purA and recA using START v2.0 software and 
the resulting 3405bp sequence alignments were phylogenetically analysed using the 
Neighbour-joining alignment method integrated in MEGA 4.0 software with the Jukes-
Cantor based algorithm and 1000 bootstrapping replications. Figure 3.8 shows the 
unrooted phylogenetic dendrogram of the 100 identified STs. In general the dataset was 
divided in to 3 large clusters with 60% of STs previously assigned to GI  in the 
UPGMA tree split to form a distinct cluster (GIb) associated to (GII). Despite this shift 
in the relation of some CCs, the overall layout of the STs within CCs is consistent with 
that provided by eBURST analysis. 
 An alignment of unique concatenated sequences was tested by ClonalFrame to infer 
their phylogenetic relatedness. The majority-role consensus tree constructed, (Figure 
3.9) again shows the two groups observed with UPGMA and NJ and almost agrees with 
the eBURST lineage display. In the eBURST analysis, CC95 is a consistent clone with 
seven STs (ST95, ST88, ST1531, ST1541, ST779, ST780 and ST1058). In 
ClonalFrame, this clone was reduced to only 4 ST (ST95, ST88, ST1531, ST1541) and 
the remaining STs joined other singletons arising from unknown ancestors. In contrast, 
CC73 extended its membership to include ST1000, which in eBURST analysis showed 
various DLVs with many CC73 members.  
The network representation of the ClonalFrame analysis output illustrated in Figure 
3.10 suggests that the common ancestor has not yet been identified and that numerous 
genotypes descended from this common ancestor have also not been identified among 
Figure ‎3.7 (previous page) Unrooted UPGMA dendrogram, based on allelic profiles of 
100 STs among the collected UPEC. 
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the studied population. However, almost all STs appear to descend from two unknown 
ancestors, which in turn directly arise from the common ancestor. 
Based on eBURST analysis, ST14 and ST405 were the founding genotypes for their 
respective clonal complexes. ClonalFrame analysis, however, does not put particular 
weight on ST14 and ST405 as clone founders and only regards ST14 as a descendant 
strain of an as yet unknown ancestor and ST 405 as descended from ST1544. 
Interestingly, ST127 which, based on eBURST analysis, fails to form its own clonal 
lineage in the dataset presented here, appears as a clonal founder in the ClonalFrame 
analysis. 
Using the Neighbour-net method integrated in splitstree 4.11, a phylogenetic network 
was constructed using the concatenated nucleotide sequences representing the dataset. 
In general, Neighbour-net identified groups in a similar way to that presented in the 
ClonalFrame output. Neighbor-net was able to resolve the conflicting signals introduced 
to nucleotide sequences by recombination, as these events are displayed by parallel 
paths in the phylogenetic network, as shown in Figure 3.11. ST806 was separated from 
CC88, which might indicate that multiple alleles were acquired by homologous 
recombination. CC73 was mostly arranged with a radial symmetry indicating that most 
diversity was generated by mutation. Parallel paths play an important role in the 
formation of most other CCs indicating the possibility of substantial recombination. 
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Figure ‎3.8 Unrooted phylogenetic 
dendogram of the identified 100 STs 
among the collected UPEC, analysed 
by Neighbour-joining method based on 
concatenated sequences (with Jukes-
Cantor based algorithm and 1000 
bootstrap replications). * denotes an ST 
does not belong to the assigned CC but 
was associated with it by DLVs. 
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Figure ‎3.9 A 50% consensus of 10 evolutionary trees generated for NW-UPEC dataset 
using ClonalFrame1.1 
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Figure ‎3.10 A network representation of the ClonalFrame output. The network shows 
inferred ancestral nodes in black and the STs in red with each line indicating a single 
ST. Nodes whose ancestral ST is not found amongst the study population are shown as 
an empty circle. The ancestral node of the network is indicated by a darker circle.
ST14 
ST405 
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Figure ‎3.11 Neighbour-net based on concatenated sequence alignment of STs representing the NW-UPEC population. 
Shadowed areas indicate CCs 
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3.5.3. Analysis of recombination 
From eBURST and ClonalFrame analysis it is clear that the dataset population evolved 
primarily by accumulation of single mutations with some recombinational events. So it 
is important to estimate the contribution of recombination in the evolution of the dataset 
population and the clonal groups. 
3.5.3.1. Maximum X2 test 
Nucleotide sequences of target genes were analysed to identify potential recombination 
events between alleles of each locus. A large number of putative recombination sites 
were identified ranging from 231 sites in icd to 528 sites in fumC and gyrB from which 
few were considered significant after 1000 random comparison trials. Table 3.6 shows 
significant putative recombination sites in each locus. Most target genes show multiple 
possible recombination sites except gyrB where, from 528 identified sites, none were 
considered significant and only one site was assigned as a significant recombination site 
in purA. 
 
 
Table ‎3.6 Frequency of significant putative recombination sites in each target gene 
 Max X
2
 
Alleles Putative significant recombination sites P value 
adk 24 
<0.05 
fumC 12 
gyrB 0 
icd 10 
mdh 12 
purA 1 
recA 113 
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3.5.3.2. Split decomposition analysis 
Concatenated allele sequences of the target genes from the 100 STs were analysed for 
evidence of recombination using a split decomposition algorithm in which the extent of 
recombination within the population is reflected by the degree of networks computed by 
the program. The star phylogeny displayed in Figure 3.11a is consistent with a clonal 
population structure.  
To further analyse the population structure, the target genes were analysed separately. 
The results are shown in Figures 3.12b-h. The structure of the split graphs varied 
substantially between the different loci. The split tree graph obtained with mdh 
presented an interconnected network indicating evidence of recombination whereas the 
remaining loci gave a tree-like structure consisting of a single central origin from which 
single branches radiate showing no evidence of recombination. 
 
 
 
 
 
Split tree decomposition 
a) Concatenated sequences 
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b) adk 
 
 
 
 
 
 
 
 
 
 
 
 
c) fumC 
 
 
 
 
 
 
 
 
 
 
 
d) gyrB 
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g) purA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
h) recA 
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Figure ‎3.12 Split decomposition analysis(a) for concatenated allele sequences of the 
target genes from the 100 STs and (b - h) for individual allele sequences of each target 
gene 
 
3.5.3.3. Pairwise homoplasy index (Φw ) test 
Since conflicting signals of recombination were observed for target genes either 
calculated in the max X
2
 test or displayed in split tree diagrams, another statistical test 
was  applied. The Φw test is considered a powerful tool to identify recombination and is 
able to distinguish recurrent mutation from recombination. However, with considerable 
parsimony informative sites, the Φw test was able to detect evidence of significant 
recombination in all loci except adk and recA (Table 3.7). 
 
 
Table ‎3.7 Pairwise homoplasy index, (Φw) test of significant recombination events in 
each target gene 
Allele No. of alleles 
Φw test 
Informative 
sites 
P value Interpretation 
adk 26 19 0.25 N.R 
fumC 33 41 0.0 S.R 
gyrB 33 17 0.0 S.R 
icd 22 14 0.0 S.R 
mdh 22 26 0.0 S.R 
purA 31 17 0.012 S.R 
recA 28 17 0.249 N.R 
S.R:significant recombination; N.R: non significant recombination. 
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3.5.3.4.  Index of association 
The level of linkage between alleles at different loci was estimated by calculating the 
index of association (I
S
A) values using the standardised method introduced by Haubold 
and Hudson in 2000 and integrated within the START2 program. The I
S
A value found 
for all isolates was 0.535 (P <0.0001) but reduced to 0.224 (P<0.0001) when only one 
representative of each ST was considered. This indicates that the population is in 
linkage disequilibrium and thus the population structure of the present dataset is clonal 
(Table 3.8). The contribution of recombination was also estimated within previously 
identified clonal complexes using both the Φw test and linkage disequilibrium analysis 
(Table 3.9). 
 
Table ‎3.8 Multilocus linkage disequilibrium analysis of the 300 UPEC isolates 
Ve, expected variance; Vo, observed variance; ISA , standardized index of association.P
a Probability of 
observing an Vo/Ve ratio as or more extreme than that found in the original data based on1000 trials. 
 
Table ‎3.9 Contribution of recombination in different phylogenetic structures within the 
NW-UPEC population 
 
 
 No. Ve Vo I
S
A Pa 
Total isolates 300 0.8341 3.512 0.535 <0.0001 
Total STs 100 0.5318 1.247 0.224 <0.0001 
CC 
No of 
STs 
Informative 
site 
Φw 
 
I
S
A value P value 
Linkage 
disequilibrium 
dataset 100 184 0.0 0.2268 0.000 LD 
GI 27 133 0.0 0.2226 0.000 LD 
CC73 8 2 1.0 -0.0873 0.996 - 
CC95 7 4 1.0 -0.1003 1.0 - 
CC14 5 0 0.95 -0.0586 0.946 - 
CC12 5 0 1.0 -0.0566 1.0 - 
GII 14 85 0.0 0.1582 0.000 LD 
CC69 3 0 1.0 -0.0188 0.878 - 
CC405 4 0 1.0 -0.0524 1.0 - 
CC10 3 0 1.0 -0.0417 1.0 - 
CC88 4 0 1.0 -0.0524 1.0 - 
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3.6. Phylogenetic typing   
E. coli may be grouped into four major phylogenetic groups A, B1, B2 and D. Of the 
300 UPEC isolates tested 175 (58%) belonged to group D followed by B2 with 77 
(26%) isolates with 36 (12%) and 11 (4% ) belonging to groups A and B1 respectively. 
To assess the phylogenetic distribution among defined STs, correspondence analysis 
was performed on frequently occurring STs and STs belonging to the nine eBURST 
CCs, whereas the remaining STs were represented collectively as singletons. Significant 
associations were detected between phylogenetic groups and different STs (P <0.0001) 
and the results expressed by the projection of each ST on a plane defined by two axes 
(F1 and F2), which account for most of the total variance (81%) allowing sorting of the 
300 UPEC in the data set among the phylogenetic groups (Figure 3.13). Ten STs 
accounted for 139 (46%) isolates clustered between B2 and D indicating shared 
phylogenetic groups, whereas group D was represented by 30 STs accounting for 69 
(23%) isolates, group A by seven STs with 27 (9%) isolates and six STs accounted for 
seven (2%) isolates associated with B1. Singletons were collectively distributed 
between groups D (the majority of singletons), A and B.  
Correspondence analysis was also carried out to describe the distribution of the 
phylogenetic groups among the eBURST CCs. Despite the presence of mixed 
phylogenetic groups within some of the CCs, a significant linkage between the 
phylogenetic groups and CCs (P <0.0001) was observed. CC10 and CC88 were 
classified as group A, CC80 as B2 and CC69, CC95, CC12 and CC405 as group D. In 
CC73, while most of the STs were classified as group D, ST73, which is the founder of 
the CC, included a mixture of D and B2 isolates. Furthermore ST786 and ST1547 of 
CC73 were classified as group B2. This mosaic, which clearly occurs in mature CCs 
could indicate genetic exchange between isolates of different CCs.   
Chapter 3                                                                                   Results 
113 
 
 
 
 
 
 
 
Figure ‎3.13 Graphical representation of the correspondence analysis of UPEC based on 
the MLST data. The F1/F2 plane accounted for 81% of total variance, with factors F1 
and F2 accounting for 57% and 24%, respectively. Arrows show the position of 
individual STs when they arise away from their respective CCs. 
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3.7. Pulsed field gel electrophoresis 
XbaI PFGE analysis was performed with modifications according to the CDC 
standardised PFGE protocol and the generated profiles were compared digitally using 
BioNumerics software. Cluster analysis of Dice similarity indices based on the UPGMA 
was used to generate a dendrogram describing the relationships among PFGE profiles of 
32 representative isolates of the common UPEC STs with different phylogenetic groups, 
10 ST69 (n=10 isolates), ST73 (n=9) and ST131 (n=13; Figure 3.14). 
As expected, finer resolution was obtained by PFGE analysis and each ST constituted a 
separate cluster. The ST131 cluster (defined at the 65% similarity level) was tied to the 
two other cluster groups (ST69 and ST73) at less than 60% similarity.  
Isolates were considered to belong to the same PFGE group if their Dice similarity 
index was ≥85% and using this criterion ST73 and ST69 clusters comprised of eight 
PFGE profiles each.  
The ST 131 cluster in turn, comprised of nine different profiles with most of the isolates 
collected from Preston forming a sub-cluster at >80% similarity. There was no evidence 
for a geographical effect in the sub-clusters of both ST73 and ST69. 
Interestingly isolates 24 and 29 of the ST73 cluster showed different phylogenetic 
groups (B2 and D) despite the fact that they both share the same PFGE profiles. 
Similarly, within the Preston ST131 sub-cluster isolates 15, 19 and 25 shared the same 
PFGE profile when they differed in their phylogenetic groups. 
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Figure ‎3.14 XbaI PFGE dendrogram for 32 UPEC isolates as produced by the UPGMA 
algorithm based on Dice similarity coefficients. Highlighted area indicates ST131 
isolates collected in Preston. The red line shows 85% cutoff. 
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3.8. Demographic distribution of STs 
Demographic parameters such as age, gender, specimen type and geographic origin of 
specimen were retrieved from laboratory records. Of the 300 MLST typed isolates, 82% 
were from females with patient‟s age ranging from <1 month to 95 years. Table 3.10 
shows the distribution of patients by age and sex. 
 
 
Table ‎3.10 Distribution of patients according to age and gender 
0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 ≥‎90
Female 6 16 43 26 28 30 34 30 25 8 246
Male 3 2 2 3 6 5 17 9 3 4 54
Total 9 18 45 29 34 35 51 39 28 12 300
Age groups(yr)
Gender Total
 
 
 
 
One hundred of the specimens were collected from patients attending inpatient wards 
while the remaining 200 were from different general practitioner‟s clinics. In Table 
3.11, the distribution of patients by gender, specimen collection type and location of 
collection showed no significant different in male/female ratio or between isolates 
collected from Manchester and those from Preston. However, distribution of specimens 
according to collection site showed a significant difference (p<0.0001) with specimens 
collected from Preston appearing to be more commonly associated with patients 
attending general practitioner‟s clinics than was seen in the Manchester collection. 
 Various specimens were collected including catheter urine, mid-stream urine and 
directly collected urine. Mid-stream urines accounted for 66% of the specimens and 
catheter urine specimens accounted for approximately 6% of the collected specimens. 
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Although no significant association between different STs and patient‟s age groups was 
observed, the distribution of STs among other demographic parameters revealed some 
statistically significance associations. ST131 showed a stronger link to hospital acquired 
than community acquired infections with a significant statistical difference (18% vs. 
10%, P <0.05; Figure 3.17). Additionally, distribution of STs according to gender 
showed a significant association of ST69 with females (11% vs. 0%, P < 0.05; Figure 
3.18). 
 
 
 
   Table ‎3.11 Distribution of patients according to gender, time and collection site 
  2007 2009 
  M F M F 
  No.(%) No.(%) No.(%) No.(%) 
Manchester 11(11) 89(89) 22(22) 78(78) 
Preston 10(20) 40(80) 11(22) 39(78) 
          
          
  2007 2009 
  Hospital aq. Community aq. Hospital aq. Community aq. 
  No.(%) No.(%) No.(%) No.(%) 
Manchester 40(40) 60(60) 43(43) 57(57) 
Preston 11(22) 39(78) 6(12) 44(88) 
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Figure ‎3.15 Distribution of common STs according to specimen collection site 
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Figure ‎3.16 Distribution of common STs according to gender 
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3.9. Biochemical activity 
Metabolic profiles were determined using the Vitek 2 ID-GNB card (Biomérieux), to 
test the organism‟s metabolic activity in 41 fluorescence based biochemical tests 
including 18 enzymatic tests, 18 fermentation tests, 2 decarboxylase tests and 3 other 
miscellaneous tests. 
On average, the biochemical activities of the tested UPEC isolates were similar to those 
of E. coli reported by others (Ewing 1986; Farmer et al. 1985). A notable difference 
was observed concerning α-Galactosidase activity, where 69% of the tested isolates 
appeared to produce an α-Galactosidase enzyme compared to almost 100% reported by 
others  (P<0.0001; Table 3.12). 
3.9.1. Association between metabolic activities 
Statistical analysis of association between results of different biochemical tests reveals 
complex associations with 52 positive associations and 26 negative associations 
involving wide range of tests. When the margin of confidence was increased and a P 
value of <0.001 considered as statistically significant, the associations were limited to 
14 biochemical tests with 22 positive associations and 12 negative association, of which 
70% occurred as overlapping associations between tests related to three types of 
metabolic reactions namely production of peptidases (tyrosine arylamidase and proline 
arylamidase), decarboxylases (ornithine decarboxylase and lysine decarboxylase) and 
alkalinisation of L- lactate and succinate. Additionally resistance to O129 was 
significantly associated with assimilation of sucrose and production of ornithine 
decarboxylase (Table 3.13). 
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Table ‎3.12 Biochemical activity profiles of UPEC studied here, compared to those 
previously reported by other groups (bold face type indicates major difference) 
Test % Activity by of 
UPEC 
% Activity for E. coli as reported by  
(Ewing, 1986) 
(n=1.231) 
(Farmer et al. 1985) 
(n=ND)  Ala-Phe-Pro-Arylamidase 0 ND ND 
Adonitol  0.7 5.6 5 
L-Pyrrolydonyl-Arylamidase 0 ND ND 
L-Arabitol 0 ND 5 
D-Cellobiose 0 2.4 2 
Beta-Galactosidase 98.7 ND 95 
H2O production 0 ND 1 
Beta-N-Acetyl-Glycosaminidase 0 ND ND 
Glutamyl Arylamidse pNA 0 ND ND 
D-Glucose 100 100 100 
Gamma-Glutamyl-Transferase 0.7 ND ND 
Fermentation/Glucose 96.7 ND 100 
Beta-Glucosidase 0 ND ND 
D-Maltose 97.4 89.9 95 
D-Mannitol 100 96.8 98 
D-Mannose 100 ND 98 
Beta-Xylosidase 0 ND ND 
Beta-Alanine Arylamidase pNA 0 ND ND 
L-Proline Arylamidase 9.3 ND ND 
Lipase 0 0 0 
Palatinose 0 ND ND 
Tyrosine Arylamidase 36.4 ND ND 
Urease 0.7 0 1 
D-sorbitol 92.1 93.4 94 
Saccharose/Sucrose 49.7 48.9 50 
D-Tagatose 7.3 ND ND 
D-Trehalose 99.3 98.8 98 
Citrate 0 ND 1 
Malonate 0.7 0 0 
5-Keto-D-Gluconate 49 ND ND 
L-Lactate alkalinisation 23.8 ND ND 
Alpha-Glucosidase 0 0 0 
Succinate alkalinisation 33.8 ND ND 
Beta-N-Acetyl-Galactosaminidase 0 ND ND 
Alpha-Galactosidase 69 ND 99 
Phosphatase 6 ND ND 
Glycine Arylamidase 0 ND ND 
Ornithine Decarboxylse 78.8 64.2 65 
Lysine Decarboxylase 95.4 88.7 90 
L-Histidine assimilation 0 ND ND 
Courmarate 100 ND ND 
Beta-Glucoronidase 94 ND ND 
O/129 Resistance 60.9 ND ND 
Glu-Gly-Arg-Arylamidase 0 ND ND 
L-Malate assimilation 2 ND ND 
Ellman 96.7 ND ND 
L-Lactate assimilation 0 ND ND 
 121 
 
 
 
 
Table ‎3.13 Associations between metabolic activities of 300 isolates representing NW-UPEC population 
 
Statistical analysis of association between biochemical tests using Fisher‟s exact test showing only P ≤ 0.001 which reflects statistical significance; not shown are 
biochemical tests that yielded P values > 0.001. 
Biochemical test ProA TyrA URE dSOR SAC dTAG dTRE MNT 5KG ILATk SUCT AGAL PHOS GlyA ODC LDC CMT BGUR O129R IMLTa ELLM
NO. 28 162 10 284 167 19 297 1 123 120 128 208 36 7 227 280 297 275 175 7 292
TyrA 162 28
0.0001
URE 10 2 10
– –
dSOR 284 25 152 10
– – –
SAC 167 20 68 6 162
– 0.0001 – –
dTAG 19 5 13 0 18 13
– – – – –
dTRE 297 28 162 10 283 166 19
– – – – – –
MNT 1 1 1 0 1 0 0 1
– – – – – – –
5KG 123 7 77 6 115 41 6 123 0
– – – – 0.0001 – – –
ILATk 120 28 118 9 112 55 12 120 1 48
0.0001 0.0001 – – – – – – –
SUCT 128 27 118 10 120 55 13 128 1 58 100
0.0001 0.0001 0.0002 – 0.0002 – – – – 0.0001
AGAL 208 28 142 10 201 106 15 208 1 96 106 118
0.0001 0.0001 – – – – – – – 0.0001 0.0001
PHOS 36 14 32 3 35 24 7 36 0 11 27 28 35
0.0001 0.0001 – – – – – – – 0.0001 0.0001 0.0001
GlyA 7 5 7 0 7 4 1 7 0 1 7 6 5 4
0.0001 – – – – – – – – – – – –
ODC 227 17 108 9 216 123 13 226 0 91 73 86 165 22 3
– 0.0001 – – – – – – – 0.0001 – – – –
LDC 280 20 145 10 266 153 14 278 1 115 107 115 193 28 6 217
0.0001 – – – – – – – – – – – 0.0009 – –
CMT 297 28 162 10 282 165 17 295 1 123 120 128 208 36 7 225 278
– – – – – – – – – – – – – – – –
BGUR 275 18 139 10 263 151 12 274 1 116 98 111 187 28 3 211 258 273
0.0001 0.0001 – – – 0.0003 – – – 0.0001 – – – – – – –
O129R 175 22 91 3 163 117 13 174 1 59 73 78 116 26 4 120 162 173 158
– – – – 0.0001 – – – – – – – – – 0.0006 – – –
IMLTa 7 6 7 0 5 7 1 7 0 1 7 6 6 3 3 4 5 7 2 7
0.0001 – – – – – – – – – – – – 0.0003 – – – 0.0001 –
ELLM 292 25 157 10 280 165 19 291 1 121 116 125 205 33 7 225 274 290 269 169 6
– – – 0.0003 – – – – – – – – – – – – – – – –
ILATa 3 3 3 0 3 3 0 3 0 0 3 3 3 2 2 3 3 3 0 3 3 3
0.0007 – – – – – – – – – – – – – – – – 0.0005 – 0.0001 –
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
(P value)
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3.9.2. Metabolic characteristics of common STs  
To assess whether isolates of certain ST share specific metabolic characteristics, two 
analytical approaches were used. First, a non-parametric comparison analysis using 
Mann-Whitney U test was used to compare the aggregate bio-scores generated for each 
ST against all others. A significant association was observed for ST131 with high bio-
scores when compared to all other STs (P ≤ 0.0001), on the other hand ST127 showed 
an significant association with low bio-scores with a significant difference from the 
other STs combined (P≤ 0.003) (Table 3.14). 
                  
                Table ‎3.14 Aggregate Bio-score in relation to STs 
ST (No) 
Aggregate Bio-score 
Median (range) 
P value 
ST10 (13) 0.55 (0.48-0.65) 0.670 
ST14 (8) 0.59 (0.55-0.72) 0.145 
ST69 (27) 0.55 (0.48-0.72) 0.967 
ST73 (50) 0.59 (0.45-0.65) 0.770 
ST88 (6) 0.52 (0.51-0.58) 0.216 
ST95 (19) 0.55 (0.45-0.62) 0.973 
ST127 (11) 0.52 (0.45-0.55) 0.003 
ST131 (37) 0.62 (0.48-0.76) 0.0001 
ST405 (5) 0.55 (0.41-0.69) 0.771 
                P values (Mann-Whitney U test) shows the significance of the different Bio-score 
                 of each ST compared to the other STs. 
Secondly, the statistical association of individual metabolic activity with common STs 
was assessed using Fisher‟s exact test. Of the 41 metabolic activities tested, common 
STs were significantly associated with 11 tests. Remarkably, ST131 exhibited 
significant associations with seven tests, which indicates distinctive biochemical 
characteristics (Table 3.15) and ST73 had a significant association to four tests. In 
contrast, isolates of ST14 and ST405 showed no difference in their metabolic activity 
compared to the rest of the tested isolates. However, production of ornithine 
decarboxylase and assimilation of sucrose appear to be key characteristics in many 
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successful STs, as they are significantly associated with the most frequently isolated 
STs.  
 
 
Table ‎3.15 Statistical analysis of association between STs and metabolic activity 
ADO ProA SAC 5KG ILATk AGAL PHOS ODC BGUR O129R ILATa
ST (No.) (6) (28) (167) (123) (120) (208) (36) (227) (275) (175) (3)
ST10 (13) 0.0012 – – – – – – 0.0001 – – –
ST14 (8) – – – – – – – – – – –
ST69 (27) – – 0.0001 0.0017 – – – 0.0001 – – –
ST73 (49) – – 0.0001 0.0001 – – 0.0014 0.0001 – – –
ST88 (6) – – – – – – – – – – –
ST95 (19) – – 0.0001 – – – – – – 0.0001 –
ST127 (9) – – – – – – – – – –
ST131 (37) – 0.0001 0.0001 0.0001 0.0041 0.0041 – 0.0034 0.0002 – 0.0017
ST405 (5) – – – – – – – – – – –
Biochemical test
 
P values (by Fisher‟s exact test) were calculated for each ST compared to the rest of the population 
shown only where P≤0.005. Bold P values are for negative associations. 
3.10. Antibiotic susceptibility 
In the present study, nearly 30% of the isolates were susceptible to all tested antibiotics, 
while the rest of the isolates demonstrated a wide range of resistance from resistance to 
just one antibiotic (11%) to resistance to 19 out of 21 tested antibiotics (< 1%).  A 
reasonably high level of resistance was demonstrated to a number of commonly used 
antibiotics: ampicillin (55%); first generation cephalosporins (38%); trimethoprim 
(37%); and nalidixic acid (21%), as shown in Figure 3.19. Interestingly, isolates 
collected from Manchester appeared to be more resistant to most antibiotics tested than 
those from Preston, with significant different (P < 0.05) in resistance to many 
commonly used antibiotics such as trimethoprim, nalidixic acid and ciprofloxacin. 
According to the generated antibiotic susceptibility profiles, different mechanisms of 
resistance were predicted against the major antibiotic families. Among the detected 
mechanisms of resistance against β-lactam antibiotics, acquired penicillinase (A.P) 
appeared to be the predominant mechanism (47%), while ESBL activity was seen in 
only 4% of the isolates. On the other hand, three patterns of enzymatic modification 
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resistance were detected against aminoglycosides mainly through two enzymes, N-
Acetytransferase (AAC) and O-Adenyltransferase (ANT) and were collectively 
acquired by 11% of the isolates. 
 
 
 
 
 
 
Figure ‎3.17A Distribution of antibiotic susceptibilities according to geographic site of 
isolation. AMP:ampicillin; AMC: amoxicillin/clavulanic acid; PIP: piperacillin; PIP/TAZ: 
piperacillin/tazobactam; CF: cefalotin; CXM: cefuroxime; FOX:  cefoxitin; CTX:  cefotaxime; CAZ: 
ceftazidime;  FEP: cefepime; ATM:  aztreonam; MEM:  meropenem; ETP:  ertapenem; S: susceptible; R: 
resistant; I : intermediate susceptibility. 
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Figure  3.19 B Distribution of antibiotic susceptibilities according to geographic site of 
isolation. AMK:  amikacin; GM:  gentamicin; TOB:  tobramycin; NA: nalidixic acid;  CIP: 
ciprofloxacin;  NIT: nitrofurantoin; TRI: trimethoprim; S: susceptible; R: resistant; I : intermediate 
susceptibility. 
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3.10.1. Association of STs with antibiotic resistance 
Sequence Types and their susceptibility to commonly used antibiotics were assessed 
using Fisher‟s exact test. Overall, STs vary considerably in their antibiotic 
susceptibilities from the most susceptible, ST95, with the lowest resistance-scores 
(median 0.0 and range 0.0-0.29) to the most resistant, ST131, with the highest score 
(median 0.38 and range 0.0-0.9). Table 3.16 shows the distribution of antibiotic resistant 
isolates according to their ST and mechanism of resistance predicted by VITEK2 AES.  
ST131 showed a distinctive antibiogram that was significantly associated with 
resistance to most of the tested antibiotic families. This antibiogram is characterised by 
production of ESBLs and AAC(6) in addition to resistance to ciprofloxacin, 
nitrofurantoin and trimethoprim. These associations, when compared to all other STs, 
were all significant (P≤0.008). Isolates of ST69 were characterised by resistance to 
trimethoprim (P ≤ 0.0001). 
 
Table ‎3.16 Association of STs and resistance to different antibiotic families 
Furanes Trimethoprim Resistance-score
A.P ESBL AAC(3) AAC(3),ANT(2) AAC(6) PR R R R
ST (No.) (141) (24) (2) (5) (23) (31) (34) (9) (112)
ST10 (13) 4 2 0 0 0 0 1 0 6 0.1(0.0-0.48)
P value ─ ─ ─ ─ ─ ─ ─ ─ ─
ST14 (8) 4 0 0 0 0 3 0 0 3 0.07(0.0-0.19)
P value ─ ─ ─ ─ ─ ─ ─ ─ ─
ST69 (27) 19 0 0 2 0 3 1 0 20 0.14(0.0-0.33)
P value ─ ─ ─ ─ ─ ─ ─ ─ 0.0001
ST73 (49) 25 0 0 0 2 3 1 0 11 0.1(0.0-0.38)
P value ─ ─ ─ ─ ─ ─ ─ ─ ─
ST88 (6) 4 0 0 0 0 2 0 1 2 0.14(0.05-0.43)
P value ─ ─ ─ ─ ─ ─ ─ ─ ─
ST95 (19) 7 0 0 0 0 2 0 0 2 0.0(0.0-0.29)
P value ─ ─ ─ ─ ─ ─ ─ ─ ─
ST127 (9) 5 1 1 0 1 0 0 0 1 0.1(0.0-0.67)
P value ─ ─ ─ ─ ─ ─ ─ ─ ─
ST131 (37) 16 13 1 0 13 3 19 3 24 0.38(0.0-0.9)
P value ─ 0.0001 ─ ─ 0.0001 ─ 0.0001 0.008 0.0004
ST405 (5) 1 2 0 0 1 1 1 0 3 0.1(0.0-0.9)
P value ─ ─ ─ ─ ─ ─ ─ ─ ─
median(range)
β-Lactams Aminoglycosides Quinolones
  
P values (by Fisher‟s exact test) shown only where P≤0.005.  
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3.11. Cluster analysis of STs based on biochemical profiles in relation 
to antibiotic susceptibility 
Unweighted pair grouping  method with arithmetic mean cluster analysis based on the 
biochemical profiles of isolates from the major STs revealed a large cluster comprised 
almost entirely of ST131 (19/21) and included 51% of the total ST131 isolates. The 
cluster was defined at the 70% similarity level and characterised by resistance to 
multiple antibiotics. The remaining ST131 isolates were found scattered through the 
dendrogram. Although there is a tendency for isolates with the same ST to cluster, only 
ST73 and ST69 gathered in clusters primarily consisting of their respective ST. Other 
than ST131, no correlation was found between the defined clusters and antibiotic 
resistance profiles (Figure 3.20). 
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Figure ‎3.18 UPGMA Cluster analysis based on the biochemical profiles of major 
sequence types 
Multiple drug resistant ST131 
ST69 
ST73 
ST69 
ST73 
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3.12. Prevalence of virulence factors   
Of the 29 virulence genes tested for, 26 were detected with a prevalence ranging from 
0.3% (nfaE) to 97% (fimH). Among the adhesin genes various Pap elements occurred in 
more than 40% of the isolates. Although the toxin associated gene, hlyA was equally 
prevalent to cnf1, both were significantly more prevalent than the colicin V production 
gene cvaC (P< 0.001). Of the siderophores, fyuA (yersiniabactin) was significantly 
more frequent than iut (aerobactin; P<0.0001). Nearly 60% of the isolates were positive 
for the group II capsule synthesis gene with K5 accounting for 61% of kpsM II positive 
isolates. The serum resistance related gene (traT) occurred in 72% of the isolates while 
the pathogenicity island (PAI) marker gene was present in 60% of the isolates (Figure 
3.21). 
 
Figure ‎3.19 Prevalence of VFs genes among 300 NW-UPEC isolates 
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3.12.1. Distribution of VFs by STs   
Genotyping of virulence traits revealed a strong correlation between VF profiles and 
STs. For frequently detected STs, each ST consisted of closely related VF profiles with 
similarity ranging from (65% to100%) which suggests vertical transmission of VFs. 
Overall, the STs varied considerably in VF contents, from ST10 with the lowest VF 
score (mean 3.7, range from 1 to 8), to ST127 with the highest VF score (mean 13.4 and 
range 9 to 17). Table 3.17 shows distinctive virulence traits that were significantly 
associated with the commonly detected STs. Although different Pap elements were 
important virulence determinants in many STs, lack of Pap elements appeared to 
significantly characterise some successful STs including ST131 and ST10. In addition 
to its deficit of Pap elements, ST131 isolates showed a significant lack of the Sialosyl-
binding adhesion gene (p<0.0001), ST127 was significantly associated with papG III 
(p<0.0001) and, ST69 isolates were negatively associated with PAI marker (P<0.0001). 
3.12.2. Phylogenetic distribution of VFs  
Projection of the VF traits onto the phylogenetic background of the isolates revealed, as 
expected, an association of most VFs with B2 and D phylogenetic groups and to a lesser 
extent to group  A, whereas none of the VF traits were found to be associated with 
group B1 (Figure 3.22). Although acquisition of VFs was more frequently associated 
with groups D and B2 and to a lesser extent group A, group A is the group with the 
greatest number of significant associations with VF‟s, with significant associations with 
17 VFs, most of which are negative associations. Group D was significantly associated 
with Pap elements with frequency of occurrence ranging between 35% - 54% compared 
to 16% - 27% in other groups (P ≤ 0.0001). 
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                       Bold values indicate significant associations ( P ≤0.05); whereas underline values indicates negative association
Category specific VF Total no. ST10 ST69 ST73 ST95 ST127 ST131
300 (no=13) (no=27) (no=49) (no=19) (no=9) (no=37)
papA 120 8 (1) 52 (14) 55 (27) 89 (17) 100 (9) 8 (3)
papC 127 0 (0) 52 (14) 57 (28) 100 (19) 100 (9) 5 (2)
papEF 129 8 (1) 70 (19) 55 (27) 84 (16) 100 (9) 8 (3)
papGII 84 0 (0) 44 (12) 41 (20) 84 (16) 11 (1) 5 (2)
papGIII 43 0 (0) 4 (1) 22 (11) 10 (2) 100 (9) 3 (1)
sfa/foc DE 95 0 (0) 4 (1) 84 (41) 10 (2) 77 (7) 0 (0)
afa/draBC 33 23 (3) 4 (1) 0 (0) 0 (0) 0 (0) 43 (16)
sfaS 23 0 (0) 0 (0) 8 (4) 10 (2) 55 (5) 0 (0)
focG 55 0 (0) 7 (2) 61 (30) 16 (3) 11 (1) 0 (0)
hlyA 78 8 (1) 0 (0) 69 (34) 5 (1) 67 (6) 8 (3)
cnf1 82 0 (0) 0 (0) 69 (34) 10 (2) 77 (7) 8 (3)
cvaC 28 8 (1) 4 (1) 0 (0) 42 (8) 0 (0) 0 (0)
fyuA 262 38 (5) 85 (23) 96 (47) 95 (18) 100 (9) 97 (36)
iutA 177 54 (7) 70 (19) 65 (32) 47 (9) 22 (2) 86 (32)
kpsM II 177 8 (1) 55 (15) 61 (30) 100 (19) 100 (9) 57 (21)
K1 53 0 (0) 7 (2) 4 (2) 100 (19) 0 (0) 3 (1)
K5 109 8 (1) 51 (14) 43 (21) 0 (0) 89 (8) 54 (20)
ibeA 32 0 (0) 0 (0) 0 (0) 10 (2) 0 (0) 24 (9)
traT 216 54 (7) 89 (24) 57 (28) 89 (17) 67 (6) 86 (32)
PAI 181 23 (3) 11 (3) 92 (45) 84 (16) 78 (7) 92 (34)
VF score 3.7,3(1-8) 7.8,9,(5-7) 11,11,(6-16) 11.8,12,(6-14) 13.4,13,(9-17) 6.9,6,4-14)
prevalence (no.) of VF by clonal group
adhesion
mean,median,(range)
capsule
siderophore
Toxins
Miscellaneous
Table ‎3.17 Distinctive virulence characteristics of common clonal groups among UPEC 
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Figure ‎3.20 Graphical representation of the correspondence analysis of UPEC associated virulence traits based on 
phylogenetic types. The F1/F2 plane accounted for 95% of total variance, with factors F1 and F2 accounting for 86% and 
9%, respectively. 
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Only three VFs (fyuA, ibeA and PAI) appeared to be significantly associated with group 
B2. Siderophore fyuA occurred in 100% of B2 isolates compared to 88% in group D, 12 
% in group A and 1.7% in group B1. Finally, although the marker gene for 
pathogenicity island (PAI) was detected in 60% of group D isolates, it was positively 
associated with group B2 with a frequency of 84% compared to 50% in other groups (P 
≤ 0.0001) (Table 3.18). However, no significant differences were observed in the 
incidence of any virulence factors between phylogenetic groups within STs clones 
(Table 3.19). 
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     Table ‎3.18 Distribution of VF genes in relation to phylogenetic group among UPEC isolates 
papAH papC papEF allele-II allele-III sfa/focDE focG bmaE hlyA cnfI fyuA kpsMT II kpsMT k1 kpsMT K5 ibeA cvaC PAI
(No.) (117) (124) (126) (81) (43) (92) (53) (11) (74) (78) (259) (173) (53) (108) (31) (28) (177)
A (36) 3 3 2 2 0 0 0 6 1 1 22 2 0 3 0 10 5
0.0001 0.0001 0.0001 0.0011 0.0042 0.0001 0.0008 0.0006 0.0004 0.0002 0.0001 0.0001 0.0008 0.0001 0.0351 0.0005 0.0001
B1 (11) 0 0 0 0 0 1 0 1 0 0 3 0 0 0 0 2 1
0.0082 0.0033 0.0031 0.0001 0.0008
B2 (78) 30 31 31 18 16 29 16 0 25 25 78 55 18 34 15 4 66
0.0001 0.0046 0.0001
D (175) 85 91 94 62 27 62 38 4 48 52 155 116 35 71 16 12 105
0.0001 0.0001 0.0001 0.0001 0.0042 0.0321P value
P value
P value
P value
VF
Phy. gp
 
      P values (by Fisher‟s exact test) shown only where P ≤ 0.05.  
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                Fisher‟s exact test indicated no significant association between virulence factors and different phylogenetic groups.
B2 (3) D (5) B2 (16) D (34) B2 (9) D (10) B2 (4) D (5) B2 (24) D (13)
papAH 2 4 6 21 8 9 4 5 3 0
papC 1 4 8 20 9 10 4 5 2 0
papEF 2 4 6 21 8 8 4 5 3 0
papG II,III 1 4 9 20 9 9 4 3 2 0
allele-II 1 3 6 14 7 9 1 0 2 0
allele-III 0 0 4 7 1 1 4 5 1 0
sfa/focDE 0 1 10 31 1 1 4 3 0 0
afa/draBC 0 0 0 0 0 0 0 0 10 6
nfaE 0 0 0 0 0 0 0 0 0 1
fimH 3 4 16 33 9 10 4 5 24 12
hlyA 1 3 11 23 1 0 2 4 3 0
cnfI 0 0 9 25 1 1 4 3 3 0
fyuA 3 4 16 31 9 9 4 5 24 12
iutA 1 4 12 20 5 4 1 1 22 10
kpsMT II 3 4 10 20 9 10 4 5 14 7
kpsMT k1 0 0 2 0 9 10 0 0 0 1
kpsMT K5 3 2 6 15 0 0 4 4 13 7
ibeA 1 0 0 0 1 1 0 0 6 3
cvaC 0 0 0 0 4 4 0 0 0 0
traT 2 3 9 19 8 9 3 3 19 13
PAI 3 4 15 30 7 9 2 5 22 12
ST127 ST131ST14 ST73 ST95
Table ‎3.19 Distribution of virulence factors associated with common STs according to phylogenetic groups B2 and D 
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3.13. Association between VFs and antibiotic susceptibility 
The relationship between antibiotic resistance and carriage of VFs was statistically 
examined and P values <0.005 used to indicate significant relationships. None of the 
adhesion related genes, such as Pap elements or S/F1C fimbriae genes, appeared to have 
a positive association with any antibiotic resistance traits. The aerobactin receptor gene 
(iutA) was positively associated with resistance to ampicillin and piperacillin as well as 
to nalidixic acid, ciprofloxacin and trimethoprim. The serum resistance gene (traT) on 
the other hand shows an association with ampicillin and piperacillin in addition to 
trimethoprim. Overall, correlation analysis reveals that resistance to advanced 
antibiotics such as third generation cephalosporins or fluoroquinolones is significantly 
associated with absence of virulence capacities starting with adhesion, as isolates 
resistant to those antibiotics are negatively associated with the presence of different 
adhesion related genes though iutA and traT remain appreciably prevalent (Table 3.20). 
3.14. Interrelation of metabolic, virulence and antibiogram profiles 
among UPEC 
To explore the interrelation between the three characteristics, Pearson‟s correlation 
coefficients were calculated for the three possible relationships that can be drawn from 
these characteristics using the aggregation score of each. The correlation coefficients 
ranged between (0.0459 – 0.1476) which indicate weak correlations despite the 
significant statistical differences (<0.0001, 0.001 and 0.005) observed for Bio-score vs. 
AST, VF vs. AST and VF vs. Bio-scores, respectively (Figure 3.23). 
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Table ‎3.20 Association of resistant to antibiotics and various VFs traits in UPEC 
isolates 
papAH papC papEF papG -III sfa/focDE sfaS afa/draBC hlyA cnfI iutA traT
(No.) (117) (124) (126) (43) (92) (23) (32) (74) (78) (173) (211)
AMP (166) 59 59 67 15 43 9 23 35 38 109 129
0.0046 0.0022 0.0022
AMC (68) 19 19 23 6 21 3 15 18 18 46 51
0.0013
PIP (162) 56 56 64 13 41 8 23 34 36 108 126
0.0009 0.0007 0.0024
CF (127) 35 38 38 10 31 7 18 27 28 79 93
0.0005 0.0006 0.0004
CXM (35) 6 6 7 3 4 2 7 3 5 23 25
0.0017
CTX (22) 2 2 3 1 1 1 6 1 2 16 17
0.0025 0.0012 0.0035
CAZ (22) 2 2 3 1 1 1 6 1 2 16 17
0.0025 0.0012 0.0035
FEP (22) 2 2 3 1 1 1 6 1 2 16 17
0.0025 0.0012 0.0035
ATM (22) 2 2 3 1 1 1 6 1 2 16 17
0.0025 0.0012 0.0035
NA (64) 15 17 21 1 5 0 14 6 5 52 51
0.0039 0.0004 0.0001 0.0024 0.0001 0.0001
CIP (33) 5 5 8 1 2 0 8 3 3 27 25
0.0024 0.0012 0.0005 0.0027
TRI (111) 32 35 38 5 18 2 22 13 15 83 91
0.0001 0.0001 0.0028 0.0002 0.0001 0.0001 0.0001 0.0007
P value
P value
P value
P value
P value
P value
P value
P value
Antibiotic
P value
P value
VFs
P value
P value
 
P values (by Fisher‟s exact test) shown only where P≤0.005. AMP:ampicillin; AMC: 
amoxicillin/clavuanic acid; PIP: piperacillin; CF: cefalotin; CXM: cefuroxime; CTX:  cefotaxime; CAZ: 
ceftazidime;  FEP: cefepime; ATM: aztreonam; NA: nalidixic acid;  CIP: ciprofloxacin; TRI: 
trimethoprim. 
 
Although no significant correlations were observed between metabolic scores and 
virulence score or resistance and antibiotic score, correlation between AST vs. Bio 
scores revealed an appreciable correlation that justified further investigation. 
Subsequent examination of the correlations among each ST revealed a weak but 
significant positive association between Bio-score and AST-score (P≤0.01) among 
ST131 isolates that could explain the correlation observed between Bio-score and AST-
score in the general population (Table 3.21).  
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Figure ‎3.21 Pearson‟s correlation coefficient for the three possible relationships 
that can be drawn from phenotype characteristics using the aggregation score of 
each. 
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                      P values (by Fisher‟s exact test) shown only where P≤0.05.  Bold indicates positive correlation
ST
Bio vs. VF Bio vs. AST AST vs. VF Bio vs. VF Bio vs. AST AST vs. VF Bio vs. VF Bio vs. AST AST vs. VF
ST10 0.0091 0.00 0.0352 ─ ─ ─ ─ ─ ─
ST14 0.1975 0.1123 0.1132 ─ ─ ─ ─ ─ ─
ST69 0.066 0.0041 0.01 ─ ─ ─ ─ ─ ─
ST73 0.0016 0.0018 0.0121 ─ ─ ─ ─ ─ ─
ST88 0.1837 0.0132 0.0366 ─ ─ ─ ─ ─ ─
ST95 0.2279 0.0325 0.0318 0.04 ─ ─ ─ ─ ─
ST127 0.267 0.1032 0.0559 ─ ─ ─ ─ ─ ─
ST131 0.025 0.3689 0.0579 ─ <0.0001 ─ ─ < 0.01 ─
ST405 0.0816 0.0608 0.1062 ─ ─ ─ ─ ─ ─
P value
statistical difference correlation significance
P valueR
2
Correlation coefficients 
Table ‎3.21 Correlation between different characteristics and different STs 
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3.15. Characterisation of the CTX-M-15 O25b ST131 clonal group and 
identification of factors predictive for this lineage.  
Phenotypic and genotypic screening of various traits and their distribution among 
different STs revealed significant associations between ST131 and many either 
metabolic or virulence factors, which raises the necessity for further examination of 
ST131 in particular. 
Of 24 isolates with an ESBL phenotype, 15 (62%) contained blaCTX-M alleles as 
demonstrated by PCR with the universal primers used (Figure 3.24). All of these 
isolates then yielded products of the expected size (approx. 415bp) with group 1-
specific primers (Figure 3.25). Thirteen of the 15 isolates typed as group 1 CTX-M 
were of ST131. 
 
 
Figure ‎3.22 PCR screening for universal CTX-M primers (M1 & M2) , 100bp ladder in 
first and last lane of each row, positive isolates generated a product at 554bp compared 
to control strains C1 & C2 (known CTX-M positive isolates). 
 
Chapter 3                                                                                   Results 
141 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎3.23 PCR screening for the group 1 CTX-M genes, 100bp ladder in first lane, 
positive isolates yielded a product at 415bp. 
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3.15.1. Prevalence of the CTX-M-15 O25b clone of ST131  
All of the 13 ST131 typed as CTX-M (group 1) contained CTX-M-15 as demonstrated 
by the specific primers used. Of these, the CTX-M-15 O25b clone accounted for 10 
isolates, which represents 29% of the total ST131 isolates (Figure 3.26). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎3.24 Multiplex PCR screening for O25b-ST131 clone producing CTX-M-15. 
100bp ladder in first and last lane of each row, positive isolates yielded products at 
500bp and 300bp 
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A nine-digit numerical code (three tests per digit) was generated using the results of 27 
biochemical tests. A total of 149 different profiles were detected, of which 19 were 
solely associated with ST131 isolates. Figure 3.27 shows the distribution of ST131 
biochemical profiles against profiles of other STs. Interestingly ST131 was divided into 
2 groups, susceptible and multidrug resistant, where multidrug resistant isolates and 
those of CTX-M-15 O25b were both significantly associated with high bio-score 
profiles. 
Cluster analysis of a simple matching coefficient based on the biochemical profiles was 
used to generate a dendrogram describing the association of ST131 and antibiogram 
profiles. This revealed a large ST131 cluster defined at 88% similarity level and 
comprised of 22 (60%) isolates that were characterised as having a multiple resistance 
antibiogram (Figure 3.28). 
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Figure ‎3.25 Distribution of metabolic profiles of ST131 isolates against other UPEC STs. ST131 displayed at the negative side of x axis (left of 
the black line crossing the x axis) were predominantly susceptible and those on the right side, resistant (as projected later by cluster analysis) 
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Figure ‎3.26 Biotype profiling of ST131 isolates, cluster analysis based on metabolic profiles. Codes above the column correspond to substrate code, 
predicted mechanism of resistance: B; β-lactam, A; aminoglycosides, Q; quinolones, F; furanes, T; trimethoprim, A.P acquired penicillinase, R; resistant, S; susceptible, 
PR; partial resistance (resistant to nalidixic acid only). 
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To investigate whether the observed distinctive characteristics of ST131 are general 
characteristics of the clone or they are only the result of O25b-CTX-M-15 ST131 
clonal spread, a comparison analysis of incidence of these characteristics in O25b-
CTX-M-15 ST131 and non-O25b-CTX-M-15 ST131 compared with non-ST131 
isolates was carried out. Although most of the characteristics are general characteristics 
of the ST131 clone, some biochemical traits were significantly associated with O25b-
CTX-M-15 ST131 such as TyrA, ILATK, PHOS, SUCT (P<0.005). Notably, other than 
resistance to fluoroquinolones, there were no significant differences in antibiotic 
resistance between non-O25b-CTX-M-15 ST131 and non-ST131 isolates (Table 3.22).  
However, statistical analysis of the distribution of different virulence factors according 
to quinolone and fluoroquinolone resistance among the ST131 clone showed that other 
than ibeA, which is significantly associated with susceptible isolates, no significant 
differences were observed in the incidence of other virulence factors (Table 3.23). 
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Table ‎3.22 Characteristics of E. coli ST131 isolates compared to non-ST131 isolates 
 
P values (by Fisher‟s exact test) are shown where P < 0.05 for virulence factors and phylogenetic groups 
and P < 0.005 for metabolic reactions and antibiotic resistant. 
O25b-CTX-M-15 Non-O25b-CTX-M-15 
(11) (26) (263)
BGAL 11 25 – 261 –
OFF 11 25 – 254 –
dMAL 10 26 – 246 –
ProA 4 9 – 15 0.0001
TyrA 11 13 0.0032 138 –
SAC 10 24 – 133 0.0001
dTAG 1 2 – 16 –
5KG 0 4 – 119 0.0001
ILATk 11 12 0.0022 97 0.0042
SUCT 10 10 0.0043 108 –
AGAL 11 22 – 175 0.0042
PHOS 7 1 0.0002 28 –
GlyA 2 1 – 4 –
ODC 10 25 – 192 0.0034
LDC 10 24 – 246 –
BGUR 7 20 – 248 0.0001
O129R 10 18 – 147 –
IMLTa 2 2 – 3 –
ILATa 2 1 – 0 0.0018
papAH 2 1 – 114 0.0001
papC 2 0 – 122 0.0001
papEF 2 1 – 123 0.0001
papG II,III 1 1 – 116 0.0001
allele-II 2 0 – 79 0.0007
allele-III 0 1 – 42 –
afa/draBC 5 11 – 16 0.0001
nfaE 0 1 – 0 –
fimH 11 25 – 257 –
hlyA 2 1 – 71 –
cnfI 2 1 – 75 0.0082
fyuA 11 25 – 223 –
iutA 11 21 – 141 0.0001
kpsMT II 4 17 – 152 –
kpsMT k1 0 1 – 52 0.0096
kpsMT K5 4 16 – 88 –
ibeA 0 9 0.0357 22 0.007
traT 9 23 – 179 –
PAI 11 23 – 143 0.0001
ESBL 10 2 0.0001 12 0.0001
aac(6) 8 5 0.0062 10 0.0001
Fluoroquinolone 10 9 0.003 15 0.0001
Furantoin 2 1 – 0 –
Trimethoprim 9 14 – 88 0.001
B2 7 17 – 53 0.0001
D 4 9 – 162 0.0039
P value
ST131 
P value Non-ST131
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Table ‎3.23 Distribution of VFs according to Quinolone and Fluoroquinolone 
susceptibility among the ST131 clone 
 
P values (by Fisher‟s exact test) are shown where P < 0.005; NS: not significant 
  
Q-R    (22) Q-S   (15) P  value FQ-R  (19) FQ-S  ( 18) P value
papAH 2 1 NS 2 1 NS
papC 2 0 NS 2 0 NS
papEF 2 1 NS 2 1 NS
papG II,III 1 1 NS 1 1 NS
allele-II 2 0 NS 2 0 NS
allele-III 0 1 NS 0 1 NS
sfa/focDE 0 0 NS 0 0 NS
afa/draBC 8 8 NS 6 10 NS
nfaE 0 1 NS 0 1 NS
fimH 22 14 NS 19 17 NS
hlyA 2 1 NS 2 1 NS
cnfI 2 1 NS 2 1 NS
fyuA 22 14 NS 19 17 NS
iutA 21 11 NS 19 13 NS
kpsMT II 9 12 NS 9 12 NS
kpsMT k1 1 0 NS 0 1 NS
kpsMT K5 9 11 NS 9 11 NS
ibeA 1 8 0.0012 0 9 0.0004
cvaC 0 0 NS 0 0 NS
traT 17 15 NS 14 18 NS
PAI 21 13 NS 18 16 NS
VF score 0.22 0.25 0.22 0.24
Quinolone and Fluoroquinolone susceptibility of ST131 isolates 
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3.15.2. Mechanisms of fluoroquinolone resistance in ST 131 UPEC 
Of the 37 tested ST131 isolates, 22 (57%) showed resistance to quinolones (nalidixic 
acid) from which 19 (90%) expressed additional resistance to fluoroquinolones 
(ciprofloxacin; Table 3.24). Among the quinolone resistant isolates, ESBL production 
was detected in 11 (58%) isolates. 
 
 
Table ‎3.24 Characterisation of quinolone resistance mechanisms found in ST 131 
UPEC isolates 
Q-S: quinolone susceptible; Q-R: resistant to quinolones alone; FQ-R: resistant to fluoroquinolones 
 
 
All ciprofloxacin resistant isolates had multiple mutations in both gyrA and parC genes, 
while the three nalidixic acid resistant isolates that failed to show resistance to 
ciprofloxacin all had single gyrA mutation at codon 83 (Ser—Leu).  
On the other hand only nine isolates carried the aac (6’)-lb-cr gene representing 47% of 
ciprofloxacin resistant isolates and 81% of the ciprofloxacin resistant ESBL producing 
isolates (Figures 3.29 and 3.30). Six of the nine aac (6)-lb-cr positive isolates that were 
resistant by mutation in both gyrA and parC belonged to the CTX-M15-O25b ST131 
clone. Of the 20 isolates tested, none carried any of the qnr genes. 
 
 
 
Quinolone 
profile 
(no) 
ESBL 
(%) 
QRDR 
aac(6')-lb-cr 
(%) 
qnr genes gyrA parC 
(S)83(L) 
(%) 
(D)87(N) 
(%) 
(S)80(N) 
(%) 
(E)84(V) 
(%) 
Q-S (15) 0 0 0 0 0 0 0 
Q-R (3) 0 3(100) 0 0 0 0 0 
FQ-R (19) 11(58) 19 (100) 19 (100) 19 (100) 19 (100) 9 (47) 0 
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Figure ‎3.27 PCR screening for the aac (6’)-lb gene100bp ladder in first lane of each 
row, positive isolates yielded a product at 520bp compared to control strains C1 & C2 
(known positives) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎3.28 RFLP digestion of 4 isolates positive to aac(6’)-lb native gene. 
Digestion with Ndel producing two fragments (453bp and 66bp) indicates 
modified variant aac(6’)-lb-cr, two positive controls were run in parallel with 
each RFLP digestion 
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N P Percentage Correct
N 255 4 98.46
P 16 21 56.76
93.24
CTX-M-15 O25b N 24 2 92.31
P 1 10 90.91
91.89Overall Percentage
CTX-M-15 O25b
1
st
 model
2
nd
 model
Overall Percentage
ST131
Observed ST131
Predicted
3.16. Multivariate logistic regression analysis 
Stepwise multivariate logistic regression analysis was used to identify independent 
biochemical test or antibiotic susceptibility or virulence traits as predictors of ST131 
and, among the ST131 clonal group, to predict the CTX-M-15/O25b sub-clonal group 
with P<0.05 considered to be the significance threshold.  
In the first model, resistance to fluoroquinolones was the strongest predictor of ST131 
(P<0.0001; OR 42) followed by carriage of three virulence factors PAI, ibeA, 
afa/draBC and finally lack of sfa/focDE, as shown in Table 3.25. The overall accuracy 
of this model to predict ST131 is 93% (positive predictive value 57%, negative 
predictive value 98.5%). 
In the second model, carriage of ESBL enzymes with (p<0.0001; OR 204) appeared to 
be the only predictor of CTX-M-15 producing O25b-ST131 strains (P= 0.0002; OR, 
120) within ST131. The overall accuracy of this model is 92% (positive predictive 
value 91%; negative predictive value 92%) 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
                 
 
 
 
 
 
                OR: odds ratio; CIP: resistance to ciprofloxacin; N: negative; P: positive.  
Lower Upper
CIP 0.0000 42.9 10.7 172.0
sfafocDE 0.9900 0.0 0.0 0.0
afadraBC 0.0001 13.3 3.7 48.1
ibeA 0.0003 11.8 3.1 44.3
PAI 0.0000 23.6 5.2 106.6
2
nd
 model ESBL 0.0002 120.0 9.7 1478.4
1
st 
model
Prediction factors
variables P value OR
95.0% C.I.for OR
Table ‎3.25 Factors predictive of ST131/O25b-ST131 as 
identified using multivariate logistic regression analysis 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                   Discussion                                                 
 
Chapter 4                                                                                Discussion 
152 
 
4. Discussion 
4.1. Multilocus sequence typing and phylogenetic analysis 
UPEC have long been recognised as distinct clones of E. coli, which exhibit specific 
characteristics such as virulence associated traits, distinctive O antigens, genotypes and 
multidrug resistance (Zhang et al. 2000). Molecular epidemiological studies have 
revealed a clonal structure characterising E. coli and clarifying the genetic linkages 
between different lineages (Goldberg, Gillespie & Singer 2006; Tartof et al. 2005).  
However, despite the increased use of MLST as a trusted epidemiological tool, the 
population structure of UPEC has been poorly studied using this technique, as most of 
the studies conducted were limited either by a bias towards certain characteristics, such 
as antimicrobial resistance and serogroup, or included a limited number of strains, 
which gave a false impression of overrepresentation of certain STs. 
The house keeping genes selected in any MLST scheme should ideally encode proteins 
that are under stabilising selection for conservation of metabolic function (Maiden 
2006).  Within the current study, for the scheme used, the ratios of non-synonymous 
(dn) to synonymous (ds) changes of all target genes were less than 1, which is normally 
taken to signify that the population is subject to stabilizing selection, validating their 
suitability as epidemiological markers. Although, dN/dS has been used widely to 
analyse MLST data derived from bacterial populations, recent reports suggested that it 
may be impossible to infer selective pressure from dN/dS obtained from a single 
population (Kryazhimskiy & Plotkin 2008; Rocha et al. 2006). 
However, the degree of sequence diversity within the housekeeping genes used in the 
current study was relatively high with polymorphic sites ranging from 5.0%-16.2%, 
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which agrees with various previous phylogenetic analyses of E. coli that show 
extensive allelic variation (Reid et al. 2000; Wirth et al. 2006). 
The global availability of MLST databases enables the characterization of bacterial 
populations on a much wider scale. MLST has been used to characterize different E. 
coli pathotypes (Adiri et al. 2003; Noller et al. 2003; Petersen et al. 2009; Tartof et al. 
2005). Although sequence type-pathotype associations do exist, allele distribution tells 
a different story with alleles shared by different STs and furthermore by different 
pathotypes (Wirth et al. 2006). In this study, although the majority of the identified 
UPEC associated alleles were found in both the ExPEC and EC databases, a degree of 
difference in prevalence was observed. The number of alleles with a significant 
difference in prevalence within the three groups was fewer when comparing the ExPEC 
database to the UPEC one (n=3), than in the comparison between EC and UPEC 
isolates (n=48). This was not unexpected given that UPEC are part of the ExPEC 
group. when three alleles that showed a significant difference in incidence between 
UPEC and ExPEC were compared, two showed a significant association with UPEC 
compared to ExPEC (fumC39, mdh17) and tracing these alleles to their possible STs 
showed an association with successful UPEC STs; fumC39 with ST10 and mdh17 with 
ST14, ST73 and ST95. Whether this finding holds any epidemiological significance 
towards understanding their success as UPEC will require further investigation. 
MLST analysis of the studied population revealed a consistent profile of STs that 
occurred repeatedly in the current collections. It consisted primarily of ST73 (16%) 
followed by ST131 (13.3%), ST69 (9%), ST95 (6.3%), ST10 (4.3%), ST127 (3.6%), 
ST14 (2.6%) and ST405 (1.6%). ST131 and ST69 (CGA) have previously been 
extensively reported for their role as antimicrobial resistant clones that spread 
universally (Johnson et al. 2009; Nicolas-Chanoine et al. 2008; Tartof et al. 2005) and 
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recent reports have associated ST 405 with the global spread of CTX-M-15 and other 
ESBL enzymes (Jones et al. 2008; Nicolas-Chanoine et al. 2008) and ST95 with avian 
pathogenic E. coli (Mora et al. 2009). ST73 was previously reported as an important 
and diverse clone within the ECOR group B2 and was associated with UPEC 
(Zdziarski et al. 2008) and formed the main clone detected in the present collection 
(16%). Other successful STs (ST127 and ST80) in the current panel have never been 
reported as remarkable pathogens. 
However, eBURST analysis of allelic profiles reinforces the status of ST73 and with its 
related STs it forms a large clonal complex that involves nine STs and accounts for 
20% of the studied population.  Spratt and colleagues suggested that the relative age of 
a CC can be estimated by how many SLVs it has and the presence of related subgroups 
(Feil et al. 2004). Using these criteria, ST73 is considered to be the oldest clonal 
complex in the population. Using the same characterisation, CC-ST405 and CC-ST69 
can be considered as relatively newly evolved clonal complexes. The failure to cluster 
with any other ST in the population and the formation of only conservative clonal 
complexes when expanding the analysis to involve other ExPEC and EPEC isolates in 
the MLST database indicates that ST131 and ST127 have also emerged as newly 
evolved STs. 
UPGMA analysis resolved the population into two large clusters, which correlates well 
with previously reported results using other molecular methods (Garcia-Martinez et al. 
1996). However, the evolutionary divergence provided by clonalframe analysis 
emphasised the clonal distribution generated by UPGMA analysis, suggesting a well 
defined structure within the E. coli population, rather than vague structures often 
generated by recombination sensitive phylogenetic methods such as the neighbour-
joining method (Jaureguy et al. 2008). Whether this clear-cut segregation within the 
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population reflected specific phenotypic characteristics of each cluster is not clearly 
established. Although no significant association between these clusters and biochemical 
characteristics was noted, similar to the situation mentioned in an earlier study (Garcia-
Martinez et al. 1996), significant correlations were detected between some phenotypic 
characteristics and frequently detected STs. The natural over representation of these 
STs within each cluster could explain the correlation reported in the earlier study 
(Garcia-Martinez et al. 1996). 
4.2. Pulse-field gel electrophoresis  
To ensure the absence of unrecognised localised point-source outbreaks that may lead 
to overrepresentation of specific clonal groups in the current isolate collection, the 
clonal background of representative isolates of the common STs were assessed using 
PFGE. The profile similarity threshold approximately corresponds to a specific number 
of band differences, which in turn may correspond to a specific number of genetic 
events (Avery et al. 2002). Choosing the threshold value that accurately identifies the 
similarity of isolates is an area of continuing disagreement. Some investigators consider 
that isolates differing by three or less bands should be regarded as related strains (Louie 
et al. 1999), whereas others suggest that those with three or more band differences in 
their PFGE profiles should be considered unique strains (Tenover et al. 1995). Using 
the published Tenover et al. guidelines (Louie et al. 1999; Tenover et al. 1995), in the 
current study strains were defined as having a clonal relationship if they possessed 85% 
or greater similarity, corresponding to the occurrence of a single genetic event. Of the 
nine tested isolates belonging to ST73, only two isolates exhibited similar PFGE 
profiles, while the 10 isolates of ST69 exhibited eight different PFGE profiles. This 
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diversity in PFGE profiles indicates the absence of overrepresentation of any clone as a 
result of focal outbreak. 
Although its primary function is to identify outbreaks involving a single clone, PFGE 
was able to cluster clonal groups. Each group exhibited a PFGE profile with similarity 
values between 60% and 65%, which is consistent with previous findings involving 
isolates of ST131, the O15:K52:H1 clonal group and CGA where PFGE was able to 
cluster isolates of each clonal group and their PFGE profile similarity values ranged 
between 66% to 74% (Johnson et al. 2009). 
Interestingly, despite the considerable similarity of PFGE profiles observed among 
isolates of ST131 included in the current study, remarkable genetic similarity was 
detected that defined Preston isolates within the ST131 clone, suggesting ongoing sub-
clonal evolution. This could either be due to abnormally slow accumulation of PFGE 
changes among the Preston ST131 isolates or abnormally rapid (point source-like) 
dissemination of the ST131 sub-clone, or both (Blackwood et al. 1997).  
4.3. Virulence profiling  
The ability of different strains of E. coli to cause different clinical syndrome is 
attributed to the cumulative impact of one or several key properties or virulence factors 
carried by these strains. For instance, carriage of genes for the K1 capsule allows 
evasion of neonatal host humoral immunity, whereas strains carrying genes for 
pyelonephritis associated pili (PAP) adhere well to urinary tract epithelial cells 
(Johnson 1991). 
Although previous urovirulence associated genotypic studies have been conducted 
mainly on bacteraemic UTI associated strains, the prevalence of virulence factors 
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screened in this study was in general agreement with reported findings (Johnson et al. 
2005d; Johnson & Stell 2000; Ramos et al. 2010).  
The high prevalence of fyuA observed among E. coli isolates confirms previously 
reported findings involving isolates collected from patients with cystitis, pyelonephritis 
and prostatitis and 50 isolates from the stools of healthy adults, among which fyuA was 
significantly more prevalent in disease causing isolates than among faecal control 
strains (Kanamaru et al. 2006a). The traT gene was also found to be considerably 
prevalent in the UPEC isolates in the current collection. Similar findings were 
previously reported, though the prevalence of traT in UPEC compared to faecal isolates 
was not always significant. Experimental evaluation of traT as a potent urovirulence 
associated VF, is needed (Johnson et al. 2005d; Moreno et al. 2008; Ramos et al. 
2010). 
Several genes associated with the acquisition and development of UTIs are encoded on 
gene blocks known as pathogenicity islands (PAIs) that provide a mechanism for 
combined horizontal transfer of VF genes (Oelschlaeger et al. 2002).  
The PAI investigated in the current study was previously identified within the 
chromosome of highly virulent uropathogenic E. coli CFT073 and appears to be found 
significantly more often in strains associated with UTI than in faecal strains (Kao et al. 
1997). The high prevalence of the PAI marker observed in this study is consistent with 
previous reports involving other clinical isolates (Guyer, Kao & Mobley 1998; Johnson 
& Stell 2000). 
The low prevalence or complete absence of some VF genes, for example cdtB, bmaE, 
gapfD and nfaE, suggested that production of the encoded proteins is not an important 
virulence property of UPEC strains. Although cytolethal toxin production associated 
the gene cdtB is primarily associated with enteric E. coli, previous report suggest an 
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association of cdtB with particular clones of bacteraemia associated E. coli (Johnson & 
Stell 2000). 
Among the adhesin genes, the pap gene family is normally found among strains 
causing UTI and these are significantly associated with pyelonephritis (Johnson 1991). 
Previous studies have reported that the prevalence of different pap genes ranged from 
50% up to 79% (Johnson et al. 2001; Leflon-Guibout et al. 2008). Notably, in the 
current study the prevalence of different pap genes was around 40%, which is relatively 
low and could be related to the increase in the prevalence of clones characterised by 
absence of pap genes, such as the ST131 clone in the UPEC population in the North 
West region of England.  
Association of specific characteristics with particular genomic backgrounds can be 
retained over the short term predominantly by vertical transmission (Jaureguy et al. 
2008). However the broad range of VF genes screened here allowed the generation of 
VF patterns that were significantly associated with different STs.  
In the ST73 clone, a major clone within the studied population, only half of the isolates 
were able to express P fimbriae, which are required for colonisation and invasion of the 
upper urinary tract. Generally, more than 80% of UPEC strains express P fimbriae and 
the proportion of strains that express P fimbriae varies considerably from a high of 70% 
among isolates from patients with pyelonephritis to 36% among cystitis isolates and 24 
% among those from asymptomatic bacteriuria (ABU) (Johnson 1991). 
 Interestingly, over 60% of the ST73 isolates expressed F1C fimbriae that mediate 
specific adherence to the collecting ducts and the distal tubules of the human kidney, as 
well as to renal tubulues cells (Antao, Wieler & Ewers 2009). This compares to 
previously reported figures of 14 to 30 % among general UPEC strains (Zdziarski et al. 
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2008), most of which were associated with pyelonephritis (Johnson et al. 2005d). 
Moreover, among the studied STs, F1C fimbriae were significantly associated with 
ST73 isolates, which suggests that F1C fimbriae may play an important role in the 
success of the ST73 clone.  
For the screened toxins, about 69% of the ST73 clone members carried genes encoding 
haemolysin (hlyA). All of these isolates simultaneously encode cytotoxic necrotizing 
factor type1 (CNF1). For general UPEC isolates, previous reports estimated prevalence 
of haemolysin production from as low as 20% among isolates from ABU patients to 
40% among isolates from cystitis patients and up to 50% among isolates from 
pyelonephritis patients (Johnson 1991; Kerenyi et al. 2005). Indeed, epidemiological 
studies have consistently shown that UPEC strains that make CNF1 also produce Hly 
(Antao et al. 2009). Moreover, Landraud et al. provided a genetic explanation for the 
association of CNF1 and Hly production by UPEC; they demonstrated that a cnf1 gene 
and an hly operon in the prototypic UPEC strain J96 are not only co-transcribed, but are 
also co-regulated (Landraud et al. 2003). 
The contribution of haemolysin and CNF1 production to urovirulence of ST73 is 
supported by the results of epidemiological studies associating the severity of UTIs 
with toxin production by UPEC isolates (Smith et al. 2008). 
Isolates of ST95 have frequently been described as Avian pathogenic E. coli (APEC) 
responsible for avian colibacillosis in domesticated and wild birds (Mora et al. 2009) 
and have also been reported to cause neonatal meningitis in human (Bert et al. 2010). 
In the current study, all ST95 isolates harboured the K1 capsular antigen. However, the 
association of ST95 with K1 capsular antigen strongly linked it to NMEC strains and 
pathogenicity.  
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Most ST95 clone members harboured P fimbriae and, to a lesser extent, other types of 
adhesins, which agreed with previous reports on ST95 isolates collected from patients 
with bacteraemia (Bert et al. 2010). Notably, over 40% of ST95 isolates harboured the 
cvaC gene, which encodes production of and resistance to colicin V and  has been 
associated with pyelonephritis (Johnson 1991). However, among the screened STs 
harbouring the cvaC gene, it appears to be significantly associated with ST95 in 
agreement with previous findings that show the cvaC gene exclusively occurred in 
ST95 isolates from bacteraemic patients (Bert et al. 2010). The unique virulence 
profiles associated with ST95, which consist of genes encoding significant adherence 
elements, production of cvaC and syntheses of capsule might explain its association 
with invasive UTIs and could explain its status as a successful UPEC clone. 
Only a few reports mention ST127, either as a UPEC (Lau et al. 2008b) or as ExPEC 
with zoonotic potential (Johnson et al. 2008). Johnson and colleagues, in their study of 
the virulence and phylogenetic background of serogroup O6 isolates from humans and 
animals, revealed a strong association of ST127 and serogroup O6 and most ST127 
isolates show a significant association with Pap elements especially papG allele III, S 
fimbriae and cytotoxin (cnf1) production (Johnson et al. 2008). 
In the current study, ST127 clone members showed great similarity in VF profiles to 
those reported previously. Moreover, all ST127 isolates harboured capsular antigen K5 
that provides a non-immunogenic shield protecting the bacteria. As a result, it is 
associated with E. coli causing serious invasive infections (Herias et al. 1997). 
Collectively, the VF associated with ST127 proposes a clone with potent virulence 
capabilities. ST127, which is suggested by phylogenetic analysis to be a newly evolved 
clone, holds the highest virulence score of all lineages in the current collection. This 
may permit its survival in the population long enough to gain antibiotic resistance. 
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Isolates of ST10 have frequently been identified among faecal isolates from healthy 
individuals and community acquired enterotoxigenic strains (Valverde et al. 2009), 
which could explain the lack of ExPEC virulence traits among ST10 clone members in 
the current study. 
The emergent clonal group ST69 corresponds to E. coli CGA, which has been 
associated with outbreaks of trimethoprim-sulfamethoxazole resistant isolates in 
different communities (Johnson et al. 2009; Manges et al. 2008; Tartof et al. 2005). 
ST69 has been also associated with bacteraemia of non-urinary tract origin (Manges et 
al. 2006) and community acquired pneumonia in a renal transplant recipient (Johnson 
& Russo 2002). However, VF profiles observed among the ST69 clone members in the 
current collection only showed lower UTI potential, as only half of the isolates 
possessed P fimbriae and almost lack any other adhesins or toxins associated with 
upper UTI. Most notably, compared to other STs isolates of ST69 were negatively 
associated with the PAI gene.  Similar results were reported by Johnson and colleagues 
where none of the CGA isolates harboured the pathogenic island marker (Johnson et al. 
2009). 
ST131 is best known for its association with production of ESBL resistance, especially 
the emergence of CTX-M-15 ESBL (Clermont et al. 2008; Coque et al. 2008; Lau et 
al. 2008a; Nicolas-Chanoine et al. 2008). As resistance comes at a cost to fitness, it is 
not surprising that the multidrug resistant ST131 clone is defined by a low virulence 
score and distinctive VF profiles that lack fimbrial adhesins, but significantly 
concentrated non-fimbrial adhesins of the Dr family and the gene encoding the invasion 
of brain endothelium phenotype (ibeA) that is responsible for neonatal meningitis in 
humans (Germon et al. 2005).  
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In general, ST131 VF profiles were consistent with those of organisms causing lower 
UTI and agreed with previous reports (Bert et al. 2010; Johnson et al. 2010b; Johnson 
et al. 2009). Although biofilm formation was not investigated in the current study, 
some of ST131 VFs may indicate potential biofilm production. Previous reports show 
some associations between biofilm-formation potential and some virulence-associated 
genes (Kanamaru et al. 2006b; Martinez-Medina et al. 2009; Ong et al. 2008). For 
example, the adhesin-coding gene sfa/focDE and the ibeA gene, required for invasion in 
meningitis/sepsis-associated E. coli (MNEC), were more frequently detected amongst 
biofilm producers. However, consistent with results presented here, several studies 
have suggested that multiply resistant strains are usually less virulent than susceptible 
strains (Houdouin et al. 2006; Johnson et al. 2003a; Moreno et al. 2006).  
The phylogenetic distribution of VFs and association of phylogenetic group B2 and D 
with extraintestinal infections are well established and results from the current study 
can be linked to these previous reports, strengthening the virulence status of B2 and D 
phylogenetic groups in UTIs (Moreno et al. 2009; Ramos et al. 2010). Despite the 
significant association of some virulence factors with different phylogenetic groups in 
the current study, the relationships were in general reflecting the association of 
virulence factors with over-represented STs among phylogenetic groups in the current 
strain collection, rather than the phylogenetic group itself. For instance, the high level 
of Pap elements detected among isolates of phylogenetic group D are in fact caused by 
the strong association of different Pap elements with ST73 and ST69. Additionally, 
within clones that consisted of isolates of different phylogenetic groups, the 
phylogenetic group assignment of an isolate did not affect its virulence profile. For 
example, no significant difference was observed in harbouring different Pap elements 
among ST73 isolates that belonged to phylogenetic group B2 or D. 
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 On the other hand, the significant differences in the prevalence of some VFs, such as 
fyuA and PAI, among phylogenetic groups B2 and D compared to groups A and B1, 
may provide evidence of the probable role of phylogenetic background in determining 
the virulence of a strain. Furthermore, Moreno et al. (2008), in a study of urovirulence 
characteristics of faecal E. coli, showed that both groups B2 and D tend to dominate 
faecal E. coli populations leading to low clonal diversity, suggesting the presence of 
shared specific bacterial factors that contribute to fitness within the intestine (Moreno 
et al. 2009). 
Since the theory that resistance comes at a cost to fitness was first proposed, several 
studies examining the relationship of antibiotic resistance with urovirulence potential 
have been published. Although they clearly show a significantly reduced prevalence of 
urovirulence genes among isolates resistant to quinolones and fluoroquinolones, the 
relationship of other antibiotic families such as trimethoprim/sulfamethoxazole, Beta-
lactams and extended spectrum cephalosporins with urovirulence traits is still under 
debate (Horcajada et al. 2005; Houdouin et al. 2006; Johnson et al. 2005b; Johnson et 
al. 2003b; Moreno et al. 2006).  
However, antibiotic resistant strains in the current study exhibited generally low 
virulence capability compared to susceptible strains and, consistent with previous 
findings (Moreno et al. 2006; Rijavec et al. 2008),  resistance to quinolones and 
fluoroquinolones was associated with reduced incidence of different  virulence traits. 
Significant associations were observed between quinolone resistance and low incidence 
of papAH, papG allele III, sfa/focDE and cnf1, which agrees with previous studies 
reporting quinolone resistant UPEC isolates having a lower prevalence of papGIII and 
hlyA (Starcic Erjavec et al. 2007), hylA and cnf1 (Horcajada et al. 2005; Moreno et al. 
2005) and papA, papGIII, sfa/focDE, hlyA and cnf1 (Moreno et al. 2006) than 
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susceptible isolates. Fluoroquinolone resistant isolates were significantly associated 
with a low incidence of papA and sfa/focDE in addition to papC, which strengthens 
previous findings (Horcajada et al. 2005; Johnson et al. 2005b; Moreno et al. 2006; 
Piatti et al. 2008). 
Several mechanisms have been proposed to explain this phenomenon. One proposal is 
that exposure to antibiotics may induce the loss of VFs. Soto et al. (2006) reported that 
UPEC strains exposed to sub-inhibitory concentrations of quinolones showed partial or 
total loss of PAIs containing VF genes (Soto, Jimenez de Anta & Vila 2006). However, 
Johnson et al. (2005) disagreed with the previous proposal and provided an alternative 
explanation, that the low level carriage of virulence determinants in quinolone and 
fluoroquinolone resistant E. coli clinical isolates was more likely due to the importation 
of resistant strains from an as-yet-undefined reservoir (for example, food animals) of 
isolates with low-virulence that are subjected to a high degree of selective pressure for 
development of resistance (Johnson et al. 2005a). 
The present study provides an additional dimension to the latter explanation; although 
fluoroquinolone resistance was significantly associated with ST131, isolates of this 
clone showed no significant difference in the prevalence of most virulence 
determinants between fluoroquinolone resistant and susceptible isolates. This may 
indicate that the low prevalence of virulence determinants in resistant strains is more 
related to the characteristics of the ST/lineage than the acquisition of fluoroquinolone 
resistance.  
Resistance to trimethoprim was associated with a reduced incidence of different 
virulence factors, including papG allele III, sfa/focDE, sfa/draBC, hlyA and cnf1, in 
keeping with the report of Moreno et al (Moreno et al. 2005), but not with some other 
reports (Houdouin et al. 2006; Johnson et al. 2005b; Vila et al. 2002). The virulence 
Chapter 4                                                                                Discussion 
165 
 
differences noted in the current study could be due to confounding effects of concurrent 
quinolone and fluoroquinolone resistance. 
On the other hand, it is worth noting that the quinolone, fluoroquinolone and 
trimethoprim resistant strains showed a high incidence of aerobactin (iutA) and serum 
resistance (traT) encoding genes, compared to susceptible strains. Although prevalence 
of aerobactin encoding genes were previously reported to be a s high as 91% (Rijavec 
et al. 2008) and 78% (Moreno et al. 2005), no significant differences were reported 
between resistant and susceptible strains in previous isolate collections. As iron 
acquisition systems are important VFs for bacterial passage to, and survival in, the 
bloodstream (Johnson & Stell 2000), the high level of aerobactin observed among 
resistant strains in the current study could be due to the over-representation of the 
ST131 clone, which has frequently been associated with bacteraemia. 
It was clear that the relationship between virulence properties and antibiotic resistance 
in E. coli, is a complex phenomenon that could be affected by the phylogenetic 
background and ST and reflecting their interplay. 
4.4. Metabolic profiling 
Metabolic reactions have been conventionally used for the classification of bacteria into 
families and species. Further subdivision of bacteria below species level into subgroups 
such as serotypes, phage types or biotypes is crucial for epidemiological investigations. 
However the usefulness of biochemical reactions as a typing system is greatly 
dependent on the variability of these markers within the species and the reproducibility 
and discriminative power of the biochemical tests used (Katouli, Kuhn & Mollby 
1990). Kuhn (1985) developed a biochemical typing method in which the kinetics of 
several biochemical reactions creates a distinctive fingerprint for bacterial strains under 
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investigation (Kuhn 1985). Recent advances in biochemical testing involving 
automated systems have overcome the low reproducibility of conventional biochemical 
tests. Additionally, in epidemiological investigations, biotyping systems are often 
coupled with different typing methods to improve their discriminative power (Katouli 
et al. 1990). The VITEK 2.0 compact system was used in the current study, as previous 
evaluation studies proved that the VITEK 2.0 compact system, through its newly 
developed fluorescence based technology, generates reliable and reproducible results, 
in addition to being less time and labour consuming (Funke et al. 1998; Gavin et al. 
2002).  
Uropathogenic isolates show similar biochemical profiles to those of the general E. coli 
population with one exception; α-galactosidase was observed in 69% of the UPEC 
isolates compared to 99% of the general E. coli population, as reported by other groups 
(Ewing 1986; Farmer et al. 1985; Leclercq et al. 2001). The reason for the discrepancy 
between the relatively low incidence of α-galactosidase among UPEC reported in the 
current study compared to the almost 100% incidence among general E. coli 
populations is not clear. However, the environment from which the E. coli strains were 
collected could play a role in the metabolic activity expressed by E. coli. Urine with its 
low pH and low glucose concentration could present a different environmental selective 
pressure on genes involved in metabolic activity. In this case transcription of the melA 
gene encoding α-galactosidase production is controlled by the cAMP-CRP regulatory 
circuit, where the presence or absence of glucose determines the concentration of 
cAMP-CRP that in turn activates expression of the melA gene (Liljestrom & Liljestrom 
1987). 
 
Some inferences could also be drawn regarding the correlation between biochemical 
tests with STs. Most of the significant correlations were confined to three types of 
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metabolic reactions: peptidase (proline and tyrosine arylamidase); decarboxylase 
(ornithine and lysine decarboxylase); and alkalinisation (L-lactate and succinate). 
Proline and tyrosine arylamidase are specific peptidase enzymes that hydrolysis proline 
and tyrosine rich proteins (Fukasawa et al. 1982). Similarly ornithine and lysine 
decarboxylase are also involved in protein metabolism.  
The other metabolic reactions such as alkalinisation of lactate and succinate observed 
with an elevated incidence could be related to bacterial efforts to relieve acid stress 
exerted by amino acid metabolism. In a study of fitness of E. coli during UTI, Alter et 
al. found, by examining expression of UPEC cytoplasmic protein during growth in 
human urine, that E. coli scavenges amino acids and peptides and that disruption of 
peptide import in UPEC significantly compromised fitness during infection. This 
suggested that short peptides taken up by UPEC are degraded to amino acids that are 
catabolised and used as intermediates for the TCA cycle and a substrate for the 
gluconeogenesis pathway (Alteri, Smith & Mobley 2009). 
Although, little is known about the contribution of bacterial metabolic activity to 
pathogenesis, several reports have shown that certain metabolic enzymes may play a 
role to enhance virulence of several microorganisms (Pancholi & Chhatwal 2003).  
Recent studies showed that the ability of UPEC to catabolise the amino acid D-serine 
during UTI not only supports bacterial growth but also acts as a signalling mechanism 
to trigger virulence gene expression (Anfora et al. 2007; Roesch et al. 2003). 
Interestingly, in the assessment of the metabolic activity of different STs, the ST131 
clone members showed a high metabolic capacity compared to other STs, which may 
compensate for the low virulence capacity and explain the virulence reported for 
members of this ST. In contrast ST127, showed the lowest metabolic capacity but held 
the highest VF-score among the commonly detected STs. 
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Reconsidering the metabolic activity as an indicator of bacterial fitness and an 
important factor in the pathogenesis of UPEC led to exploration of its interplay with 
virulence score and antibiotic resistance score. Although no significant association was 
observed between the three characteristics in general UPEC, re-examining the 
correlation at ST level revealed an appreciable negative correlation between metabolic 
score and the antibiotic resistance score of members of the ST131 clone. 
The remarkable association of ST131 with several biochemical tests observed in the 
current study revealed distinctive biochemical profiles. Moreover, in cluster analysis 
based on biochemical profiles over half of the ST131 isolates shared 70% similarity, 
forming a single large cluster that was characterised by multiple antibiotic resistance 
profiles, compared to the rest of the ST131 isolates. This suggests ongoing subclonal 
spread of ST131. The association of clonal groups to specific biochemical profiles was 
previously reported for the O157:H7 clone (Leclercq et al. 2001) and the O15:K52:H1 
and O25:K4 ST131 clones (Cagnacci et al. 2008), using API 20E tests. 
Although, sequence types such ST73 and ST69 shows only few significant associations 
with individual biochemical tests, each ST tended to form a few small clusters 
indicating association with a small number of distinctive biochemical profiles, with no 
significant association to antibiotic resistance. 
4.5. Antibiogram profiling 
Analysis of antimicrobial resistance patterns revealed high-level resistance to β-lactam 
antibiotics in 55% of the tested isolates and over 38% were resistant to trimethoprim, 
followed by the quinolones, which collectively accounted for 15% of the isolates. 
These results were expected as they are commonly used first line antibiotics for the 
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treatment of UTI and they agree with those reported following Health Protection 
Agency surveillance (Johnson 2005). 
The observed low prevalence of antibiotic resistant isolates among the Preston 
collection compared isolates from Manchester was expected as the Preston collection 
largely consisted of isolates collected from patients with community acquired UTI, 
where antibiotic resistance is less common.  
Evidence of an association between E. coli clones and certain antibiotic resistance 
patterns has been previously reported.  In an intercontinental study Nicolas-Chanoine et 
al (2008) described broad dissemination of the CTX-M15 clonal group with MLST 
profile ST131 that exhibited multiple antibiotic resistances including to ciprofloxacin 
(95%) and co-trimoxazole (50%) (Nicolas-Chanoine et al. 2008). Similarly, after 
examining 43 CTX-M-15 producing E. coli from different countries, Coque and 
colleagues (2008) showed that clonal complexes ST131 and ST405 widely associated 
with the CTX-M-15 enzyme (Coque et al. 2008). Consistent with the strong correlation 
between ST131 and resistance to ciprofloxacin and trimethoprim found in the previous 
studies, the ST131 clone reported in the current study was characterised by multiple 
antibiotic resistance patterns and showed a significant association with all antibiotic 
families tested.  
The significant association of ST131 with multiple resistance profiles has been 
previously reported (Coque et al. 2008; Lau et al. 2008a). In the latter of these studies 
isolates, were collected from the same area covered in the current study and findings 
suggests that it is a result of co-selection of resistance determinants as a result of pre-
exposure to antibiotic treatment.  
The worldwide CGA isolates characteristically exhibit multidrug resistance and are 
greatly associated with resistance to co-trimoxazole. In 2005, Tartof  et al. significantly 
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associated CGA isolates with ST69, which could explain the high level of resistance to 
trimethoprim among ST69 isolates tested in the current study (Tartof et al. 2005). 
 
In the present study, the ST clones were compared against patient demographic data, 
and the main correlation was seen for isolates of ST69 showed a significant association 
with recovery from females. Although it was first reported among women (Johnson et 
al. 2002), CGA association to certain gender groups is not well established (Johnson et 
al. 2005c). 
Similarly ST131 was previously recovered from hospital patients as well as from the 
community (Peirano & Pitout 2010). The high prevalence of ST131 among community 
acquired infection group reported in the current study could be related to the previously 
reported dissemination of the ST131 community onset UPEC clone (Nicolas-Chanoine 
et al. 2008).  
This correlation between phenotypic characteristics and STs gives rise to the question 
of how much horizontal transfer contributes to the evolution of these clusters. 
Generally, the extent and the significance of recombination in bacterial populations has 
always been a matter of debate (Feil et al. 2001). In some studies, the high levels of 
linkage disequilibrium between alleles and the existence of a clonal population 
structure, suggest that recombination rarely occurs in house keeping genes (Feil et al. 
2001; Perez-Losada et al. 2006), while others propose a relative contribution of 
recombination to clonal diversification (Lacher et al. 2007). Results from the current 
study suggest an early role of recombination in the diversity of E. coli populations, 
whereas recurrent mutations are responsible for the diversity within clonal groups.  
In contrast, the mosaic structure observed when phylogenetic groups were assigned to 
different isolates indicates a much more complex population, in congruence with 
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previous study (Wirth et al. 2006) that revealed the presence of hybrid groups within 
the ABD lineage classification system. Data recorded here shows that 10 STs 
accounting for 46% of the studied population, consisted of mixed phylogenetic groups, 
which could indicate recent genetic exchange of phylogenetic group markers between 
STs.  
4.6. ST131 and CTX-M-15 producing O25b ST131 subclone 
Compared to other successful STs, the ST131 clone always displayed distinctive 
phenotypic and genotypic characteristics that set it apart from other STs. ST131 
accounts for 12% of the total UPEC, 50% of ESBL producing isolates and 79% of 
fluoroquinolone resistant isolates. Similar high prevalence values were previously 
reported (Johnson et al. 2010a) suggesting ongoing spread of ST131 as a major 
multidrug resistant extraintestinal pathogen. 
However, recent dissemination of ST131 lineage isolates associated with CTX-M-15 
and serogroup O25 has been widely reported (Coque et al. 2008; Nicolas-Chanoine et 
al. 2008; Yumuk et al. 2008). These isolates are usually fluoroquinolone resistant and 
unlike most historical antimicrobial resistant strains, this clone derives from the most 
virulent phylogenetic group B2 (Blanco et al. 2009). Analysis of ST131 isolates in the 
current collection revealed that CTX-M-15 producing O25b ST131 subclone accounted 
for 11 (30%) of the total ST131 isolates.  
Several factors may play a role in the success of the ST131 clone; Peirano and Pitout 
(2010) suggest a combination of phylogenetic group B2 and certain virulence factors 
and fluoroquinolone resistance as important factors in the success of the ST131 clone in 
causing UTI, whereas the acquisition of CTX-M-15 carrying plasmids have facilitated 
the rapid global spread of the clone (Peirano & Pitout).  
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Although, ST131 isolates in the present study were significantly more likely to be from 
group B2 than non-ST131 isolates, they did not exhibit the classical virulence traits 
associated with phylogenetic group B2, such as P and S adhesins, Hly and CNF1 toxins 
and K1 invasive antigen, which is in agreement with similar findings (Blanco et al. 
2009; Clermont et al. 2008). 
In the current study, much of the virulence potential of ST131 isolates was due to a few 
virulence traits that may not explain their success as ExPEC. Johnson et al. (2010) 
suggest that undefined group B2 associated factors provide fitness advantages to 
ST131, independent of its virulence traits (Johnson et al. 2010a). However, there was 
no significant difference in phylogenetic background between the successful O25b-
CTX-M-15 clone and the rest of the ST131 isolates.  
On the other hand, apart from resistance to fluoroquinolones, most of the significant 
associations of ST131 with antibiotic resistance were largely caused by the O25b-CTX-
M-15 subclone. CTX-M–encoding genes are usually carried by closely related IncFII 
plasmids embedded in class 1 integron containing additional resistance genes 
conferring resistance to β-lactams, fluoroquinolones, aminoglycosides, and 
trimethoprim-sulfamethoxazole (Peirano & Pitout 2010). 
The identification of IncF plasmids carrying the FII and FIA replicons and association 
with the blaCTX-M-15 gene was demonstrated in O25-ST131 in the UK and other 
countries (Coque et al. 2008; Karisik et al. 2006) and Woodford et al. (2009) 
sequenced IncFII plasmids carried by an isolate of the CTX-M ESBL producing ST131 
clone demonstrating that the IncFII plasmids harbouring blaCTX-M-15, blaOXA-1, tetA, 
aac(6‟)-lb-cr and aac(3)-II have played a key role in the rapid spread of CTX-M-15 β-
lactamases in E. coli (Woodford et al. 2009). These plasmids might carry important, 
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but still unknown, VFs that have supported the spread of the epidemic clone O25b:H4-
ST131 (Blanco et al. 2009). 
Moreover, the exclusive association of aac(6’)-lb-cr with ESBL producing 
ciprofloxacin resistant E. coli observed in the current study, strongly supports the role 
of plasmids in the resistance capacities of ST131 isolates. However, the high level of 
fluoroquinolone resistance among non-O25b-CTX-M-15-ST131 isolates suggests the 
involvement of a different mechanism. Interestingly, all fluoroquinolone resistant 
ST131 isolates showed multiple mutations in both gyrA and parC genes, a pattern of 
mutation frequently reported (Drlica & Zhao 1997; Jacoby 2005) and associated with 
high-level fluoroquinolone resistance. Thus, it appears that resistance to 
fluoroquinolones in ST131 is due to mutations of the chromosomal targets of these 
drugs, as opposed to acquisition of plasmid mediated resistance determinants. As 
recently demonstrated by (Cerquetti et al. 2010). 
The high prevalence of isolates of the ST131 clone among fluoroquinolone resistant E. 
coli (Cerquetti et al. 2010; Uchida et al. 2010) and the acquisition of β-lactamase 
enzymes other than CTX-M-15 by ST131 in different geographical regions, suggested 
that spread of ST131 E. coli as a clone precedes the acquisition of antibiotic resistance 
(Cerquetti et al. 2010), which was supported by the prevalence of antibiotic susceptible 
ST131 reported in the current study. Although previous reports suggested that the 
strong linkage between this clone and quinolone resistance could be promoted by the 
high prevalence of aac(6)-lb-cr among isolates of this clone (Jones et al. 2008), the 
fluoroquinolone resistance reported in the current study occurs in ST131 UPEC as a 
result of accumulated point mutations in both gyrA and parC genes despite their 
acquisition of any plasmid mediated resistance. 
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The multiple antibiotic resistance that characterised ST131 can not completely explain 
the success of the clone as an ExPEC, especially with its lack of ExPEC key virulence 
capabilities. The introduction of bacterial metabolism as an important factor in the 
pathogenesis process provides new perspectives in understanding the basis of bacterial 
pathogenesis (Le Bouguenec & Schouler 2010). 
The high aggregative bio-scores among ST131 isolates compared to other commonly 
detected clonal groups and the association of the O25b-CTX-M-15-ST131 clone with 
distinctive biochemical profiles that share 88% similarity, suggested that biochemical 
capabilities could play an important role in the success of ST131 as an ExPEC clone by 
facilitating the adaptation of strains to their host environment by modifying catabolic 
pathways, and taking advantage of available nutrients present in the urine such as 
amino acids and small peptides. This may subsequently promote colonisation of the 
host and increase the pathogenic potential of the bacteria(Le Bouguenec & Schouler 
2010). 
The main conclusion of these previous investigations is that the ST131 clonal group in 
general, and O25b-ST131 CTX-M-15 producing strains in particular, exhibit unique 
characteristics and that no single factor is responsible for their success as ExPEC. 
Multivariate logistic regression analysis was used to determine which factors 
collectively most likely describe the ST131 clone and the O25b-CTX-M-15 ST131 sub-
clone. In the first model, ST131 is best described by its fluoroquinolone resistance and 
possession of PAI, ibeA, and Dr antigen-specific adhesins, whereas in the second 
model, the O25b-CTX-M-15 ST131 sub-clone was only differentiated from the rest of 
ST131 clone members by the production of an ESBL enzyme. 
The report by Diard et al. (2010) that ExPEC PAIs play an important role in intestinal 
colonisation (Diard et al. 2010) and demonstration by Moreno et al. (2009) that both 
Chapter 4                                                                                Discussion 
175 
 
groups B2 and D tend to dominate faecal E. coli populations prior to extraintestinal 
infections, suggest the presence of shared specific bacterial factors that contribute to 
fitness within the intestine (Moreno et al. 2009). All these observations in addition to 
the detection of E. coli belong to the ST131 clone in the faeces of healthy individuals 
(Leflon-Guibout et al. 2008) indicate that ST131 isolates colonise the intestine were 
they compete with and dominate the faecal E. coli population increasing the chance of 
transmission to the urinary tract. On the other hand, Diard et al. (2010) showed that 
PAIs diminish fitness of their carrier during growth in urine (Diard et al. 2010). 
However, maintenance of fitness requires many properties, among which metabolic 
competence is of the utmost importance as is resistance to different stresses or urine 
flow, such as through biofilm formation. Although biofilm formation was not examined 
in the current study, some observation, such as the association of ST131 with the ibeA 
gene and the high incidence among catheterised patients suggest that biofilm could 
facilitate ST131 colonisation. The fact that the O25b-CTX-M-15 ST131 sub-clone was 
only differentiate from the rest of ST131 clone by its acquisition of CTX-M-15 ESBL 
enzyme indicates it‟s recent diversion from the main clone. 
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4.7. Summary  
In conclusion, the use of MLST to characterise the UPEC population circulating in the 
North West region of England between June 2007 and June 2009, has proven to be a 
powerful epidemiological tool that has significantly contributed to our understanding of 
the various phylogenetic and phenotypic characteristics, previously associated with 
UPEC strains. 
The first part of the current study described the population structure of a defined UPEC 
population, based on MLST and phylogenetic analysis and the facilitated their 
distribution into phylogenetic groups and clonal groups in an unbiased way. The 
findings of this part of the current study can be summarised as follows:  
 
 The findings contradict the results of studies using other, lower resolution, 
methods that tend to mask the real correlations between strains in the population 
by over representation of certain clones in a group. 
 A consistent profile of STs repeatedly appeared in the population over an 
extended time period. 
 ST73 was the most commonly detected lineage, followed by ST131 and 
eBURST analysis of allelic profiles reinforced the status of ST73 in the 
population and identified it as the founder of the largest CC. 
 Phylogenetic analysis in current study provided evidence that ST131 and ST127 
have emerged as newly evolved STs. 
  PFGE profiles observed among isolates of ST131 included in the current study 
suggest that sub-clonal evolution has already taken place, as demonstrated by a 
sub-cluster of ST131 isolates collected in Preston. 
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 Although many of the detected STs were previously been reported, other 
successful STs such ST127 and ST80 presented in this study have never been 
reported as remarkable pathogens. 
 
The second part of the study determined the metabolic and the virulence capacity of the 
UPEC population, in addition to their antibiotic resistance profiles, using different 
phenotypic and genotypic methods and analysed the prevalence of these traits in 
relation to the defined ST clones. Several correlations were identified between the 
successful STs and key traits and these patterns could help to explain why isolates from 
certain STs are successful ExPEC clones. 
 
 Despite a low metabolic capacity, ST127, which was suggested by phylogenetic 
analysis to be a newly evolved clone, holds the highest virulence score of all 
lineages in the current collection. This may permit survival of ST127 isolates in 
the population long enough for them to gain antibiotic resistance markers. 
 As resistance comes at a cost to fitness, it is not surprising that the multidrug 
resistant ST131 clone was defined by a low virulence score and distinctive VF 
profiles lacking fimbrial adhesins. This, however, was balanced by significant 
concentration of non-fimbrial adhesins of the Dr family and the gene encoding 
the invasion of brain endothelium phenotype (ibeA) that is responsible for 
neonatal meningitis in humans. 
 ST131 revealed distinctive biochemical profiles and was characterised by a high 
metabolic capacity compared to other STs, which may compensate for the low 
virulence capacity and explain the fitness for causing infection reported for 
members of this ST. 
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The third part of the study concentrated on analysing characteristics of members of the 
ST131 clone and assessment of the importance of all of the phenotypic and genotypic 
characteristics that showed a significant association with ST131 isolates. This was 
carried out to determine the possible role in the success of the isolates from the ST131 
clone and the O25b-CTX-M-15 ST131 sub-clone as pathogenic ExPEC strains. 
 
 The introduction of bacterial metabolism as an important factor in the 
pathogenesis process provided a new perspective on understanding the success 
of ST131 by facilitating the adaptation of strains to their host environment using 
modified catabolic pathways, allowing isolates to take advantage of available 
nutrients present in the urine, such as amino acids and small peptides. 
 ST131 is best described by its fluoroquinolone resistance and possession of 
PAI, ibeA, and Dr antigen-specific adhesins, whereas the O25b-CTX-M-15 
ST131 sub-clone was only differentiated from the rest of the ST131 clone 
members by the production of an ESBL enzyme. 
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4.8. Additional further work  
 
In addition to the points mentioned above, further analyses may increase the impact of 
the work described in this thesis. It would be useful to study the association of different 
STs to typing using other phenotypic techniques such as serotyping, as this may lead to 
a better understanding of the phylogeny of UPEC. 
The high metabolic capacity associated with ST131 in the absence of any clear 
virulence advantage over other STs gives rise to the question of the contribution of 
bacterial metabolic activity to ST131 pathogenesis. Further studies are warranted 
involving screening for expression of genes involved in metabolic activity associated 
with increased virulence of UPEC isolates. This could be carried out using techniques 
such as microarray or „RNAseq‟. During such experiments, tested isolates should be 
grown in conditions similar to that experienced by UPEC during urinary tract infection 
so RNA would be extracted from isolates used in animal models of infection and 
following growth in urine.  
It would be useful to further study some of the other STs, such as ST73, to fully 
understand its virulence potential and factors associated with its domination of the 
UPEC population. This may contribute to a better understanding of the potential for 
emergence of other STs such as may be the case ST127, which could be a significant 
future UPEC lineage. 
Inclusion of more clinical data associated with isolates presented in this study could 
have provided a deeper insight in to the pathogenesis of each ST. 
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